≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback

Hypoplasia of dental enamel , including avohilmo

EFO Endpoint Browser PheWeb

K11_HYPOPLASIA_ENAMEL_INCLAVO

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519870

1. Apply sex-specific rule

None

519870

2. Check conditions

None

519870

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Primary healthcare outpatient: ICD-10 — K00.40
  • Hospital discharge: ICD-10 — K00.40
  • Cause of death: ICD-10 — K00.40

3 out of 7 registries used, show all original rules.

1542

4. Check minimum number of events

None

1542

5. Include endpoints

None

1542

6. Filter based on genotype QC (FinnGen only)

1436

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze
DF7

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 24724 13480 11211
Only index persons 17689 9945 7744
Unadjusted period prevalence (%)
Whole population 0.35 0.39 0.31
Only index persons 0.33 0.37 0.30
Median age at first event (years)
Whole population 11.17 11.64 10.55
Only index persons 13.49 14.09 12.72

-FinnGen-

Key figures

All Female Male
Number of individuals 1436 995 441
Unadjusted period prevalence (%) 0.31 0.35 0.20
Median age at first event (years) 24.22 27.60 16.60

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
1542
Matched controls
14814
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
K00.40
ICD-10 Finland
Postnatal enamel hypoplasia
+∞
307.7
1542
*
K02.0
ICD-10 Finland
Caries limited to enamel
4.1
159.2
982
4408
127
Kela drug reimbursment
Transplant complication
16.6
153.1
135
85
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
14.0
150.2
146
110
L04AD02
ATC
tacrolimus; systemic
18.2
134.8
113
64
Z94.0
ICD-10 Finland
Kidney transplant status
21.1
131.6
103
50
K00.41
ICD-10 Finland
Prenatal enamel hypoplasia
28.5
113.4
79
28
H02AB09
ATC
hydrocortisone; systemic
7.2
113.1
182
270
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
17.2
108.4
93
55
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
29.1
108.4
75
26
A11CC03
ATC
alfacalcidol; systemic
12.7
107.1
109
88
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
8.6
104.3
142
173
B03XA01
ATC
erythropoietin; parenteral
46.9
100.3
61
13
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
23.8
95.6
71
30
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
17.6
94.4
80
46
137
Kela drug reimbursment
Uraemia requiring dialysis
25.4
91.2
66
26
A12AA04
ATC
calcium carbonate; oral
18.8
89.1
73
39
K03.00
ICD-10 Finland
Approximal wear
4.3
87.8
265
688
XF602
NOMESCO Finland
Bloodpressure monitoring
13.8
85.2
82
60
K06.18
ICD-10 Finland
Another gingival hyperplasia
20.7
84.0
66
32
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
4.9
83.1
201
437
K00.50
ICD-10 Finland
Dentinal dysplasia
15.4
79.6
72
47
KAC00
NOMESCO Finland
Nephrectomy
38.2
78.3
50
13
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
5.9
76.7
148
262
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
4.4
72.0
198
476
B05DA
ATC
Isotonic solutions
25.3
70.4
51
20
L04AD01
ATC
ciclosporin; systemic
8.2
70.0
97
120
L04AA06
ATC
mycophenolic acid; systemic
9.0
69.4
89
100
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
7.6
68.7
102
137
L04AX01
ATC
azathioprine; systemic
5.6
68.1
139
259
5AB14, ,
NOMESCO Finland
36.2
67.9
44
12
Z99.2
ICD-10 Finland
Dependence on renal dialysis
38.6
67.5
43
11
ZYB02
NOMESCO Finland
Outreach service at unit of another specialty
11.3
66.3
72
64
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
19.8
65.2
52
26
TJA35
NOMESCO Finland
Removal of peritoneal dialysis catheter
26.8
64.8
46
17
Z49.2
ICD-10 Finland
Other dialysis
26.8
64.8
46
17
N18.8
ICD-10 Finland
Other chronic renal failure
14.7
63.8
59
40
K03.64
ICD-10 Finland
Dental calculus supragingival
2.4
62.3
885
5279
Z49.1
ICD-10 Finland
Extracorporeal dialysis
23.9
62.2
46
19
K03.66
ICD-10 Finland
Tooth plaque
2.9
61.9
352
1353
JAK10
NOMESCO Finland
Laparotomy and insertion of peritoneal dialysis catheter
22.1
61.7
47
21
K06.19
ICD-10 Finland
Gingival hyperplasia UNS
17.2
61.0
52
30
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
4.8
60.0
145
313
ZX199
NOMESCO Finland
Other rote
15.5
59.0
53
34
Z94.4
ICD-10 Finland
Liver transplant status
21.7
57.3
44
20
L04AA01
ATC
[U] ciclosporin
15.2
57.3
52
34
Z2221
NOMESCO Finland
Medical doctor
2.4
56.1
534
2636
EBA15
NOMESCO Finland
Extraction of multiple teeth
5.8
55.8
108
191
TK800
NOMESCO Finland
Hemodialysis
12.7
55.6
56
44
602
Kela drug reimbursment
Children's severe malnutrition
5.6
55.5
112
206
Z3226
NOMESCO Finland
Physiotherapist
2.6
54.4
412
1824
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
8.5
52.7
70
82
Z01.2
ICD-10 Finland
Dental examination
2.4
51.6
1123
7778
V03AG01
ATC
sodium cellulose phosphate; systemic
14.4
51.4
48
33
Z2446
NOMESCO Finland
Social worker
2.8
50.0
297
1158
B05DB
ATC
Hypertonic solutions
22.0
49.7
38
17
ZX120
NOMESCO Finland
Intravenous
3.6
49.3
181
531
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.4
45.4
421
2024
SAA02
NOMESCO Finland
Basic examination of mouth
4.2
44.8
1448
11668
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
4.1
42.5
125
313
EB1SA, ,
SPAT
3.2
42.5
187
613
N04.80
ICD-10 Finland
Congenital nephrotic syndrome of the Finnish type
212.3
41.4
43
*
H02AB04
ATC
methylprednisolone; systemic
3.2
41.1
176
567
R4110
NOMESCO Finland
Physiotherapy
2.2
40.4
452
2335
RD210, ,
NOMESCO Finland
3.6
39.1
136
383
WX882
NOMESCO Finland
High dependency care
3.2
39.0
166
532
SDA04
NOMESCO Finland
Demanding periodontal treatment
2.1
38.8
510
2800
B03XA02
ATC
darbepoetin alfa; parenteral
13.5
38.2
37
27
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
7.6
37.7
55
72
FM2CE, ,
NOMESCO Finland
3.5
37.6
137
398
Z3229
NOMESCO Finland
Other healthcare associate professional
2.9
37.6
199
723
WX408
NOMESCO Finland
General anesthesy, balanced
2.1
37.4
464
2486
TPH07
NOMESCO Finland
Cathetrisation of artery
3.1
37.3
174
589
ZXE10
NOMESCO Finland
More than one and less than three hours
2.1
36.6
487
2674
ZXE20
NOMESCO Finland
More than three and less than five hours
2.8
36.4
209
793
205
Kela drug reimbursment
Chronic hypertension
3.6
35.0
121
339
SCE00
NOMESCO Finland
Fissure sealant
2.3
34.9
312
1458
F59
ICD-10 Finland
Unspecified behavioural syndromes associated with physiological disturbances and physical factors
8.3
34.8
47
56
Z63.7
ICD-10 Finland
Other stressful life events affecting family and household
3.3
34.0
141
444
K03.28
ICD-10 Finland
Other erosion of teeth
4.2
33.7
95
230
SDA03
NOMESCO Finland
Periodontal treatment
1.9
33.6
675
4258
ZXD10
NOMESCO Finland
Scheduled procedure
2.0
33.5
555
3277
XW000
NOMESCO Finland
Bone marrow biopsy
5.0
33.5
75
151
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.6
33.2
221
901
A41.9
ICD-10 Finland
Sepsis, unspecified
4.7
33.1
79
168
EB1WA, ,
NOMESCO Finland
13.1
32.5
32
24
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
2.0
32.3
1111
8325
C08CA02
ATC
felodipine; oral
6.1
32.2
57
92
XF400
NOMESCO Finland
ECG with 12 standard connections
2.3
31.2
274
1265
Z2445
NOMESCO Finland
Psychologist
2.5
30.2
217
916
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
6.2
30.1
53
85
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.3
30.0
251
1134
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.2
29.7
316
1577
Z3231
NOMESCO Finland
Registered nurse
1.9
29.5
534
3221
TK820
NOMESCO Finland
Peritoneal dialysis
29.5
28.9
39
13
ZX121
NOMESCO Finland
Central venous catheter
7.5
28.8
42
55
ZXE30
NOMESCO Finland
More than five and less than seven hours
3.4
28.8
111
334
XX4AW, ,
NOMESCO Finland
4.9
28.5
64
129
WW500
NOMESCO Finland
Blood transfusion
3.9
27.6
84
215
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.1
26.9
324
1690
ZXE00
NOMESCO Finland
One hour or less
1.8
26.8
624
4043
RS220, ,
NOMESCO Finland
4.7
26.6
63
133
BE00A, ,
NOMESCO Finland
40.4
26.3
33
8
ZXD05
NOMESCO Finland
Urgent procedure
1.9
25.8
437
2560
SFA10
NOMESCO Finland
One-surface restoration
1.8
25.4
1014
7644
Z29.9
ICD-10 Finland
Prophylactic measure, unspecified
7.7
25.2
36
46
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
3.3
25.0
97
293
TFC99
NOMESCO Finland
Catheterisation of heart with other procedure
6.0
24.5
44
72
6BA02, ,
NOMESCO Finland
8.9
24.4
31
34
SAA04
NOMESCO Finland
Special examination of mouth
2.2
23.9
215
997
XF622
NOMESCO Finland
Measurement of minute volume of heart
9.8
23.6
28
28
SBB00
NOMESCO Finland
Clinical photography of mouth and teeth
2.3
23.2
187
827
KA9AE
NOMESCO Finland
Ultrasound examination transplanted kidney
24.1
22.6
32
13
4AA09, ,
NOMESCO Finland
29.4
22.4
30
10
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.5
22.3
147
593
R4190
NOMESCO Finland
Nutritional therapy
2.2
22.1
196
902
K03.65
ICD-10 Finland
Deposits [accretions] on teeth betel
1.9
21.9
317
1750
RS221, ,
NOMESCO Finland
4.0
21.9
63
155
K02.1
ICD-10 Finland
Caries of dentine
1.8
21.6
1088
8551
TPX10
NOMESCO Finland
Implantation of vascular injection port
4.2
21.5
59
140
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.8
21.4
113
407
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.2
21.4
198
927
ZXA00
NOMESCO Finland
Right side
2.1
21.1
234
1174
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
6.7
21.0
34
50
C08CA01
ATC
amlodipine; oral
2.2
20.9
185
850
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
2.3
20.8
174
780
KAS20
NOMESCO Finland
Allogenic transplantation of kidney from living donor
20.2
20.8
31
15
K03.19
ICD-10 Finland
Abrasion of the teeth UNS
6.8
20.2
32
46
D19
ICPC
Teeth/gum symptom/complaint
1.7
20.1
638
4408
C03CA01
ATC
furosemide; systemic
2.6
19.9
123
481
TPH04
NOMESCO Finland
Cathetrisation of vein
1.9
19.8
278
1515
WX402
NOMESCO Finland
General anaesthesia
1.8
19.7
390
2366
XA800
NOMESCO Finland
Neuropsychological investigation
2.4
19.6
139
580
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
3.2
19.4
77
236
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
1.8
19.2
400
2462
R50.9
ICD-10 Finland
Fever, unspecified
1.8
18.7
340
2007
BC00A, ,
NOMESCO Finland
19.5
18.7
28
14
SAA03
NOMESCO Finland
Extended examination of mouth
1.6
18.6
913
6984
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
2.9
18.2
88
302
WX110
NOMESCO Finland
Infiltration anesthesia
1.8
18.2
1218
10069
SFA20
NOMESCO Finland
Two-surface restoration
1.6
18.0
896
6856
C09AA02
ATC
enalapril; systemic
2.7
17.5
100
376
XX4BW, ,
NOMESCO Finland
6.4
17.4
29
44
IEP02
NOMESCO Finland
Child-centred family therapy
3.1
17.3
72
227
V03AE01
ATC
polystyrene sulfonate; oral
15.2
17.1
28
18
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
5.4
17.0
34
62
Z94.1
ICD-10 Finland
Heart transplant status
13.5
16.9
29
21
3A013, ,
NOMESCO Finland
61.5
16.5
19
*
ZXA10
NOMESCO Finland
Bilateral
1.9
16.2
244
1354
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.7
16.2
430
2805
N25.8
ICD-10 Finland
Other disorders resulting from impaired renal tubular function
15.9
16.2
26
16
K07.24
ICD-10 Finland
Open bite
2.9
16.1
78
268
KA1AE
NOMESCO Finland
Kidney ultrasound examination
4.2
16.1
43
100
N18.0
ICD-10 Finland
End-stage renal disease
22.4
16.1
23
10
GAE10
NOMESCO Finland
Closure of previous incision of chest wall
5.9
16.0
29
48
ZXA05
NOMESCO Finland
Left side
2.0
16.0
201
1051
K03.29
ICD-10 Finland
Erosion of teeth occupational
3.9
15.7
47
119
TJA33
NOMESCO Finland
Percutaneous introduction of peritoneal dialysis catheter
46.1
15.7
19
*
J10.1
ICD-10 Finland
Influenza with other respiratory manifestations, seasonal influenza virus identified
3.7
15.7
51
137
A05AA02
ATC
ursodeoxycholic acid; oral
3.6
15.6
52
142
RK220, ,
NOMESCO Finland
5.9
15.6
28
46
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
4.1
15.5
43
103
ZXD20
NOMESCO Finland
Day surgery
2.1
15.4
165
815
RL140, ,
NOMESCO Finland
4.2
15.3
41
96
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.9
15.2
218
1191
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.6
15.1
402
2618
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
4.1
15.1
41
97
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
5.0
15.0
32
62
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.7
14.9
84
313
U14
ICPC
Kidney symptom/complaint
6.7
14.9
24
35
TAB00
NOMESCO Finland
Lumbar puncture
2.6
14.9
92
359
SDA02
NOMESCO Finland
Periodontal treatment, brief
1.5
14.9
638
4643
SAA01
NOMESCO Finland
Simple examination of mouth
1.7
14.8
1270
10805
IGY02
NOMESCO Finland
Psychiatric monitoring contact
2.0
14.7
160
794
WX110, ,
SPAT
2.2
14.7
135
628
FN1BC
NOMESCO Finland
Extensive angiography of hear and/or coronary arteries
3.5
14.7
50
139
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.1
14.6
144
688
TPW99
NOMESCO Finland
Other minor surgical procedure on peripheral vessel or lymphatic system
4.3
14.6
38
87
201
Kela drug reimbursment
Chronic cardiac insufficiency
3.8
14.5
44
113
SDE03
NOMESCO Finland
Periodontal treatment by dental hygienist, extensive
1.8
14.4
233
1320
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
5.9
14.4
26
43
TK823
NOMESCO Finland
Peritoneal permeability analysis
77.7
14.3
16
*
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
4.5
14.3
35
76
WZC00
NOMESCO Finland
Treatment plan or consultation
1.5
14.2
683
5081
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
3.6
14.1
46
124
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
2.6
14.1
86
334
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.6
14.1
458
3123
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.0
14.0
169
869
B34.9
ICD-10 Finland
Viral infection, unspecified
2.2
14.0
127
588
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
2.8
13.9
72
257
RS121, ,
NOMESCO Finland
4.3
13.9
36
82
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
2.1
13.8
145
710
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
3.8
13.8
42
108
WX002
NOMESCO Finland
Sedation and analgesia
1.9
13.7
181
961
I15.8
ICD-10 Finland
Other secondary hypertension
10.6
13.6
26
24
ZX114
NOMESCO Finland
Intramuscular
3.8
13.6
42
109
783, ,
NOMESCO Finland
51.7
13.6
16
*
1AB02, ,
NOMESCO Finland
10.1
13.4
26
25
RK110, ,
NOMESCO Finland
5.7
13.3
25
43
SBB20
NOMESCO Finland
Tooth X-ray examination in conjunction with visit to dentist
5.1
13.2
28
54
ZXE40
NOMESCO Finland
More than seven and less than nine hours
3.2
12.9
52
161
PA6AE
NOMESCO Finland
Ulrasound examination of neck vasculature
10.2
12.9
25
24
SCA01
NOMESCO Finland
Preventive oral health care, short
1.5
12.8
967
7826
C07AB02
ATC
metoprolol; systemic
2.2
12.7
112
512
AA5HE
NOMESCO Finland
Brain ultrasound examination in a child
2.8
12.5
64
227
K03.82
ICD-10 Finland
Split tooth for reasons other than trauma
1.7
12.2
282
1760
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.1
12.2
124
600
WW200
NOMESCO Finland
Immunization
3.0
12.0
52
168
ZY010
NOMESCO Finland
Hospital outpatient
1.8
11.8
173
949
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
2.1
11.7
115
549
B07.9
ICD-10 Finland
Verruca simplex
2.2
11.5
99
448
Z71.8
ICD-10 Finland
Other specified counselling
1.5
11.4
608
4555
IEP03
NOMESCO Finland
Focused parental counselling
2.6
11.4
65
245
D89.89
ICD-10 Finland
Other specified disorders involving the immune mechanism, not elsewhere classified
12.1
11.3
20
16
ZX131
NOMESCO Finland
Intrathecal
10.7
11.2
21
19
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
2.4
11.2
77
317
XF600
NOMESCO Finland
Bloodpressure measurement
1.9
11.2
144
757
TK810
NOMESCO Finland
Hemofiltration
13.2
11.2
19
14
FN1BB
NOMESCO Finland
Contrast angiography of heart and/or coronary arteries after bypass surgery
4.0
11.1
31
75
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.1
11.1
114
554
R62.0
ICD-10 Finland
Delayed milestone
2.3
11.1
81
343
JJ9AE
NOMESCO Finland
Ultrasound examination of liver transplant
14.6
11.0
18
12
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.6
11.0
289
1860
RT150, ,
NOMESCO Finland
3.4
10.9
39
112
K05.19
ICD-10 Finland
Gingivitis (chronic) ulcerative
2.4
10.9
72
291
Q23.4
ICD-10 Finland
Hypoplastic left heart syndrome
12.3
10.9
19
15
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
1.9
10.8
134
696
N19
ICD-10 Finland
Unspecified kidney failure
5.2
10.7
22
41
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
1.8
10.7
165
918
N04.9
ICD-10 Finland
Nephrotic syndrome, unspecified
9.7
10.7
21
21
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
4.2
10.6
28
65
WX892
NOMESCO Finland
Monitored bed care
2.1
10.6
104
497
KAB00
NOMESCO Finland
Biopsy of kidney or pelvis of kidney
27.1
10.5
14
5
FXA00
NOMESCO Finland
Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure
2.6
10.5
59
221
TJD20
NOMESCO Finland
Change of gastrostomy tube
4.2
10.3
27
62
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.3
10.3
75
317
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
3.4
10.3
37
107
N04.0
ICD-10 Finland
Nephrotic syndrome, minor glomerular abnormality
13.7
10.2
17
12
B01.9
ICD-10 Finland
Varicella without complication
3.2
10.2
41
127
FDA00
NOMESCO Finland
Aortoplasty and aorto-pulmonary shunt for HLHS
15.5
10.1
16
10
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
2.1
10.1
96
453
RK230, ,
NOMESCO Finland
5.1
10.0
21
40
Z94.9
ICD-10 Finland
Transplanted organ and tissue status, unspecified
38.7
9.8
12
*
WW400
NOMESCO Finland
Plasmaferesis
14.1
9.8
16
11
ZX100
NOMESCO Finland
Oral
5.0
9.8
21
41
SDE02
NOMESCO Finland
Periodontal treatment by dental hygienist
1.5
9.7
315
2123
F43.8
ICD-10 Finland
Other reactions to severe stress
2.3
9.7
71
301
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
4.4
9.7
24
53
F70.0
ICD-10 Finland
Mild mental retardation, With the statement of no, or minimal, impairment of behaviour
3.3
9.6
35
102
JAH00
NOMESCO Finland
Laparotomy
3.4
9.5
34
98
D82
ICPC
Teeth/gum disease
1.4
9.5
683
5354
K03.0
ICD-10 Finland
Excessive attrition of teeth
2.9
9.4
44
149
K00.39
ICD-10 Finland
Indefinite enamel capacities
12.9
9.4
16
12
EB1AA, ,
SPAT
2.0
9.4
97
472
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.6
9.3
236
1501
2AX05, ,
NOMESCO Finland
+∞
9.2
9
*
JJC00
NOMESCO Finland
Allogenic transplantation of liver
17.0
9.2
14
8
RS222, ,
NOMESCO Finland
3.2
9.1
36
111
JL5AG
NOMESCO Finland
Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet
4.9
9.0
20
40
TFJ02
NOMESCO Finland
Muscle biopsy of heart
10.3
9.0
17
16
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
2.2
9.0
76
342
Z49.0
ICD-10 Finland
Preparatory care for dialysis
13.2
9.0
15
11
SFA00
NOMESCO Finland
Small restoration
1.7
9.0
188
1141
K07.25
ICD-10 Finland
Anomalies of dental arch relationship
1.8
8.9
143
806
QXB05
NOMESCO Finland
Skin wound assessment, unspecified location
4.7
8.8
20
41
IGY99
NOMESCO Finland
Other psychiatric treatment contact
1.9
8.8
119
636
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
9.7
8.8
17
17
J05AB01
ATC
aciclovir; systemic
1.6
8.7
240
1557
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.6
8.7
224
1430
UDC00
NOMESCO Finland
Ear microscopy
1.8
8.6
121
655
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
3.6
8.6
28
76
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.6
8.6
195
1208
WW409
NOMESCO Finland
Other aferesis
9.2
8.5
17
18
R1220
NOMESCO Finland
Psychological examination of need and possibilities to rehabilitation
2.5
8.5
53
209
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.4
8.5
717
5738
ZXX02
NOMESCO Finland
Extent of procedure, 2 units
3.3
8.5
31
91
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.4
8.4
440
3249
Q20.48
ICD-10 Finland
Single ventricle
11.2
8.4
15
13
H01AC01
ATC
somatropin; parenteral
2.5
8.3
53
212
N0480, Z940,
ICD-10 Finland
+∞
8.2
8
*
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
2.1
8.2
82
395
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
2.2
8.2
64
280
ZX090
NOMESCO Finland
Other technic of radiotherapy
4.6
8.1
19
40
F81.8
ICD-10 Finland
Other developmental disorders of scholastic skills
3.1
8.0
32
99
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.7
8.0
42
152
C03DA01
ATC
spironolactone; oral
2.0
8.0
80
386
K06.10
ICD-10 Finland
Gingival fibromatosis
32.2
7.9
10
*
K00.48
ICD-10 Finland
Other specified disorder of tooth formation
21.3
7.8
11
5
ZX197, ,
NOMESCO Finland
21.3
7.8
11
5
1XC02, ,
NOMESCO Finland
9.7
7.8
15
15
Z31.5
ICD-10 Finland
Genetic counselling
1.8
7.8
129
734
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
3.5
7.8
26
72
WX1PA
NOMESCO Finland
Total body mineral density measurement with Dual energy X-ray absorptiometry (DXA)
6.1
7.7
20
32
Q44.21
ICD-10 Finland
Atresia of extrahepatic bile ducts
12.6
7.7
13
10
SPC01
NOMESCO Finland
Fixed dental crown
4.2
7.7
20
46
FDF05
NOMESCO Finland
Percutaneous transluminal occlusion of aorto-pulmonary collaterals
10.4
7.6
14
13
TJW99
NOMESCO Finland
Other minor procedure in gastrointestinal endoscopy
10.4
7.6
14
13
SFA30
NOMESCO Finland
Three-surface restoration
1.4
7.6
397
2922
H72.0
ICD-10 Finland
Central perforation of tympanic membrane
3.0
7.6
33
108
RL130, ,
NOMESCO Finland
3.0
7.5
32
103
7AX01, ,
NOMESCO Finland
6.7
7.5
18
26
JAB00
NOMESCO Finland
Division and ligature of inguinal hernia sac
2.7
7.5
40
146
SCF03
NOMESCO Finland
Preventive oral care by dental hygienist, extensive
2.5
7.4
47
187
YNB20
NOMESCO Finland
Storage of stem cells for transplant
17.7
7.4
11
6
Z94.2
ICD-10 Finland
Lung transplant status
17.7
7.4
11
6
L04AA05
ATC
[U] tacrolimus
17.7
7.4
11
6
C64.80
ICD-10 Finland
Wilms tumour
17.7
7.4
11
6
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.7
7.4
137
804
B01AA03
ATC
warfarin; systemic
2.3
7.4
57
248
320
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
11.4
7.4
13
11
GD1LA
NOMESCO Finland
GD
7.8
7.4
16
20
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.5
7.3
240
1615
R1260
NOMESCO Finland
Evaluation of communicative skills
3.0
7.3
31
100
G04BE03
ATC
sildenafil; oral
4.2
7.2
19
44
L01BB02
ATC
mercaptopurine; oral
2.8
7.2
35
122
Z940, N0480,
ICD-10 Finland
+∞
7.2
7
*
K00.68
ICD-10 Finland
Other disturbance in the tooth eruption
1.9
7.2
91
477
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.8
7.2
110
612
K83.0
ICD-10 Finland
Cholangitis
3.8
7.2
21
53
H26.3
ICD-10 Finland
Drug-induced cataract
8.1
7.1
15
18
D80.9
ICD-10 Finland
Immunodeficiency with predominantly antibody defects, unspecified
15.2
7.1
11
7
FAE00
NOMESCO Finland
Anastomosis to pulmonary artery from superior vena cava
15.2
7.1
11
7
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
3.2
7.0
27
82
N18.5
ICD-10 Finland
Chronic kidney disease, stage 5
19.3
7.0
10
5
H66.9
ICD-10 Finland
Otitis media, unspecified
1.4
7.0
301
2137
Q64.2
ICD-10 Finland
Congenital posterior urethral valves
11.6
6.9
12
10
V03AE02
ATC
sevelamer; oral
11.6
6.9
12
10
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
1.6
6.9
156
965
H66.0
ICD-10 Finland
Acute suppurative otitis media
1.4
6.8
364
2680
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.3
6.8
536
4200
TJF80
NOMESCO Finland
Ostomy education
3.7
6.8
21
55
RS211, ,
NOMESCO Finland
3.0
6.8
29
94
K03.2
ICD-10 Finland
Erosion of teeth
2.8
6.8
32
110
F82
ICD-10 Finland
Specific developmental disorder of motor function
2.3
6.8
49
208
Z85.6
ICD-10 Finland
Personal history of leukaemia
6.1
6.7
17
27
Z98.8
ICD-10 Finland
Other specified postsurgical states
3.2
6.6
25
75
K03.22
ICD-10 Finland
Erosion of teeth due to: diet
2.7
6.6
34
122
TKA05
NOMESCO Finland
Aspiration cytology of kidney
38.6
6.6
8
*
K07.30
ICD-10 Finland
Spacing, abnormal of tooth or teeth
1.5
6.6
202
1337
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
6.5
6.6
16
24
JJC10
NOMESCO Finland
Allogenic partial transplantation of liver
16.1
6.6
10
6
P85
ICPC
Mental retardation
2.7
6.6
33
117
E34.35
ICD-10 Finland
Abnormal growth retardation
2.3
6.6
50
217
WX290, ,
SPAT
2.0
6.5
72
360
Z01.1
ICD-10 Finland
Examination of ears and hearing
1.5
6.5
217
1462
T86.1
ICD-10 Finland
Kidney transplant failure and rejection
21.7
6.5
9
*
K02.3
ICD-10 Finland
Arrested dental caries
2.3
6.5
48
205
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
2.6
6.5
37
140
FXA10
NOMESCO Finland
Total cardiopulmonary bypass in deep hypothermia at concurrent surgical procedure
5.5
6.5
18
32
LC2DE
NOMESCO Finland
Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods
2.0
6.5
64
308
A28
ICPC
Limited function/disability NOS
1.8
6.4
100
559
B05XA03
ATC
sodium chloride; parenteral
9.7
6.4
12
12
FQA00
NOMESCO Finland
Orthotopic transplantation of heart
9.7
6.4
12
12
TK822
NOMESCO Finland
Assessment of adequacy of peritoneal dialysis
67.4
6.3
7
*
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.0
6.3
66
325
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
1.8
6.3
85
456
NE1AA
NOMESCO Finland
Pelvis X-ray examination
2.2
6.3
48
209
Z01.6
ICD-10 Finland
Radiological examination, not elsewhere classified
1.6
6.2
158
1004
Z71.9
ICD-10 Finland
Counselling, unspecified
1.7
6.2
110
638
A08.0
ICD-10 Finland
Rotaviral enteritis
2.7
6.2
31
110
XKD00
NOMESCO Finland
Uroflowmetry
2.0
6.2
69
347
61
HP
Catheterization and pressure measurement of the left side of the heart
7.9
6.2
13
16
K03.21
ICD-10 Finland
Erosion of teeth due to: persistent vomiting
10.6
6.1
11
10
SCA02
NOMESCO Finland
Preventive oral health care
1.3
6.1
437
3364
Q44.29
ICD-10 Finland
Atresia of bile ducts
8.9
6.1
12
13
JKD50
NOMESCO Finland
Hepatoportoenterostomy
8.9
6.1
12
13
K00.88
ICD-10 Finland
Other disorders of tooth development
25.7
6.1
8
*
K00.4
ICD-10 Finland
Disturbances in tooth formation
25.7
6.1
8
*
ZX196, ,
NOMESCO Finland
25.7
6.1
8
*
H52.0
ICD-10 Finland
Hypermetropia
2.0
6.0
65
323

TimeCodeWAS

↥

TODO / Current known limitations:

  • Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
  • Legend / how to read the glyphs.
  • Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
  • Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
  • Download CSV.
  • No filters and sorters.
  • Limited amount of endpoints (~400) having TimeCodeWAS data.
  • Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Kidney transplant status
Z94.0 [45566477]
3.3e+00
3.3e+00
3.4e+00
—
3.4e+00
3.3e+00
3.7e+00
cases:4.30%
controls:0.16%
cases:4.40%
controls:0.17%
cases:2.30%
controls:0.08%
—
—
cases:2.86%
controls:0.10%
cases:4.90%
controls:0.18%
cases:6.85%
controls:0.19%
63
23
1403
14504
65
25
1413
14603
34
12
1444
14616
—
42
15
1426
14530
68
25
1320
13594
62
17
843
9036
tacrolimus; oral, parenteral
L04AD02 [21603925]
2.7e+00
3.0e+00
2.6e+00
—
3.1e+00
3.0e+00
3.2e+00
cases:3.21%
controls:0.22%
cases:4.06%
controls:0.21%
cases:1.49%
controls:0.11%
—
—
cases:1.63%
controls:0.08%
cases:4.47%
controls:0.23%
cases:6.52%
controls:0.28%
47
32
1419
14495
60
31
1418
14597
22
16
1456
14612
—
24
11
1444
14534
62
31
1326
13588
59
25
846
9028
ciclosporin; oral, parenteral
L04AD01 [21603924]
2.4e+00
2.7e+00
2.8e+00
—
2.6e+00
2.7e+00
3.5e+00
cases:3.68%
controls:0.34%
cases:2.84%
controls:0.19%
cases:1.49%
controls:0.10%
—
—
cases:1.23%
controls:0.10%
cases:2.88%
controls:0.20%
cases:4.20%
controls:0.13%
54
49
1412
14478
42
28
1436
14600
22
14
1456
14614
—
18
14
1450
14531
40
27
1348
13592
38
12
867
9041
methylprednisolone; oral, parenteral
H02AB04 [21602732]
1.9e+00
2.8e+00
3.6e+00
—
2.7e+00
2.9e+00
2.7e+00
cases:5.73%
controls:0.89%
cases:5.89%
controls:0.36%
cases:1.89%
controls:0.05%
—
—
cases:1.43%
controls:0.10%
cases:6.27%
controls:0.36%
cases:8.95%
controls:0.66%
84
129
1382
14398
87
53
1391
14575
28
8
1450
14620
—
21
14
1447
14531
87
49
1301
13570
81
60
824
8993
Liver transplant status
Z94.4 [45566478]
3.3e+00
3.2e+00
3.1e+00
1.0e+50
—
3.4e+00
3.6e+00
cases:1.77%
controls:0.07%
cases:1.69%
controls:0.07%
cases:0.88%
controls:0.04%
cases:1.42%
controls:0.00%
—
—
cases:1.95%
controls:0.07%
cases:2.87%
controls:0.08%
26
10
1440
14517
25
10
1453
14618
13
6
1465
14622
21
0
1456
14628
—
27
9
1361
13610
26
7
879
9046
Tacrolimus [Mass/volume] in Blood
11253-2 [3026250]
2.2e+00
2.4e+00
2.7e+00
—
2.4e+00
2.6e+00
3.0e+00
cases:1.71%
controls:0.20%
cases:2.10%
controls:0.18%
cases:1.42%
controls:0.10%
—
—
cases:1.29%
controls:0.12%
cases:2.45%
controls:0.18%
cases:5.64%
controls:0.29%
25
29
1441
14498
31
27
1447
14601
21
14
1457
14614
—
19
18
1449
14527
34
25
1354
13594
51
26
854
9027
Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
43730-1 [3043849]
1.5e+00
2.2e+00
3.2e+00
1.0e+50
2.5e+00
2.4e+00
2.6e+00
cases:2.73%
controls:0.59%
cases:3.11%
controls:0.35%
cases:0.81%
controls:0.03%
cases:1.08%
controls:0.00%
cases:0.82%
controls:0.07%
cases:3.31%
controls:0.31%
cases:6.96%
controls:0.55%
40
86
1426
14441
46
51
1432
14577
12
5
1466
14623
16
0
1461
14628
12
10
1456
14535
46
42
1342
13577
63
50
842
9003
JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
49413-8 [3032185]
3.4e+00
3.4e+00
—
1.0e+50
—
3.4e+00
4.1e+00
cases:1.36%
controls:0.05%
cases:1.42%
controls:0.05%
—
—
cases:0.68%
controls:0.00%
—
—
cases:1.51%
controls:0.05%
cases:3.31%
controls:0.06%
20
7
1446
14520
21
7
1457
14621
—
10
0
1467
14628
—
21
7
1367
13612
30
5
875
9048
cycloSPORINE [Mass/volume] in Blood
3520-4 [3010375]
1.8e+00
2.5e+00
1.8e+00
—
2.8e+00
2.4e+00
2.8e+00
cases:1.91%
controls:0.31%
cases:1.89%
controls:0.16%
cases:0.47%
controls:0.08%
—
—
cases:0.89%
controls:0.06%
cases:1.66%
controls:0.15%
cases:2.98%
controls:0.19%
28
45
1438
14482
28
23
1450
14605
7
11
1471
14617
—
13
8
1455
14537
23
20
1365
13599
27
17
878
9036
ANTIHYPERTENSIVE_DRUG - yes
ANTIHYPERTENSIVE_DRUG-1 [2002330215]
3.2e+00
3.5e+00
—
—
—
3.9e+00
3.3e+00
cases:2.52%
controls:0.10%
cases:1.62%
controls:0.05%
—
—
—
—
—
—
cases:1.73%
controls:0.04%
cases:3.20%
controls:0.12%
37
15
1429
14512
24
7
1454
14621
—
—
—
24
5
1364
13614
29
11
876
9042
Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
72493-0 [43055120]
1.6e+00
2.2e+00
3.1e+00
1.0e+50
2.5e+00
2.0e+00
2.5e+00
cases:3.14%
controls:0.67%
cases:3.18%
controls:0.38%
cases:0.74%
controls:0.03%
cases:1.15%
controls:0.00%
cases:0.95%
controls:0.08%
cases:3.03%
controls:0.40%
cases:7.29%
controls:0.64%
46
97
1420
14430
47
55
1431
14573
11
5
1467
14623
17
0
1460
14628
14
11
1454
14534
42
55
1346
13564
66
58
839
8995
Heart transplant status
Z94.1 [45590779]
1.8e+00
2.4e+00
1.9e+00
1.0e+50
2.0e+00
2.5e+00
3.0e+00
cases:0.48%
controls:0.08%
cases:0.81%
controls:0.08%
cases:0.47%
controls:0.07%
cases:0.47%
controls:0.00%
cases:0.48%
controls:0.06%
cases:0.79%
controls:0.07%
cases:1.33%
controls:0.07%
7
11
1459
14516
12
11
1466
14617
7
10
1471
14618
7
0
1470
14628
7
9
1461
14536
11
9
1377
13610
12
6
893
9047
JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
49411-2 [3032390]
2.7e+00
3.2e+00
—
1.0e+50
—
3.5e+00
4.1e+00
cases:1.36%
controls:0.09%
cases:1.56%
controls:0.06%
—
—
cases:0.61%
controls:0.00%
—
—
cases:1.44%
controls:0.04%
cases:3.20%
controls:0.06%
20
13
1446
14514
23
9
1455
14619
—
9
0
1468
14628
—
20
6
1368
13613
29
5
876
9048
BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
32285-9 [3003752]
2.7e+00
3.2e+00
—
1.0e+50
—
3.6e+00
3.9e+00
cases:1.36%
controls:0.09%
cases:1.56%
controls:0.06%
—
—
cases:0.61%
controls:0.00%
—
—
cases:1.51%
controls:0.04%
cases:3.31%
controls:0.07%
20
13
1446
14514
23
9
1455
14619
—
9
0
1468
14628
—
21
6
1367
13613
30
6
875
9047
Glomerular filtration rate (GFR) Isotope mesurement
KA1MN [2001305637]
2.6e+00
3.5e+00
—
1.0e+50
—
3.7e+00
3.5e+00
cases:5.05%
controls:0.38%
cases:3.65%
controls:0.11%
—
—
cases:0.88%
controls:0.00%
—
—
cases:3.75%
controls:0.10%
cases:7.18%
controls:0.24%
74
55
1392
14472
54
16
1424
14612
—
13
0
1464
14628
—
52
13
1336
13606
65
22
840
9031
BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
32284-2 [3000504]
2.8e+00
3.3e+00
—
1.0e+50
—
3.3e+00
3.8e+00
cases:1.57%
controls:0.10%
cases:1.83%
controls:0.07%
—
—
cases:0.81%
controls:0.00%
—
—
cases:1.73%
controls:0.07%
cases:3.76%
controls:0.09%
23
14
1443
14513
27
10
1451
14618
—
12
0
1465
14628
—
24
9
1364
13610
34
8
871
9045
alfacalcidol; oral, parenteral
A11CC03 [21600818]
2.4e+00
2.4e+00
—
—
3.3e+00
2.8e+00
2.2e+00
cases:3.62%
controls:0.34%
cases:2.30%
controls:0.21%
—
—
—
—
cases:0.89%
controls:0.03%
cases:2.31%
controls:0.15%
cases:3.43%
controls:0.40%
53
50
1413
14477
34
30
1444
14598
—
—
13
5
1455
14540
32
20
1356
13599
31
36
874
9017
azathioprine; oral, parenteral
L04AX01 [21603927]
1.8e+00
2.1e+00
1.6e+00
—
2.6e+00
2.2e+00
2.5e+00
cases:4.84%
controls:0.84%
cases:4.47%
controls:0.58%
cases:0.95%
controls:0.18%
—
—
cases:1.77%
controls:0.13%
cases:4.90%
controls:0.59%
cases:7.51%
controls:0.70%
71
122
1395
14405
66
85
1412
14543
14
27
1464
14601
—
26
19
1442
14526
68
80
1320
13539
68
63
837
8990
calcium carbonate
A02AC01 [21600065]
2.0e+00
2.2e+00
2.3e+00
—
—
2.6e+00
2.8e+00
cases:3.14%
controls:0.43%
cases:1.96%
controls:0.21%
cases:0.41%
controls:0.04%
—
—
—
—
cases:1.95%
controls:0.15%
cases:3.43%
controls:0.21%
46
62
1420
14465
29
31
1449
14597
6
6
1472
14622
—
—
27
20
1361
13599
31
19
874
9034
calcium carbonate; oral
A12AA04 [21600863]
2.0e+00
2.2e+00
2.3e+00
—
—
2.6e+00
2.8e+00
cases:3.14%
controls:0.43%
cases:1.96%
controls:0.21%
cases:0.41%
controls:0.04%
—
—
—
—
cases:1.95%
controls:0.15%
cases:3.43%
controls:0.21%
46
62
1420
14465
29
31
1449
14597
6
6
1472
14622
—
—
27
20
1361
13599
31
19
874
9034
Pediatric Nephrology
OMOP4822026 [45756813]
1.5e+00
1.9e+00
1.9e+00
—
2.5e+00
1.9e+00
2.1e+00
cases:5.18%
controls:1.21%
cases:5.41%
controls:0.85%
cases:1.42%
controls:0.23%
—
—
cases:2.32%
controls:0.19%
cases:5.40%
controls:0.81%
cases:9.39%
controls:1.25%
76
176
1390
14351
80
124
1398
14504
21
33
1457
14595
—
34
27
1434
14518
75
110
1313
13509
85
113
820
8940
Other healthcare associate professional
Z3229 [2001311561]
8.5e-01
1.7e+00
2.0e+00
—
2.5e+00
2.3e+00
2.2e+00
cases:3.75%
controls:1.63%
cases:2.30%
controls:0.41%
cases:0.47%
controls:0.06%
—
—
cases:0.68%
controls:0.06%
cases:2.16%
controls:0.22%
cases:4.86%
controls:0.54%
55
237
1411
14290
34
60
1444
14568
7
9
1471
14619
—
10
8
1458
14537
30
30
1358
13589
44
49
861
9004
Medical doctor
Z2221 [2001311556]
1.0e+00
1.7e+00
1.9e+00
—
2.6e+00
2.3e+00
2.3e+00
cases:12.41%
controls:4.87%
cases:6.29%
controls:1.26%
cases:1.35%
controls:0.21%
—
—
cases:2.25%
controls:0.18%
cases:7.35%
controls:0.79%
cases:14.92%
controls:1.76%
182
708
1284
13819
93
184
1385
14444
20
31
1458
14597
—
33
26
1435
14519
102
107
1286
13512
135
159
770
8894
Physiotherapist
Z3226 [2001311560]
8.6e-01
1.7e+00
2.0e+00
—
2.5e+00
2.1e+00
2.5e+00
cases:8.46%
controls:3.76%
cases:4.94%
controls:0.92%
cases:0.88%
controls:0.12%
—
—
cases:1.09%
controls:0.09%
cases:3.67%
controls:0.45%
cases:7.62%
controls:0.71%
124
546
1342
13981
73
135
1405
14493
13
18
1465
14610
—
16
13
1452
14532
51
61
1337
13558
69
64
836
8989
Bloodpressure monitoring
XF602 [2001303378]
2.2e+00
3.0e+00
—
—
—
2.6e+00
3.7e+00
cases:1.77%
controls:0.19%
cases:0.68%
controls:0.03%
—
—
—
—
—
—
cases:0.58%
controls:0.04%
cases:5.08%
controls:0.13%
26
28
1440
14499
10
5
1468
14623
—
—
—
8
6
1380
13613
46
12
859
9041
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
JN3DE [2001305565]
2.0e+00
2.6e+00
—
—
—
3.0e+00
3.4e+00
cases:1.77%
controls:0.23%
cases:1.01%
controls:0.08%
—
—
—
—
—
—
cases:0.86%
controls:0.04%
cases:2.87%
controls:0.10%
26
34
1440
14493
15
11
1463
14617
—
—
—
12
6
1376
13613
26
9
879
9044
Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
33941-6 [3029493]
2.1e+00
2.9e+00
—
—
—
2.6e+00
3.3e+00
cases:1.57%
controls:0.20%
cases:1.35%
controls:0.08%
—
—
—
—
—
—
cases:0.50%
controls:0.04%
cases:1.99%
controls:0.08%
23
29
1443
14498
20
11
1458
14617
—
—
—
7
5
1381
13614
18
7
887
9046
Hypoplastic left heart syndrome
Q23.4 [45568057]
2.5e+00
2.9e+00
—
1.0e+50
—
2.6e+00
2.5e+00
cases:0.95%
controls:0.08%
cases:0.95%
controls:0.05%
—
—
cases:0.41%
controls:0.00%
—
—
cases:0.86%
controls:0.07%
cases:1.10%
controls:0.09%
14
12
1452
14515
14
8
1464
14620
—
6
0
1471
14628
—
12
9
1376
13610
10
8
895
9045
Scheduled procedure
ZXD10 [2001311387]
9.6e-01
1.3e+00
1.7e+00
1.0e+50
2.3e+00
2.0e+00
2.0e+00
cases:13.30%
controls:5.56%
cases:4.47%
controls:1.24%
cases:0.81%
controls:0.14%
cases:0.54%
controls:0.00%
cases:1.02%
controls:0.10%
cases:3.89%
controls:0.55%
cases:8.84%
controls:1.33%
195
808
1271
13719
66
181
1412
14447
12
21
1466
14607
8
0
1469
14628
15
15
1453
14530
54
75
1334
13544
80
120
825
8933
Kidney Pathology biopsy report
65757-7 [40768446]
2.2e+00
2.3e+00
—
—
—
2.7e+00
2.7e+00
cases:1.57%
controls:0.18%
cases:1.01%
controls:0.10%
—
—
—
—
—
—
cases:0.79%
controls:0.05%
cases:1.66%
controls:0.11%
23
26
1443
14501
15
15
1463
14613
—
—
—
11
7
1377
13612
15
10
890
9043
Mycophenolate [Mass/volume] in Serum or Plasma
23905-3 [3027653]
2.2e+00
2.3e+00
—
1.0e+50
—
2.3e+00
3.0e+00
cases:1.16%
controls:0.12%
cases:1.22%
controls:0.12%
—
—
cases:0.41%
controls:0.00%
—
—
cases:1.01%
controls:0.10%
cases:2.65%
controls:0.13%
17
18
1449
14509
18
18
1460
14610
—
6
0
1471
14628
—
14
14
1374
13605
24
12
881
9041
Outreach service at unit of another specialty
ZYB02 [2001311571]
1.9e+00
2.7e+00
—
—
—
2.3e+00
2.9e+00
cases:1.16%
controls:0.18%
cases:0.61%
controls:0.04%
—
—
—
—
—
—
cases:0.43%
controls:0.04%
cases:1.44%
controls:0.08%
17
26
1449
14501
9
6
1469
14622
—
—
—
6
6
1382
13613
13
7
892
9046
More than one and less than three hours
ZXE10 [2001311401]
8.3e-01
1.3e+00
1.8e+00
1.0e+50
2.2e+00
1.8e+00
1.6e+00
cases:12.01%
controls:5.60%
cases:4.19%
controls:1.13%
cases:0.54%
controls:0.09%
cases:0.61%
controls:0.00%
cases:1.02%
controls:0.12%
cases:3.82%
controls:0.64%
cases:9.61%
controls:2.17%
176
813
1290
13714
62
165
1416
14463
8
13
1470
14615
9
0
1468
14628
15
17
1453
14528
53
87
1335
13532
87
196
818
8857
Measurement of bone age from hand and elbow using X-ray
NK6MA [2001308495]
1.4e+00
2.4e+00
—
1.0e+50
—
2.9e+00
2.7e+00
cases:4.98%
controls:1.27%
cases:3.59%
controls:0.34%
—
—
cases:0.88%
controls:0.00%
—
—
cases:3.24%
controls:0.19%
cases:8.29%
controls:0.59%
73
185
1393
14342
53
50
1425
14578
—
13
0
1464
14628
—
45
26
1343
13593
75
53
830
9000
darbepoetin alfa; parenteral
B03XA02 [21601134]
1.8e+00
2.2e+00
—
—
—
2.3e+00
3.0e+00
cases:0.61%
controls:0.10%
cases:0.54%
controls:0.06%
—
—
—
—
—
—
cases:0.58%
controls:0.06%
cases:1.33%
controls:0.07%
9
15
1457
14512
8
9
1470
14619
—
—
—
8
8
1380
13611
12
6
893
9047
Prenatal enamel hypoplasia
K00.41 [2000502633]
3.2e+00
2.6e+00
—
1.0e+50
—
—
3.5e+00
cases:1.43%
controls:0.06%
cases:0.47%
controls:0.03%
—
—
cases:0.34%
controls:0.00%
—
—
—
—
cases:2.10%
controls:0.07%
21
9
1445
14518
7
5
1471
14623
—
5
0
1472
14628
—
—
19
6
886
9047
Protein [Mass/volume] in Urine
2888-6 [3037121]
8.4e-01
1.4e+00
1.4e+00
—
2.4e+00
1.3e+00
1.6e+00
cases:3.34%
controls:1.47%
cases:2.77%
controls:0.72%
cases:0.68%
controls:0.16%
—
—
cases:0.82%
controls:0.08%
cases:2.31%
controls:0.62%
cases:6.30%
controls:1.36%
49
214
1417
14313
41
105
1437
14523
10
24
1468
14604
—
12
11
1456
14534
32
85
1356
13534
57
123
848
8930
Cystatin C [Mass/volume] in Serum or Plasma
33863-2 [3030366]
9.8e-01
1.3e+00
1.7e+00
—
1.9e+00
1.5e+00
1.5e+00
cases:6.41%
controls:2.51%
cases:6.02%
controls:1.70%
cases:2.57%
controls:0.48%
—
—
cases:2.25%
controls:0.34%
cases:5.98%
controls:1.43%
cases:10.83%
controls:2.62%
94
364
1372
14163
89
248
1389
14380
38
70
1440
14558
—
33
49
1435
14496
83
195
1305
13424
98
237
807
8816
Congenital posterior urethral valves
Q64.2 [45572978]
2.0e+00
2.3e+00
—
1.0e+50
—
2.4e+00
2.0e+00
cases:0.68%
controls:0.09%
cases:0.68%
controls:0.07%
—
—
cases:0.34%
controls:0.00%
—
—
cases:0.72%
controls:0.07%
cases:0.99%
controls:0.13%
10
13
1456
14514
10
10
1468
14618
—
5
0
1472
14628
—
10
9
1378
13610
9
12
896
9041
Other therapy enhancing rehabilitation
R4160 [2001310240]
1.6e+00
2.3e+00
—
—
—
2.3e+00
2.6e+00
cases:1.91%
controls:0.40%
cases:1.08%
controls:0.11%
—
—
—
—
—
—
cases:0.94%
controls:0.10%
cases:1.44%
controls:0.11%
28
58
1438
14469
16
16
1462
14612
—
—
—
13
13
1375
13606
13
10
892
9043
Caries of dentine
K02.1 [45548134]
2.5e-01
2.0e-01
3.0e-01
6.4e+00
1.3e+00
7.9e-01
1.2e-01
cases:30.76%
controls:25.79%
cases:13.19%
controls:11.08%
cases:2.17%
controls:1.61%
cases:24.51%
controls:0.05%
cases:6.13%
controls:1.80%
cases:21.40%
controls:11.03%
cases:33.92%
controls:31.19%
451
3746
1015
10781
195
1621
1283
13007
32
236
1446
14392
362
8
1115
14620
90
262
1378
14283
297
1502
1091
12117
307
2824
598
6229
B lymphocytes [#/volume] in Blood
11130-2 [3000060]
8.5e-01
1.6e+00
2.6e+00
—
1.7e+00
1.6e+00
1.9e+00
cases:1.50%
controls:0.65%
cases:1.56%
controls:0.32%
cases:0.47%
controls:0.03%
—
—
cases:0.34%
controls:0.06%
cases:1.22%
controls:0.24%
cases:2.54%
controls:0.40%
22
94
1444
14433
23
47
1455
14581
7
5
1471
14623
—
5
9
1463
14536
17
33
1371
13586
23
36
882
9017
Parathyrin.intact [Mass/volume] in Serum or Plasma
2731-8 [3000067]
9.4e-01
1.2e+00
1.5e+00
—
1.8e+00
1.4e+00
1.7e+00
cases:5.93%
controls:2.41%
cases:4.94%
controls:1.47%
cases:1.29%
controls:0.29%
—
—
cases:1.23%
controls:0.21%
cases:4.90%
controls:1.27%
cases:10.39%
controls:2.17%
87
350
1379
14177
73
215
1405
14413
19
42
1459
14586
—
18
30
1450
14515
68
173
1320
13446
94
196
811
8857
Measurement of bone density from two or more locations with X-ray
NK6QA [2001308500]
1.5e+00
2.3e+00
2.1e+00
—
—
2.0e+00
2.7e+00
cases:3.41%
controls:0.79%
cases:2.30%
controls:0.24%
cases:0.34%
controls:0.04%
—
—
—
—
cases:2.02%
controls:0.27%
cases:6.52%
controls:0.46%
50
115
1416
14412
34
35
1444
14593
5
6
1473
14622
—
—
28
37
1360
13582
59
42
846
9011
Urea [Moles/volume] in Serum or Plasma
22664-7 [3020779]
7.5e-01
1.3e+00
1.7e+00
—
1.8e+00
1.3e+00
1.5e+00
cases:7.50%
controls:3.69%
cases:6.22%
controls:1.78%
cases:2.10%
controls:0.38%
—
—
cases:1.98%
controls:0.32%
cases:6.05%
controls:1.67%
cases:12.15%
controls:2.91%
110
536
1356
13991
92
261
1386
14367
31
55
1447
14573
—
29
47
1439
14498
84
227
1304
13392
110
263
795
8790
Psychiatric consultation in another specialty
IAZ97 [2001304038]
1.4e+00
1.6e+00
—
—
1.8e+00
1.6e+00
1.9e+00
cases:2.05%
controls:0.50%
cases:1.69%
controls:0.34%
—
—
—
—
cases:0.48%
controls:0.08%
cases:1.59%
controls:0.31%
cases:4.53%
controls:0.68%
30
72
1436
14455
25
50
1453
14578
—
—
7
11
1461
14534
22
42
1366
13577
41
62
864
8991
One-surface restoration
SFA10 [2001310358]
2.4e-01
8.4e-02
-5.0e-01
5.5e+00
1.5e+00
9.1e-01
3.0e-01
cases:24.83%
controls:20.68%
cases:7.92%
controls:7.33%
cases:0.61%
controls:1.00%
cases:10.56%
controls:0.05%
cases:3.88%
controls:0.93%
cases:16.07%
controls:7.18%
cases:29.83%
controls:23.99%
364
3004
1102
11523
117
1072
1361
13556
9
147
1469
14481
156
7
1321
14621
57
135
1411
14410
223
978
1165
12641
270
2172
635
6881
Bacteria [Presence] in Urine
87829-8 [36304419]
3.5e-01
7.8e-01
9.5e-01
3.2e+00
1.5e+00
7.8e-01
9.1e-01
cases:12.82%
controls:9.43%
cases:7.58%
controls:3.62%
cases:1.35%
controls:0.53%
cases:0.81%
controls:0.03%
cases:1.70%
controls:0.40%
cases:6.34%
controls:3.00%
cases:16.91%
controls:7.60%
188
1370
1278
13157
112
530
1366
14098
20
77
1458
14551
12
5
1465
14623
25
58
1443
14487
88
409
1300
13210
153
688
752
8365
Bone marrow biopsy
XW000 [2001310618]
1.4e+00
2.4e+00
—
—
—
2.3e+00
2.3e+00
cases:1.98%
controls:0.51%
cases:1.42%
controls:0.13%
—
—
—
—
—
—
cases:0.94%
controls:0.10%
cases:1.33%
controls:0.13%
29
74
1437
14453
21
19
1457
14609
—
—
—
13
13
1375
13606
12
12
893
9041
Pediatric Medicine
37 [38004477]
2.4e-01
5.6e-01
6.4e-01
4.4e+00
1.1e+00
6.8e-01
6.7e-01
cases:25.51%
controls:21.15%
cases:18.34%
controls:11.33%
cases:5.01%
controls:2.71%
cases:6.50%
controls:0.08%
cases:6.61%
controls:2.25%
cases:17.36%
controls:9.58%
cases:25.08%
controls:14.66%
374
3072
1092
11455
271
1657
1207
12971
74
397
1404
14231
96
12
1381
14616
97
327
1371
14218
241
1305
1147
12314
227
1327
678
7726
magnesium hydroxide; oral
A02AA04 [21600052]
1.3e+00
2.6e+00
—
—
—
2.1e+00
2.3e+00
cases:1.16%
controls:0.31%
cases:1.08%
controls:0.08%
—
—
—
—
—
—
cases:0.86%
controls:0.10%
cases:2.21%
controls:0.23%
17
45
1449
14482
16
12
1462
14616
—
—
—
12
14
1376
13605
20
21
885
9032
magnesium hydroxide; oral
G04BX01 [21602658]
1.3e+00
2.6e+00
—
—
—
2.1e+00
2.3e+00
cases:1.16%
controls:0.31%
cases:1.08%
controls:0.08%
—
—
—
—
—
—
cases:0.86%
controls:0.10%
cases:2.21%
controls:0.23%
17
45
1449
14482
16
12
1462
14616
—
—
—
12
14
1376
13605
20
21
885
9032
Casts [#/volume] in Urine by Automated count
51483-6 [3030467]
3.4e-01
7.6e-01
1.0e+00
3.2e+00
1.4e+00
6.9e-01
8.6e-01
cases:12.69%
controls:9.35%
cases:7.58%
controls:3.71%
cases:1.42%
controls:0.51%
cases:0.81%
controls:0.03%
cases:1.70%
controls:0.41%
cases:6.12%
controls:3.18%
cases:16.46%
controls:7.70%
186
1358
1280
13169
112
542
1366
14086
21
75
1457
14553
12
5
1465
14623
25
60
1443
14485
85
433
1303
13186
149
697
756
8356
CD3-CD19+ cells/cells in Blood
15196-9 [3006245]
7.9e-01
1.6e+00
2.5e+00
—
1.7e+00
1.6e+00
1.8e+00
cases:1.57%
controls:0.72%
cases:1.56%
controls:0.33%
cases:0.47%
controls:0.04%
—
—
cases:0.34%
controls:0.06%
cases:1.22%
controls:0.26%
cases:2.76%
controls:0.46%
23
104
1443
14423
23
48
1455
14580
7
6
1471
14622
—
5
9
1463
14536
17
35
1371
13584
25
42
880
9011
Other minor procedure in endocrine surgery
TBW99 [2001300856]
9.3e-01
1.6e+00
—
—
—
3.1e+00
2.5e+00
cases:1.57%
controls:0.63%
cases:0.74%
controls:0.15%
—
—
—
—
—
—
cases:0.79%
controls:0.04%
cases:1.77%
controls:0.14%
23
91
1443
14436
11
22
1467
14606
—
—
—
11
5
1377
13614
16
13
889
9040
Bicarbonate [Moles/volume] in Serum or Plasma
1963-8 [3016293]
3.7e-01
7.5e-01
8.4e-01
3.5e+00
1.3e+00
9.3e-01
1.3e+00
cases:7.78%
controls:5.49%
cases:5.14%
controls:2.49%
cases:1.29%
controls:0.56%
cases:1.35%
controls:0.04%
cases:1.36%
controls:0.39%
cases:4.83%
controls:1.95%
cases:11.60%
controls:3.55%
114
797
1352
13730
76
364
1402
14264
19
82
1459
14546
20
6
1457
14622
20
57
1448
14488
67
266
1321
13353
105
321
800
8732
Unspecified behavioural syndromes associated with physiological disturbances and physical factors
F59 [45591148]
2.3e+00
2.8e+00
—
—
—
—
2.9e+00
cases:0.89%
controls:0.09%
cases:0.54%
controls:0.03%
—
—
—
—
—
—
—
—
cases:1.22%
controls:0.07%
13
13
1453
14514
8
5
1470
14623
—
—
—
—
11
6
894
9047
Adenovirus Ag [Presence] in Stool
31711-5 [3020393]
1.2e+00
2.0e+00
—
—
—
2.6e+00
2.1e+00
cases:1.43%
controls:0.44%
cases:0.68%
controls:0.09%
—
—
—
—
—
—
cases:0.50%
controls:0.04%
cases:1.10%
controls:0.13%
21
64
1445
14463
10
13
1468
14615
—
—
—
7
5
1381
13614
10
12
895
9041
Social worker
Z2446 [2001311559]
8.7e-01
1.3e+00
1.6e+00
—
2.1e+00
1.6e+00
2.1e+00
cases:5.87%
controls:2.55%
cases:2.44%
controls:0.66%
cases:0.34%
controls:0.07%
—
—
cases:0.61%
controls:0.08%
cases:1.59%
controls:0.34%
cases:4.64%
controls:0.59%
86
371
1380
14156
36
97
1442
14531
5
10
1473
14618
—
9
11
1459
14534
22
46
1366
13573
42
53
863
9000
Magnesium [Moles/volume] in Serum or Plasma
2601-3 [3012095]
6.8e-01
1.2e+00
1.6e+00
—
1.7e+00
1.3e+00
1.3e+00
cases:7.50%
controls:3.93%
cases:5.01%
controls:1.63%
cases:1.42%
controls:0.29%
—
—
cases:1.50%
controls:0.28%
cases:5.40%
controls:1.49%
cases:11.93%
controls:3.50%
110
571
1356
13956
74
238
1404
14390
21
43
1457
14585
—
22
40
1446
14505
75
203
1313
13416
108
317
797
8736
Erythrocytes [#/volume] in Urine
30391-7 [3002582]
2.8e-01
6.6e-01
8.9e-01
3.2e+00
1.4e+00
6.3e-01
7.6e-01
cases:13.23%
controls:10.35%
cases:7.78%
controls:4.16%
cases:1.42%
controls:0.59%
cases:0.81%
controls:0.03%
cases:1.77%
controls:0.45%
cases:6.63%
controls:3.66%
cases:17.68%
controls:9.09%
194
1503
1272
13024
115
609
1363
14019
21
86
1457
14542
12
5
1465
14623
26
66
1442
14479
92
498
1296
13121
160
823
745
8230
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
3.8e-01
6.6e-01
1.1e+00
3.3e+00
9.7e-01
6.1e-01
7.3e-01
cases:14.80%
controls:10.62%
cases:9.27%
controls:5.01%
cases:2.37%
controls:0.80%
cases:1.08%
controls:0.04%
cases:2.11%
controls:0.81%
cases:8.50%
controls:4.79%
cases:18.67%
controls:9.96%
217
1543
1249
12984
137
733
1341
13895
35
117
1443
14511
16
6
1461
14622
31
118
1437
14427
118
652
1270
12967
169
902
736
8151
Pediatric Hematology-Oncology
OMOP4822028 [45756811]
8.2e-01
1.1e+00
1.5e+00
—
1.6e+00
1.2e+00
1.5e+00
cases:3.75%
controls:1.69%
cases:3.45%
controls:1.13%
cases:1.76%
controls:0.40%
—
—
cases:1.57%
controls:0.32%
cases:3.31%
controls:1.02%
cases:5.86%
controls:1.41%
55
245
1411
14282
51
165
1427
14463
26
59
1452
14569
—
23
46
1445
14499
46
139
1342
13480
53
128
852
8925
Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 [3029287]
2.6e-01
6.9e-01
1.0e+00
3.1e+00
1.4e+00
7.0e-01
8.4e-01
cases:13.92%
controls:11.07%
cases:8.12%
controls:4.22%
cases:1.56%
controls:0.57%
cases:0.88%
controls:0.04%
cases:1.84%
controls:0.47%
cases:7.20%
controls:3.72%
cases:18.78%
controls:9.05%
204
1608
1262
12919
120
618
1358
14010
23
83
1455
14545
13
6
1464
14622
27
68
1441
14477
100
506
1288
13113
170
819
735
8234
Leukocytes [#/volume] in Urine
30405-5 [3018095]
3.2e-01
6.9e-01
8.1e-01
3.3e+00
1.2e+00
7.3e-01
6.3e-01
cases:16.23%
controls:12.36%
cases:10.55%
controls:5.61%
cases:1.83%
controls:0.82%
cases:0.88%
controls:0.03%
cases:2.18%
controls:0.67%
cases:10.01%
controls:5.10%
cases:20.99%
controls:12.45%
238
1795
1228
12732
156
821
1322
13807
27
120
1451
14508
13
5
1464
14623
32
98
1436
14447
139
694
1249
12925
190
1127
715
7926
Differential panel, method unspecified - Blood
69738-3 [42870588]
3.3e-01
6.0e-01
1.0e+00
3.4e+00
9.2e-01
6.6e-01
6.7e-01
cases:18.89%
controls:14.31%
cases:12.79%
controls:7.46%
cases:4.67%
controls:1.70%
cases:1.35%
controls:0.05%
cases:3.54%
controls:1.44%
cases:12.61%
controls:6.96%
cases:23.87%
controls:13.87%
277
2079
1189
12448
189
1091
1289
13537
69
249
1409
14379
20
7
1457
14621
52
209
1416
14336
175
948
1213
12671
216
1256
689
7797
Reticulocytes/Erythrocytes in Blood
4679-7 [3027945]
6.4e-01
1.2e+00
1.5e+00
1.0e+50
1.6e+00
1.3e+00
1.2e+00
cases:6.55%
controls:3.58%
cases:5.01%
controls:1.58%
cases:1.01%
controls:0.22%
cases:1.08%
controls:0.00%
cases:1.23%
controls:0.25%
cases:4.61%
controls:1.24%
cases:11.05%
controls:3.53%
96
520
1370
14007
74
231
1404
14397
15
32
1463
14596
16
0
1461
14628
18
36
1450
14509
64
169
1324
13450
100
320
805
8733
Reticulocytes [#/volume] in Blood
14196-0 [3023520]
6.9e-01
1.3e+00
1.5e+00
1.0e+50
1.6e+00
1.3e+00
1.2e+00
cases:3.89%
controls:1.98%
cases:3.25%
controls:0.91%
cases:0.61%
controls:0.14%
cases:0.68%
controls:0.00%
cases:0.75%
controls:0.15%
cases:3.10%
controls:0.88%
cases:7.85%
controls:2.57%
57
288
1409
14239
48
133
1430
14495
9
20
1469
14608
10
0
1467
14628
11
22
1457
14523
43
120
1345
13499
71
233
834
8820
Insulin [Units/volume] in Serum or Plasma
20448-7 [3016244]
7.3e-01
1.4e+00
—
—
2.3e+00
1.3e+00
1.8e+00
cases:1.84%
controls:0.89%
cases:1.62%
controls:0.42%
—
—
—
—
cases:0.48%
controls:0.05%
cases:1.37%
controls:0.37%
cases:5.41%
controls:0.92%
27
130
1439
14397
24
61
1454
14567
—
—
7
7
1461
14538
19
51
1369
13568
49
83
856
8970
aPTT in Platelet poor plasma by Coagulation assay
14979-9 [3018677]
6.5e-01
9.5e-01
1.8e+00
—
1.7e+00
1.1e+00
1.3e+00
cases:8.25%
controls:4.48%
cases:4.74%
controls:1.89%
cases:1.35%
controls:0.23%
—
—
cases:0.95%
controls:0.17%
cases:3.53%
controls:1.17%
cases:9.94%
controls:2.99%
121
651
1345
13876
70
277
1408
14351
20
34
1458
14594
—
14
25
1454
14520
49
159
1339
13460
90
271
815
8782
CD4 cells/Lymphocytes in Specimen
80223-1 [21494815]
6.7e-01
1.5e+00
2.8e+00
—
—
1.5e+00
1.7e+00
cases:1.43%
controls:0.74%
cases:1.35%
controls:0.31%
cases:0.54%
controls:0.03%
—
—
—
—
cases:1.08%
controls:0.23%
cases:2.65%
controls:0.51%
21
107
1445
14420
20
46
1458
14582
8
5
1470
14623
—
—
15
32
1373
13587
24
46
881
9007
Other chronic renal failure
N18.8 [45534123]
2.1e+00
1.9e+00
—
—
—
1.5e+00
1.9e+00
cases:1.77%
controls:0.23%
cases:1.01%
controls:0.15%
—
—
—
—
—
—
cases:0.72%
controls:0.15%
cases:1.77%
controls:0.28%
26
33
1440
14494
15
22
1463
14606
—
—
—
10
21
1378
13598
16
25
889
9028
mycophenolic acid; oral, parenteral
L04AA06 [21603896]
1.6e+00
1.5e+00
1.7e+00
—
1.4e+00
1.9e+00
2.5e+00
cases:1.30%
controls:0.28%
cases:1.29%
controls:0.30%
cases:0.47%
controls:0.09%
—
—
cases:0.41%
controls:0.10%
cases:1.80%
controls:0.29%
cases:3.09%
controls:0.25%
19
40
1447
14487
19
44
1459
14584
7
13
1471
14615
—
6
14
1462
14531
25
39
1363
13580
28
23
877
9030
General anesthesia, balanced
WX408 [2001310808]
6.5e-01
1.2e+00
1.5e+00
1.0e+50
1.8e+00
1.0e+00
1.1e+00
cases:11.39%
controls:6.26%
cases:3.99%
controls:1.27%
cases:0.61%
controls:0.13%
cases:0.41%
controls:0.00%
cases:0.68%
controls:0.12%
cases:2.52%
controls:0.90%
cases:7.85%
controls:2.86%
167
910
1299
13617
59
186
1419
14442
9
19
1469
14609
6
0
1471
14628
10
17
1458
14528
35
123
1353
13496
71
259
834
8794
felodipine; oral
C08CA02 [21601748]
2.3e+00
1.6e+00
—
—
—
1.7e+00
1.7e+00
cases:2.18%
controls:0.23%
cases:1.08%
controls:0.22%
—
—
—
—
—
—
cases:1.22%
controls:0.23%
cases:1.33%
controls:0.25%
32
33
1434
14494
16
32
1462
14596
—
—
—
17
32
1371
13587
12
23
893
9030
General evaluation of the need for rehabilitation
R1100 [2001310172]
1.2e+00
2.0e+00
—
—
—
1.5e+00
2.4e+00
cases:2.05%
controls:0.60%
cases:0.95%
controls:0.12%
—
—
—
—
—
—
cases:0.65%
controls:0.14%
cases:2.76%
controls:0.27%
30
87
1436
14440
14
18
1464
14610
—
—
—
9
19
1379
13600
25
24
880
9029
Abdominal ultrasound examination
JN3AE [2001305555]
8.0e-01
1.3e+00
2.5e+00
—
1.8e+00
1.4e+00
1.2e+00
cases:7.09%
controls:3.33%
cases:3.25%
controls:0.93%
cases:0.61%
controls:0.05%
—
—
cases:0.34%
controls:0.06%
cases:2.74%
controls:0.71%
cases:7.40%
controls:2.37%
104
484
1362
14043
48
136
1430
14492
9
7
1469
14621
—
5
8
1463
14537
38
97
1350
13522
67
215
838
8838
Immunohistochemistry procedure
117617002 [4035726]
6.1e-01
1.1e+00
—
—
2.5e+00
1.5e+00
1.5e+00
cases:2.73%
controls:1.51%
cases:1.35%
controls:0.45%
—
—
—
—
cases:0.41%
controls:0.03%
cases:1.15%
controls:0.26%
cases:3.20%
controls:0.74%
40
219
1426
14308
20
66
1458
14562
—
—
6
5
1462
14540
16
36
1372
13583
29
67
876
8986
CD3-CD16+CD56+ (Natural killer) cells/cells in Blood
8112-5 [3027831]
7.0e-01
1.4e+00
2.5e+00
—
—
1.4e+00
1.7e+00
cases:1.57%
controls:0.78%
cases:1.35%
controls:0.33%
cases:0.47%
controls:0.04%
—
—
—
—
cases:1.08%
controls:0.26%
cases:2.98%
controls:0.54%
23
114
1443
14413
20
48
1458
14580
7
6
1471
14622
—
—
15
35
1373
13584
27
49
878
9004
Case Management Agency
251B00000X [38004193]
3.9e-01
2.0e-01
3.7e-01
5.2e+00
5.9e-01
4.5e-01
4.1e-01
cases:93.52%
controls:90.71%
cases:88.97%
controls:86.85%
cases:48.58%
controls:39.55%
cases:83.89%
controls:2.67%
cases:53.20%
controls:38.76%
cases:92.22%
controls:88.31%
cases:98.56%
controls:97.86%
1371
13178
95
1349
1315
12704
163
1924
718
5785
760
8843
1239
390
238
14238
781
5637
687
8908
1280
12027
108
1592
892
8859
13
194
Extraction of multiple teeth
EBA15 [2001301927]
1.6e+00
1.5e+00
—
1.0e+50
—
2.4e+00
1.5e+00
cases:2.11%
controls:0.43%
cases:0.68%
controls:0.15%
—
—
cases:0.88%
controls:0.00%
—
—
cases:1.37%
controls:0.12%
cases:1.88%
controls:0.42%
31
63
1435
14464
10
22
1468
14606
—
13
0
1464
14628
—
19
17
1369
13602
17
38
888
9015
Pediatric Gastroenterology
OMOP4822029 [45756810]
8.7e-01
1.1e+00
1.5e+00
—
1.4e+00
1.2e+00
1.0e+00
cases:4.30%
controls:1.85%
cases:2.57%
controls:0.86%
cases:0.74%
controls:0.17%
—
—
cases:0.75%
controls:0.19%
cases:2.16%
controls:0.68%
cases:4.09%
controls:1.49%
63
269
1403
14258
38
126
1440
14502
11
25
1467
14603
—
11
28
1457
14517
30
93
1358
13526
37
135
868
8918
Infiltration anesthesia
WX110 [2001310767]
2.1e-01
2.1e-01
4.3e-01
4.5e+00
1.2e+00
7.6e-01
3.3e-01
cases:35.40%
controls:30.74%
cases:13.80%
controls:11.46%
cases:2.37%
controls:1.55%
cases:6.77%
controls:0.08%
cases:4.97%
controls:1.51%
cases:21.25%
controls:11.16%
cases:39.67%
controls:32.07%
519
4466
947
10061
204
1676
1274
12952
35
227
1443
14401
100
12
1377
14616
73
220
1395
14325
295
1520
1093
12099
359
2903
546
6150
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
2.1e-01
5.7e-01
1.0e+00
3.0e+00
9.4e-01
6.4e-01
8.3e-01
cases:16.98%
controls:14.22%
cases:10.22%
controls:6.02%
cases:3.04%
controls:1.11%
cases:1.49%
controls:0.08%
cases:2.25%
controls:0.89%
cases:9.22%
controls:5.08%
cases:22.65%
controls:11.37%
249
2066
1217
12461
151
881
1327
13747
45
163
1433
14465
22
11
1455
14617
33
130
1435
14415
128
692
1260
12927
205
1029
700
8024
Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
80721-4 [21493690]
6.7e-01
1.5e+00
2.5e+00
—
—
1.4e+00
1.7e+00
cases:1.57%
controls:0.81%
cases:1.42%
controls:0.33%
cases:0.47%
controls:0.04%
—
—
—
—
cases:1.08%
controls:0.26%
cases:2.87%
controls:0.56%
23
118
1443
14409
21
48
1457
14580
7
6
1471
14622
—
—
15
36
1373
13583
26
51
879
9002
IgG [Mass/volume] in Serum or Plasma
2465-3 [3005719]
5.4e-01
9.9e-01
2.0e+00
—
1.5e+00
1.0e+00
9.4e-01
cases:5.59%
controls:3.35%
cases:3.52%
controls:1.34%
cases:1.35%
controls:0.18%
—
—
cases:0.89%
controls:0.19%
cases:2.81%
controls:1.06%
cases:6.52%
controls:2.65%
82
487
1384
14040
52
196
1426
14432
20
27
1458
14601
—
13
28
1455
14517
39
144
1349
13475
59
240
846
8813
Other disorders resulting from impaired renal tubular function
N25.8 [45582397]
2.8e+00
2.0e+00
—
—
—
—
2.2e+00
cases:1.09%
controls:0.07%
cases:0.41%
controls:0.05%
—
—
—
—
—
—
—
—
cases:0.88%
controls:0.10%
16
10
1450
14517
6
8
1472
14620
—
—
—
—
8
9
897
9044
CD3 cells/Lymphocytes in Blood
90304-7 [1175426]
7.0e-01
1.4e+00
2.5e+00
—
—
1.4e+00
1.7e+00
cases:1.57%
controls:0.78%
cases:1.35%
controls:0.34%
cases:0.47%
controls:0.04%
—
—
—
—
cases:1.08%
controls:0.26%
cases:2.98%
controls:0.56%
23
114
1443
14413
20
50
1458
14578
7
6
1471
14622
—
—
15
35
1373
13584
27
51
878
9002
CD3 cells [#/volume] in Blood
8122-4 [3011412]
6.2e-01
1.3e+00
2.5e+00
—
—
1.4e+00
1.7e+00
cases:1.57%
controls:0.85%
cases:1.35%
controls:0.36%
cases:0.47%
controls:0.04%
—
—
—
—
cases:1.08%
controls:0.26%
cases:3.09%
controls:0.56%
23
124
1443
14403
20
52
1458
14576
7
6
1471
14622
—
—
15
36
1373
13583
28
51
877
9002
CD3+CD8+ (T8 suppressor) cells/cells in Blood
8101-8 [3007449]
6.9e-01
1.3e+00
2.5e+00
—
—
1.3e+00
1.8e+00
cases:1.36%
controls:0.69%
cases:1.15%
controls:0.31%
cases:0.41%
controls:0.03%
—
—
—
—
cases:0.94%
controls:0.25%
cases:2.43%
controls:0.43%
20
100
1446
14427
17
45
1461
14583
6
5
1472
14623
—
—
13
34
1375
13585
22
39
883
9014
Urate [Moles/volume] in Serum or Plasma
14933-6 [3026493]
5.7e-01
1.1e+00
1.3e+00
—
1.8e+00
1.0e+00
1.1e+00
cases:7.57%
controls:4.44%
cases:4.87%
controls:1.72%
cases:0.81%
controls:0.23%
—
—
cases:1.16%
controls:0.19%
cases:3.89%
controls:1.42%
cases:11.16%
controls:3.83%
111
645
1355
13882
72
252
1406
14376
12
34
1466
14594
—
17
28
1451
14517
54
194
1334
13425
101
347
804
8706
Intravenous general anesthesia
WX404 [2001310807]
8.1e-01
1.2e+00
1.2e+00
—
2.0e+00
1.5e+00
1.3e+00
cases:12.28%
controls:5.85%
cases:4.60%
controls:1.39%
cases:0.68%
controls:0.21%
—
—
cases:1.02%
controls:0.14%
cases:3.31%
controls:0.79%
cases:7.40%
controls:2.03%
180
850
1286
13677
68
203
1410
14425
10
31
1468
14597
—
15
20
1453
14525
46
107
1342
13512
67
184
838
8869
CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
14135-8 [3001405]
5.8e-01
1.3e+00
2.5e+00
—
—
1.3e+00
1.8e+00
cases:1.36%
controls:0.77%
cases:1.15%
controls:0.33%
cases:0.41%
controls:0.03%
—
—
—
—
cases:0.94%
controls:0.25%
cases:2.65%
controls:0.46%
20
112
1446
14415
17
48
1461
14580
6
5
1472
14623
—
—
13
34
1375
13585
24
42
881
9011
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
1.9e-01
5.1e-01
9.8e-01
3.0e+00
8.9e-01
5.9e-01
8.0e-01
cases:17.87%
controls:15.24%
cases:10.69%
controls:6.68%
cases:3.11%
controls:1.20%
cases:1.42%
controls:0.07%
cases:2.38%
controls:0.99%
cases:9.65%
controls:5.61%
cases:24.53%
controls:12.74%
262
2214
1204
12313
158
977
1320
13651
46
175
1432
14453
21
10
1456
14618
35
144
1433
14401
134
764
1254
12855
222
1153
683
7900
CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
9728-7 [3025271]
5.8e-01
1.3e+00
2.5e+00
—
—
1.3e+00
1.7e+00
cases:1.36%
controls:0.77%
cases:1.22%
controls:0.33%
cases:0.47%
controls:0.04%
—
—
—
—
cases:1.01%
controls:0.26%
cases:2.65%
controls:0.50%
20
112
1446
14415
18
49
1460
14579
7
6
1471
14622
—
—
14
36
1374
13583
24
45
881
9008
Phosphate [Moles/volume] in Serum or Plasma
14879-1 [3003458]
5.4e-01
9.8e-01
1.4e+00
—
1.5e+00
1.2e+00
1.2e+00
cases:9.14%
controls:5.55%
cases:6.77%
controls:2.65%
cases:2.03%
controls:0.53%
—
—
cases:1.77%
controls:0.40%
cases:6.56%
controls:2.17%
cases:13.70%
controls:4.66%
134
806
1332
13721
100
388
1378
14240
30
78
1448
14550
—
26
58
1442
14487
91
295
1297
13324
124
422
781
8631
sulfadiazine and trimethoprim
J01EE02 [21602962]
6.2e-01
1.1e+00
1.6e+00
—
1.5e+00
1.0e+00
6.8e-01
cases:9.62%
controls:5.40%
cases:4.40%
controls:1.47%
cases:1.62%
controls:0.32%
—
—
cases:1.23%
controls:0.28%
cases:3.31%
controls:1.20%
cases:5.30%
controls:2.75%
141
785
1325
13742
65
215
1413
14413
24
47
1454
14581
—
18
40
1450
14505
46
164
1342
13455
48
249
857
8804
Monocytes/Leukocytes in Blood
26485-3 [3019069]
1.7e-01
4.4e-01
8.9e-01
3.3e+00
7.6e-01
6.1e-01
6.0e-01
cases:22.65%
controls:19.83%
cases:14.75%
controls:10.04%
cases:5.21%
controls:2.21%
cases:1.62%
controls:0.06%
cases:3.95%
controls:1.89%
cases:15.27%
controls:8.91%
cases:30.06%
controls:19.02%
332
2881
1134
11646
218
1469
1260
13159
77
324
1401
14304
24
9
1453
14619
58
275
1410
14270
212
1214
1176
12405
272
1722
633
7331
Gas panel - Venous blood
24339-4 [3000991]
5.0e-01
9.3e-01
1.0e+00
—
1.7e+00
1.1e+00
1.3e+00
cases:7.91%
controls:4.95%
cases:5.41%
controls:2.20%
cases:1.22%
controls:0.44%
—
—
cases:1.36%
controls:0.25%
cases:4.76%
controls:1.67%
cases:12.27%
controls:3.50%
116
719
1350
13808
80
322
1398
14306
18
64
1460
14564
—
20
37
1448
14508
66
227
1322
13392
111
317
794
8736
Another gingival hyperplasia
K06.18 [2000502738]
2.6e+00
—
—
1.0e+50
—
—
4.0e+00
cases:0.89%
controls:0.07%
—
—
—
—
cases:0.61%
controls:0.00%
—
—
—
—
cases:2.98%
controls:0.06%
13
10
1453
14517
—
—
9
0
1468
14628
—
—
27
5
878
9048
Eosinophils/Leukocytes in Blood
26450-7 [3006504]
1.7e-01
4.4e-01
8.6e-01
3.3e+00
7.7e-01
6.1e-01
6.0e-01
cases:22.58%
controls:19.74%
cases:14.82%
controls:10.04%
cases:5.07%
controls:2.22%
cases:1.62%
controls:0.06%
cases:3.95%
controls:1.88%
cases:15.27%
controls:8.92%
cases:30.06%
controls:19.01%
331
2868
1135
11659
219
1469
1259
13159
75
325
1403
14303
24
9
1453
14619
58
273
1410
14272
212
1215
1176
12404
272
1721
633
7332
Preventive oral health care, short
SCA01 [2001310302]
1.4e-01
-6.1e-02
4.6e-01
5.1e+00
1.2e+00
2.3e-01
3.2e-01
cases:26.81%
controls:24.18%
cases:8.05%
controls:8.52%
cases:1.22%
controls:0.77%
cases:6.16%
controls:0.04%
cases:2.66%
controls:0.84%
cases:10.09%
controls:8.19%
cases:31.71%
controls:25.23%
393
3512
1073
11015
119
1246
1359
13382
18
113
1460
14515
91
6
1386
14622
39
122
1429
14423
140
1115
1248
12504
287
2284
618
6769
Basophils/Leukocytes in Blood
30180-4 [3022096]
1.8e-01
4.5e-01
8.9e-01
3.3e+00
7.3e-01
6.1e-01
6.1e-01
cases:22.58%
controls:19.66%
cases:14.82%
controls:10.03%
cases:5.21%
controls:2.21%
cases:1.62%
controls:0.06%
cases:3.81%
controls:1.88%
cases:15.27%
controls:8.94%
cases:30.06%
controls:18.98%
331
2856
1135
11671
219
1467
1259
13161
77
324
1401
14304
24
9
1453
14619
56
274
1412
14271
212
1218
1176
12401
272
1718
633
7335
Lymphocytes/Leukocytes in Blood
26478-8 [3002030]
1.7e-01
4.2e-01
8.8e-01
3.3e+00
7.6e-01
5.7e-01
5.8e-01
cases:23.67%
controls:20.81%
cases:15.02%
controls:10.44%
cases:5.28%
controls:2.27%
cases:1.69%
controls:0.06%
cases:4.02%
controls:1.93%
cases:15.42%
controls:9.35%
cases:31.05%
controls:20.13%
347
3023
1119
11504
222
1527
1256
13101
78
332
1400
14296
25
9
1452
14619
59
280
1409
14265
214
1273
1174
12346
281
1822
624
7231
Dentinal dysplasia
K00.50 [2000502640]
3.5e+00
—
—
—
—
—
3.1e+00
cases:1.30%
controls:0.04%
—
—
—
—
—
—
—
—
—
—
cases:2.10%
controls:0.10%
19
6
1447
14521
—
—
—
—
—
19
9
886
9044
Simple examination of mouth
SAA01 [2001310274]
1.9e-01
5.1e-01
5.8e-01
4.5e+00
4.9e-01
3.9e-01
3.3e-01
cases:40.38%
controls:35.94%
cases:21.31%
controls:14.03%
cases:3.04%
controls:1.72%
cases:10.16%
controls:0.12%
cases:2.72%
controls:1.69%
cases:18.66%
controls:13.48%
cases:45.86%
controls:37.80%
592
5221
874
9306
315
2052
1163
12576
45
252
1433
14376
150
18
1327
14610
40
246
1428
14299
259
1836
1129
11783
415
3422
490
5631
Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
78445-4 [21492711]
1.7e+00
1.3e+00
—
—
—
1.8e+00
1.7e+00
cases:1.91%
controls:0.34%
cases:0.81%
controls:0.23%
—
—
—
—
—
—
cases:1.22%
controls:0.21%
cases:2.43%
controls:0.45%
28
49
1438
14478
12
34
1466
14594
—
—
—
17
28
1371
13591
22
41
883
9012
Neutrophils/Leukocytes in Blood
26511-6 [3018010]
1.7e-01
4.2e-01
8.5e-01
3.3e+00
6.7e-01
6.1e-01
6.3e-01
cases:23.12%
controls:20.29%
cases:14.95%
controls:10.36%
cases:5.14%
controls:2.27%
cases:1.62%
controls:0.06%
cases:3.75%
controls:1.95%
cases:15.56%
controls:9.11%
cases:30.94%
controls:19.30%
339
2947
1127
11580
221
1516
1257
13112
76
332
1402
14296
24
9
1453
14619
55
284
1413
14261
216
1241
1172
12378
280
1747
625
7306
Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
7853-5 [3015635]
1.2e+00
1.6e+00
—
1.0e+50
—
1.8e+00
1.8e+00
cases:3.82%
controls:1.14%
cases:2.23%
controls:0.47%
—
—
cases:0.47%
controls:0.00%
—
—
cases:1.87%
controls:0.31%
cases:5.41%
controls:0.94%
56
165
1410
14362
33
69
1445
14559
—
7
0
1470
14628
—
26
42
1362
13577
49
85
856
8968
Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
22246-3 [3017918]
1.3e+00
1.5e+00
—
1.0e+50
—
1.8e+00
1.8e+00
cases:3.89%
controls:1.11%
cases:2.17%
controls:0.48%
—
—
cases:0.47%
controls:0.00%
—
—
cases:1.87%
controls:0.31%
cases:5.30%
controls:0.95%
57
161
1409
14366
32
70
1446
14558
—
7
0
1470
14628
—
26
42
1362
13577
48
86
857
8967
Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
7852-7 [3010130]
1.3e+00
1.5e+00
—
1.0e+50
—
1.8e+00
1.7e+00
cases:3.82%
controls:1.12%
cases:2.17%
controls:0.47%
—
—
cases:0.47%
controls:0.00%
—
—
cases:1.87%
controls:0.30%
cases:5.08%
controls:0.94%
56
163
1410
14364
32
69
1446
14559
—
7
0
1470
14628
—
26
41
1362
13578
46
85
859
8968
Sepsis, unspecified
A41.9 [45585911]
1.9e+00
2.2e+00
—
—
—
1.8e+00
2.3e+00
cases:1.77%
controls:0.28%
cases:0.61%
controls:0.07%
—
—
—
—
—
—
cases:0.36%
controls:0.06%
cases:0.88%
controls:0.09%
26
41
1440
14486
9
10
1469
14618
—
—
—
5
8
1383
13611
8
8
897
9045
pH of Urine
2756-5 [3015736]
2.8e-01
5.9e-01
9.2e-01
2.9e+00
8.7e-01
4.8e-01
3.0e-01
cases:15.69%
controls:12.33%
cases:9.34%
controls:5.41%
cases:1.96%
controls:0.79%
cases:0.74%
controls:0.04%
cases:1.63%
controls:0.69%
cases:8.72%
controls:5.60%
cases:19.67%
controls:15.37%
230
1791
1236
12736
138
791
1340
13837
29
116
1449
14512
11
6
1466
14622
24
101
1444
14444
121
763
1267
12856
178
1391
727
7662
IgM [Mass/volume] in Serum or Plasma
2472-9 [3028026]
5.4e-01
8.4e-01
2.1e+00
—
1.9e+00
6.8e-01
9.2e-01
cases:4.50%
controls:2.66%
cases:2.30%
controls:1.00%
cases:0.61%
controls:0.08%
—
—
cases:0.54%
controls:0.08%
cases:1.30%
controls:0.66%
cases:4.75%
controls:1.96%
66
387
1400
14140
34
147
1444
14481
9
11
1469
14617
—
8
12
1460
14533
18
90
1370
13529
43
177
862
8876
Intraoral radiographic dental examination
EB1AA [2001301903]
6.1e-03
4.4e-01
1.2e+00
4.7e+00
3.1e-01
1.5e-01
2.2e-01
cases:15.96%
controls:15.88%
cases:7.17%
controls:4.76%
cases:1.49%
controls:0.45%
cases:3.45%
controls:0.03%
cases:0.82%
controls:0.60%
cases:4.83%
controls:4.19%
cases:17.13%
controls:14.21%
234
2307
1232
12220
106
696
1372
13932
22
66
1456
14562
51
5
1426
14623
12
87
1456
14458
67
571
1321
13048
155
1286
750
7767
Catheterisation of heart with other procedure
TFC99 [2001303401]
1.9e+00
2.3e+00
—
—
—
—
2.0e+00
cases:1.43%
controls:0.21%
cases:0.41%
controls:0.04%
—
—
—
—
—
—
—
—
cases:1.44%
controls:0.19%
21
31
1445
14496
6
6
1472
14622
—
—
—
—
13
17
892
9036
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
2.5e-01
3.2e-01
9.0e-01
3.2e+00
6.1e-01
3.8e-01
5.6e-01
cases:27.15%
controls:22.50%
cases:15.83%
controls:11.98%
cases:4.87%
controls:2.04%
cases:1.35%
controls:0.05%
cases:3.27%
controls:1.81%
cases:15.35%
controls:11.01%
cases:33.92%
controls:22.63%
398
3269
1068
11258
234
1753
1244
12875
72
298
1406
14330
20
8
1457
14620
48
263
1420
14282
213
1500
1175
12119
307
2049
598
7004
Eosinophils [#/volume] in Blood
26449-9 [3013115]
1.6e-01
3.8e-01
8.0e-01
3.3e+00
6.9e-01
5.6e-01
5.2e-01
cases:24.08%
controls:21.35%
cases:15.49%
controls:11.17%
cases:5.35%
controls:2.48%
cases:1.76%
controls:0.07%
cases:4.22%
controls:2.17%
cases:16.57%
controls:10.20%
cases:32.15%
controls:21.93%
353
3101
1113
11426
229
1634
1249
12994
79
363
1399
14265
26
10
1451
14618
62
315
1406
14230
230
1389
1158
12230
291
1985
614
7068
Bicarbonate [Moles/volume] standard in Venous blood
19232-8 [3007628]
5.2e-01
9.6e-01
1.0e+00
—
1.4e+00
9.6e-01
1.4e+00
cases:8.05%
controls:4.94%
cases:5.41%
controls:2.15%
cases:1.22%
controls:0.45%
—
—
cases:1.09%
controls:0.28%
cases:4.25%
controls:1.67%
cases:11.82%
controls:3.27%
118
717
1348
13810
80
315
1398
14313
18
66
1460
14562
—
16
40
1452
14505
59
227
1329
13392
107
296
798
8757
Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
5159-9 [3007844]
1.2e+00
1.7e+00
—
1.0e+50
—
1.9e+00
1.4e+00
cases:4.30%
controls:1.30%
cases:2.44%
controls:0.46%
—
—
cases:0.47%
controls:0.00%
—
—
cases:2.02%
controls:0.29%
cases:4.42%
controls:1.18%
63
189
1403
14338
36
68
1442
14560
—
7
0
1470
14628
—
28
40
1360
13579
40
107
865
8946
ECG with 12 standard connections
XF400 [2001303368]
8.7e-01
1.1e+00
1.9e+00
1.0e+50
—
1.3e+00
9.7e-01
cases:8.39%
controls:3.68%
cases:2.84%
controls:0.98%
cases:0.74%
controls:0.11%
cases:0.68%
controls:0.00%
—
—
cases:2.31%
controls:0.62%
cases:6.19%
controls:2.44%
123
535
1343
13992
42
143
1436
14485
11
16
1467
14612
10
0
1467
14628
—
32
84
1356
13535
56
221
849
8832
ursodeoxycholic acid; oral
A05AA02 [21600513]
1.4e+00
1.5e+00
—
—
—
1.4e+00
1.8e+00
cases:1.36%
controls:0.34%
cases:1.01%
controls:0.23%
—
—
—
—
—
—
cases:1.08%
controls:0.26%
cases:1.99%
controls:0.33%
20
49
1446
14478
15
33
1463
14595
—
—
—
15
35
1373
13584
18
30
887
9023
Urinalysis macro (dipstick) panel - Urine
24357-6 [3037467]
1.5e-01
3.0e-01
5.9e-01
3.4e+00
7.2e-01
5.2e-01
6.3e-01
cases:28.38%
controls:25.45%
cases:13.53%
controls:10.42%
cases:2.71%
controls:1.52%
cases:1.22%
controls:0.04%
cases:2.72%
controls:1.34%
cases:14.55%
controls:9.21%
cases:36.24%
controls:23.24%
416
3697
1050
10830
200
1524
1278
13104
40
223
1438
14405
18
6
1459
14622
40
195
1428
14350
202
1254
1186
12365
328
2104
577
6949
Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
31374-2 [3007080]
1.2e+00
1.7e+00
—
1.0e+50
—
1.9e+00
1.3e+00
cases:4.23%
controls:1.27%
cases:2.44%
controls:0.46%
—
—
cases:0.47%
controls:0.00%
—
—
cases:2.02%
controls:0.30%
cases:4.09%
controls:1.15%
62
185
1404
14342
36
67
1442
14561
—
7
0
1470
14628
—
28
41
1360
13578
37
104
868
8949
Monocytes [#/volume] in Blood
26484-6 [3001604]
1.6e-01
3.9e-01
8.0e-01
3.2e+00
6.3e-01
5.5e-01
5.7e-01
cases:23.40%
controls:20.66%
cases:15.22%
controls:10.82%
cases:5.21%
controls:2.42%
cases:1.62%
controls:0.07%
cases:3.88%
controls:2.10%
cases:16.07%
controls:9.95%
cases:31.82%
controls:20.82%
343
3001
1123
11526
225
1583
1253
13045
77
354
1401
14274
24
10
1453
14618
57
305
1411
14240
223
1355
1165
12264
288
1885
617
7168
Basophils [#/volume] in Blood
26444-0 [3006315]
1.5e-01
3.9e-01
7.9e-01
3.2e+00
6.3e-01
5.5e-01
5.7e-01
cases:23.33%
controls:20.69%
cases:15.22%
controls:10.82%
cases:5.21%
controls:2.43%
cases:1.62%
controls:0.07%
cases:3.88%
controls:2.10%
cases:16.07%
controls:9.97%
cases:31.71%
controls:20.80%
342
3006
1124
11521
225
1583
1253
13045
77
355
1401
14273
24
10
1453
14618
57
305
1411
14240
223
1358
1165
12261
287
1883
618
7170
Lymphocytes [#/volume] in Blood
26474-7 [3019198]
1.5e-01
3.8e-01
7.8e-01
3.2e+00
6.3e-01
5.3e-01
5.9e-01
cases:24.22%
controls:21.53%
cases:15.36%
controls:11.06%
cases:5.21%
controls:2.47%
cases:1.62%
controls:0.07%
cases:3.88%
controls:2.10%
cases:15.99%
controls:10.05%
cases:32.71%
controls:21.29%
355
3128
1111
11399
227
1618
1251
13010
77
361
1401
14267
24
10
1453
14618
57
305
1411
14240
222
1369
1166
12250
296
1927
609
7126
Child and Adolescent Psychiatry
OMOP4821986 [45756756]
5.5e-01
7.5e-01
6.0e-01
1.8e+00
7.4e-01
7.6e-01
8.6e-01
cases:9.55%
controls:5.73%
cases:6.56%
controls:3.21%
cases:2.71%
controls:1.51%
cases:0.74%
controls:0.12%
cases:2.86%
controls:1.38%
cases:6.56%
controls:3.18%
cases:13.59%
controls:6.25%
140
833
1326
13694
97
469
1381
14159
40
221
1438
14407
11
18
1466
14610
42
201
1426
14344
91
433
1297
13186
123
566
782
8487
Extensive angiography of hear and/or coronary arteries
FN1BC [2001303000]
1.5e+00
2.1e+00
—
—
—
1.9e+00
2.5e+00
cases:1.50%
controls:0.34%
cases:0.54%
controls:0.07%
—
—
—
—
—
—
cases:0.43%
controls:0.07%
cases:1.33%
controls:0.11%
22
50
1444
14477
8
10
1470
14618
—
—
—
6
9
1382
13610
12
10
893
9043
Transplant complication
127 [2001600125]
2.5e+00
3.6e+00
—
—
—
—
—
cases:2.66%
controls:0.23%
cases:1.22%
controls:0.03%
—
—
—
—
—
—
—
—
—
—
39
34
1427
14493
18
5
1460
14623
—
—
—
—
—
One hour or less
ZXE00 [2001311394]
6.5e-01
1.1e+00
1.2e+00
—
1.8e+00
1.3e+00
1.2e+00
cases:14.94%
controls:8.42%
cases:4.80%
controls:1.72%
cases:0.61%
controls:0.18%
—
—
cases:0.82%
controls:0.13%
cases:3.75%
controls:1.05%
cases:10.28%
controls:3.39%
219
1223
1247
13304
71
251
1407
14377
9
26
1469
14602
—
12
19
1456
14526
52
143
1336
13476
93
307
812
8746
Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
3193-0 [3005757]
9.7e-01
1.5e+00
1.5e+00
—
—
1.5e+00
2.1e+00
cases:1.91%
controls:0.73%
cases:1.56%
controls:0.36%
cases:0.34%
controls:0.08%
—
—
—
—
cases:1.30%
controls:0.29%
cases:3.54%
controls:0.46%
28
106
1438
14421
23
53
1455
14575
5
11
1473
14617
—
—
18
40
1370
13579
32
42
873
9011
Bacteria [#/volume] in Urine by Automated count
51480-2 [3031040]
1.3e-01
3.7e-01
8.0e-01
2.9e+00
6.8e-01
5.3e-01
6.2e-01
cases:26.53%
controls:24.03%
cases:12.52%
controls:8.99%
cases:2.64%
controls:1.20%
cases:0.88%
controls:0.05%
cases:2.25%
controls:1.15%
cases:12.68%
controls:7.87%
cases:33.81%
controls:21.53%
389
3491
1077
11036
185
1315
1293
13313
39
176
1439
14452
13
7
1464
14621
33
167
1435
14378
176
1072
1212
12547
306
1949
599
7104
Physiotherapy
R4110 [2001310233]
6.4e-01
6.9e-01
1.1e+00
—
1.3e+00
9.9e-01
1.1e+00
cases:11.53%
controls:6.42%
cases:4.94%
controls:2.55%
cases:1.22%
controls:0.39%
—
—
cases:1.23%
controls:0.32%
cases:5.55%
controls:2.13%
cases:12.04%
controls:4.40%
169
932
1297
13595
73
373
1405
14255
18
57
1460
14571
—
18
47
1450
14498
77
290
1311
13329
109
398
796
8655
Base excess in Venous blood by calculation
1927-3 [3002032]
4.2e-01
9.1e-01
9.7e-01
—
1.4e+00
9.3e-01
1.2e+00
cases:8.32%
controls:5.62%
cases:5.68%
controls:2.38%
cases:1.29%
controls:0.49%
—
—
cases:1.16%
controls:0.29%
cases:4.76%
controls:1.94%
cases:12.93%
controls:4.19%
122
816
1344
13711
84
348
1394
14280
19
72
1459
14556
—
17
42
1451
14503
66
264
1322
13355
117
379
788
8674
Pediatric Cardiology
OMOP4821938 [45756805]
5.2e-01
8.2e-01
1.2e+00
1.0e+50
1.6e+00
7.6e-01
9.0e-01
cases:6.21%
controls:3.78%
cases:3.99%
controls:1.80%
cases:0.81%
controls:0.24%
cases:0.61%
controls:0.00%
cases:1.16%
controls:0.23%
cases:3.39%
controls:1.61%
cases:7.29%
controls:3.10%
91
549
1375
13978
59
264
1419
14364
12
35
1466
14593
9
0
1468
14628
17
34
1451
14511
47
219
1341
13400
66
281
839
8772
Supplier / Service Provider
OMOP5117446 [33004]
-3.7e-01
-5.4e-01
-8.3e-01
—
2.1e+00
1.8e+00
2.8e+00
cases:25.99%
controls:33.69%
cases:6.43%
controls:10.58%
cases:0.54%
controls:1.23%
—
—
cases:0.68%
controls:0.08%
cases:5.26%
controls:0.87%
cases:24.53%
controls:1.96%
381
4894
1085
9633
95
1548
1383
13080
8
180
1470
14448
—
10
12
1458
14533
73
119
1315
13500
222
177
683
8876
Carbon dioxide [Partial pressure] in Venous blood
2021-4 [3021447]
4.3e-01
8.8e-01
9.5e-01
—
1.4e+00
9.3e-01
1.2e+00
cases:8.39%
controls:5.64%
cases:5.68%
controls:2.43%
cases:1.29%
controls:0.50%
—
—
cases:1.16%
controls:0.30%
cases:4.90%
controls:1.98%
cases:12.93%
controls:4.21%
123
819
1343
13708
84
355
1394
14273
19
73
1459
14555
—
17
44
1451
14501
68
270
1320
13349
117
381
788
8672
Nitrite [Presence] in Urine by Test strip
5802-4 [3021601]
1.9e-01
4.2e-01
7.4e-01
3.1e+00
7.5e-01
4.2e-01
3.5e-01
cases:18.01%
controls:15.33%
cases:10.69%
controls:7.31%
cases:2.30%
controls:1.11%
cases:0.74%
controls:0.03%
cases:2.18%
controls:1.05%
cases:11.02%
controls:7.53%
cases:25.30%
controls:19.25%
264
2227
1202
12300
158
1069
1320
13559
34
162
1444
14466
11
5
1466
14623
32
152
1436
14393
153
1025
1235
12594
229
1743
676
7310
Tooth plaque
K03.66 [2000502691]
5.0e-01
7.9e-01
—
—
2.3e+00
1.0e+00
1.1e+00
cases:5.12%
controls:3.17%
cases:2.64%
controls:1.21%
—
—
—
—
cases:1.09%
controls:0.11%
cases:3.89%
controls:1.44%
cases:13.92%
controls:4.88%
75
460
1391
14067
39
177
1439
14451
—
—
16
16
1452
14529
54
196
1334
13423
126
442
779
8611
Prothrombin time (PT) actual/Normal
5894-1 [3033658]
4.9e-01
8.0e-01
1.3e+00
—
1.4e+00
8.4e-01
9.2e-01
cases:13.17%
controls:8.49%
cases:7.24%
controls:3.40%
cases:2.03%
controls:0.54%
—
—
cases:1.57%
controls:0.40%
cases:5.98%
controls:2.68%
cases:14.36%
controls:6.26%
193
1234
1273
13293
107
497
1371
14131
30
79
1448
14549
—
23
58
1445
14487
83
365
1305
13254
130
567
775
8486
pH of Venous blood
2746-6 [3012544]
4.3e-01
8.9e-01
9.3e-01
—
1.4e+00
9.1e-01
1.2e+00
cases:8.46%
controls:5.65%
cases:5.68%
controls:2.41%
cases:1.29%
controls:0.51%
—
—
cases:1.16%
controls:0.30%
cases:4.76%
controls:1.98%
cases:13.04%
controls:4.24%
124
821
1342
13706
84
352
1394
14276
19
75
1459
14553
—
17
43
1451
14502
66
269
1322
13350
118
384
787
8669
Chronic kidney disease
N18 [45582391]
2.8e+00
—
—
—
—
—
2.9e+00
cases:1.84%
controls:0.11%
—
—
—
—
—
—
—
—
—
—
cases:1.22%
controls:0.07%
27
16
1439
14511
—
—
—
—
—
11
6
894
9047
Periodontal treatment by dental hygienist, extensive
SDE03 [2001310351]
5.3e-01
1.5e+00
—
—
2.5e+00
1.7e+00
2.0e-01
cases:3.21%
controls:1.91%
cases:0.81%
controls:0.18%
—
—
—
—
cases:0.61%
controls:0.05%
cases:1.22%
controls:0.23%
cases:1.10%
controls:0.91%
47
278
1419
14249
12
27
1466
14601
—
—
9
7
1459
14538
17
31
1371
13588
10
82
895
8971
Glucose [Presence] in Urine by Test strip
25428-4 [3009261]
1.9e-01
4.2e-01
6.8e-01
3.1e+00
7.4e-01
4.4e-01
3.5e-01
cases:18.28%
controls:15.57%
cases:10.89%
controls:7.45%
cases:2.23%
controls:1.14%
cases:0.74%
controls:0.03%
cases:2.18%
controls:1.05%
cases:11.31%
controls:7.61%
cases:25.64%
controls:19.47%
268
2262
1198
12265
161
1090
1317
13538
33
167
1445
14461
11
5
1466
14623
32
153
1436
14392
157
1037
1231
12582
232
1763
673
7290
Ketones [Presence] in Urine by Test strip
2514-8 [3035350]
1.7e-01
4.0e-01
7.0e-01
3.1e+00
7.3e-01
4.4e-01
3.5e-01
cases:17.94%
controls:15.53%
cases:10.83%
controls:7.49%
cases:2.23%
controls:1.12%
cases:0.74%
controls:0.03%
cases:2.18%
controls:1.06%
cases:11.24%
controls:7.57%
cases:25.64%
controls:19.50%
263
2256
1203
12271
160
1096
1318
13532
33
164
1445
14464
11
5
1466
14623
32
154
1436
14391
156
1031
1232
12588
232
1765
673
7288
Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]
1.6e-01
3.5e-01
6.9e-01
2.9e+00
6.6e-01
5.4e-01
6.0e-01
cases:25.99%
controls:23.04%
cases:16.31%
controls:12.06%
cases:5.48%
controls:2.83%
cases:1.76%
controls:0.10%
cases:4.70%
controls:2.48%
cases:17.00%
controls:10.67%
cases:34.14%
controls:22.24%
381
3347
1085
11180
241
1764
1237
12864
81
414
1397
14214
26
15
1451
14613
69
360
1399
14185
236
1453
1152
12166
309
2013
596
7040
Other blockage of nerve
WX290 [2001310792]
1.6e-01
9.2e-02
-2.9e-04
4.1e+00
8.7e-01
6.9e-01
2.0e-02
cases:18.28%
controls:15.99%
cases:6.16%
controls:5.65%
cases:0.68%
controls:0.68%
cases:2.37%
controls:0.04%
cases:1.77%
controls:0.75%
cases:10.66%
controls:5.66%
cases:19.01%
controls:18.70%
268
2323
1198
12204
91
826
1387
13802
10
99
1468
14529
35
6
1442
14622
26
109
1442
14436
148
771
1240
12848
172
1693
733
7360
Short blood count panel - Blood
55429-5 [40758558]
3.4e-01
2.1e-01
6.5e-01
3.3e+00
9.9e-01
3.7e-01
9.1e-01
cases:14.67%
controls:10.89%
cases:5.35%
controls:4.39%
cases:1.76%
controls:0.92%
cases:0.95%
controls:0.03%
cases:2.18%
controls:0.83%
cases:5.48%
controls:3.86%
cases:17.46%
controls:7.83%
215
1582
1251
12945
79
642
1399
13986
26
135
1452
14493
14
5
1463
14623
32
120
1436
14425
76
526
1312
13093
158
709
747
8344
More than three and less than five hours
ZXE20 [2001311408]
7.5e-01
1.4e+00
—
—
—
2.1e+00
1.3e+00
cases:3.34%
controls:1.61%
cases:1.22%
controls:0.29%
—
—
—
—
—
—
cases:1.01%
controls:0.12%
cases:2.21%
controls:0.62%
49
234
1417
14293
18
43
1460
14585
—
—
—
14
17
1374
13602
20
56
885
8997
Teeth/gum symptom/complaint
D19 [2002000318]
3.9e-01
9.1e-01
1.6e+00
—
1.6e+00
1.0e+00
2.6e-01
cases:12.14%
controls:8.52%
cases:7.85%
controls:3.32%
cases:1.89%
controls:0.40%
—
—
cases:2.59%
controls:0.52%
cases:9.80%
controls:3.69%
cases:14.03%
controls:11.22%
178
1238
1288
13289
116
485
1362
14143
28
58
1450
14570
—
38
75
1430
14470
136
502
1252
13117
127
1016
778
8037
Psychologist
Z2445 [2001311558]
7.6e-01
1.2e+00
1.1e+00
—
1.3e+00
1.6e+00
2.0e+00
cases:4.57%
controls:2.19%
cases:2.10%
controls:0.66%
cases:0.47%
controls:0.16%
—
—
cases:0.41%
controls:0.11%
cases:1.80%
controls:0.37%
cases:5.08%
controls:0.71%
67
318
1399
14209
31
97
1447
14531
7
23
1471
14605
—
6
16
1462
14529
25
51
1363
13568
46
64
859
8989
HLA Ab [Presence] in Serum
44534-6 [3042733]
2.3e+00
3.3e+00
—
—
—
—
—
cases:1.57%
controls:0.17%
cases:0.88%
controls:0.03%
—
—
—
—
—
—
—
—
—
—
23
24
1443
14503
13
5
1465
14623
—
—
—
—
—
Chronic disorders of vitamin D metabolism
123 [2001600122]
3.0e+00
2.5e+00
—
—
—
—
—
cases:1.98%
controls:0.10%
cases:0.41%
controls:0.03%
—
—
—
—
—
—
—
—
—
—
29
14
1437
14513
6
5
1472
14623
—
—
—
—
—
calcium (different salts in combination); oral
A12AA20 [21600872]
6.4e-01
8.5e-01
9.7e-01
—
1.1e+00
7.8e-01
1.2e+00
cases:7.03%
controls:3.83%
cases:5.68%
controls:2.51%
cases:1.56%
controls:0.59%
—
—
cases:1.57%
controls:0.54%
cases:5.12%
controls:2.41%
cases:9.83%
controls:3.23%
103
557
1363
13970
84
367
1394
14261
23
87
1455
14541
—
23
78
1445
14467
71
328
1317
13291
89
292
816
8761
Epithelial cells.squamous [#/volume] in Urine by Automated count
51486-9 [3029879]
4.9e-01
9.0e-01
1.0e+00
—
1.3e+00
8.1e-01
8.5e-01
cases:8.46%
controls:5.37%
cases:5.14%
controls:2.15%
cases:1.01%
controls:0.38%
—
—
cases:0.95%
controls:0.26%
cases:4.76%
controls:2.17%
cases:11.16%
controls:5.08%
124
780
1342
13747
76
314
1402
14314
15
55
1463
14573
—
14
38
1454
14507
66
296
1322
13323
101
460
804
8593
Normoblasts [#/volume] in Blood
715-3 [3021589]
1.2e-01
2.1e-01
6.5e-01
3.0e+00
6.5e-01
4.4e-01
6.2e-01
cases:22.44%
controls:20.45%
cases:14.68%
controls:12.22%
cases:4.87%
controls:2.61%
cases:1.76%
controls:0.09%
cases:4.43%
controls:2.37%
cases:16.35%
controls:11.22%
cases:30.72%
controls:19.25%
329
2971
1137
11556
217
1788
1261
12840
72
382
1406
14246
26
13
1451
14615
65
345
1403
14200
227
1528
1161
12091
278
1743
627
7310
Outpatient Visit
OP [9202]
6.4e-02
2.6e-01
5.8e-01
3.1e+00
6.0e-01
3.2e-01
4.8e-01
cases:85.95%
controls:85.16%
cases:60.83%
controls:54.59%
cases:17.32%
controls:10.45%
cases:8.87%
controls:0.43%
cases:17.10%
controls:10.14%
cases:59.08%
controls:51.28%
cases:89.17%
controls:83.64%
1260
12371
206
2156
899
7985
579
6643
256
1529
1222
13099
131
63
1346
14565
251
1475
1217
13070
820
6984
568
6635
807
7572
98
1481
Paranasal sinuses X-ray examination in one projection
DM1QA [2001301761]
1.2e+00
2.5e+00
—
—
—
1.4e+00
1.7e+00
cases:1.50%
controls:0.47%
cases:0.95%
controls:0.08%
—
—
—
—
—
—
cases:0.36%
controls:0.09%
cases:2.10%
controls:0.39%
22
68
1444
14459
14
12
1464
14616
—
—
—
5
12
1383
13607
19
35
886
9018
Other stressful life events affecting family and household
Z63.7 [45537662]
9.4e-01
1.3e+00
5.0e-01
—
1.3e+00
1.5e+00
1.5e+00
cases:3.14%
controls:1.25%
cases:2.30%
controls:0.63%
cases:0.34%
controls:0.21%
—
—
cases:0.61%
controls:0.17%
cases:2.31%
controls:0.51%
cases:4.09%
controls:0.92%
46
181
1420
14346
34
92
1444
14536
5
30
1473
14598
—
9
24
1459
14521
32
69
1356
13550
37
83
868
8970
Gas panel - Capillary blood
24337-8 [3022313]
3.8e-01
8.6e-01
1.2e+00
—
1.5e+00
1.1e+00
1.5e+00
cases:6.55%
controls:4.56%
cases:3.65%
controls:1.58%
cases:0.81%
controls:0.25%
—
—
cases:0.89%
controls:0.19%
cases:3.03%
controls:1.06%
cases:7.18%
controls:1.75%
96
662
1370
13865
54
231
1424
14397
12
37
1466
14591
—
13
28
1455
14517
42
145
1346
13474
65
158
840
8895
ABO and Rh group [Type] in Blood by Confirmatory method
77397-8 [46236098]
4.4e-01
7.0e-01
1.4e+00
—
1.2e+00
8.1e-01
7.8e-01
cases:11.05%
controls:7.41%
cases:5.28%
controls:2.70%
cases:1.15%
controls:0.29%
—
—
cases:1.02%
controls:0.31%
cases:4.61%
controls:2.11%
cases:12.38%
controls:6.06%
162
1077
1304
13450
78
395
1400
14233
17
43
1461
14585
—
15
45
1453
14500
64
288
1324
13331
112
549
793
8504
Muscle biopsy of heart
TFJ02 [2001303405]
—
2.7e+00
—
—
—
2.6e+00
—
—
—
cases:0.61%
controls:0.04%
—
—
—
—
—
—
cases:0.58%
controls:0.04%
—
—
—
9
6
1469
14622
—
—
—
8
6
1380
13613
—
Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
41001-9 [3042596]
1.3e+00
2.4e+00
—
—
—
1.2e+00
1.6e+00
cases:2.05%
controls:0.56%
cases:1.08%
controls:0.10%
—
—
—
—
—
—
cases:0.50%
controls:0.15%
cases:1.66%
controls:0.34%
30
81
1436
14446
16
15
1462
14613
—
—
—
7
21
1381
13598
15
31
890
9022
Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
3216-9 [3020427]
1.2e+00
2.1e+00
—
—
—
1.9e+00
1.0e+00
cases:1.77%
controls:0.52%
cases:1.15%
controls:0.14%
—
—
—
—
—
—
cases:0.58%
controls:0.09%
cases:0.99%
controls:0.35%
26
75
1440
14452
17
21
1461
14607
—
—
—
8
12
1380
13607
9
32
896
9021
Extracorporeal dialysis
Z49.1 [45537649]
3.1e+00
—
—
—
—
—
2.1e+00
cases:1.09%
controls:0.05%
—
—
—
—
—
—
—
—
—
—
cases:0.88%
controls:0.11%
16
7
1450
14520
—
—
—
—
—
8
10
897
9043
Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
50548-7 [3030692]
1.4e+00
2.2e+00
—
—
—
1.7e+00
1.6e+00
cases:2.25%
controls:0.56%
cases:1.01%
controls:0.12%
—
—
—
—
—
—
cases:0.50%
controls:0.10%
cases:1.22%
controls:0.25%
33
81
1433
14446
15
17
1463
14611
—
—
—
7
13
1381
13606
11
23
894
9030
General Practice Dentistry
1223G0001X [38003675]
6.5e-01
6.6e-01
—
—
1.9e+00
9.3e-01
9.9e-01
cases:3.41%
controls:1.80%
cases:2.50%
controls:1.31%
—
—
—
—
cases:1.23%
controls:0.19%
cases:3.46%
controls:1.39%
cases:10.39%
controls:4.13%
50
262
1416
14265
37
192
1441
14436
—
—
18
27
1450
14518
48
189
1340
13430
94
374
811
8679
Biopsy of kidney with ultrasound guidance
KA3AT [2001305778]
1.8e+00
1.8e+00
—
—
—
—
3.3e+00
cases:0.95%
controls:0.15%
cases:0.34%
controls:0.05%
—
—
—
—
—
—
—
—
cases:1.44%
controls:0.06%
14
22
1452
14505
5
8
1473
14620
—
—
—
—
13
5
892
9048
acetylsalicylic acid; oral, parenteral, rectal
N02BA01 [21604305]
8.7e-01
1.4e+00
—
—
—
1.2e+00
1.6e+00
cases:1.84%
controls:0.78%
cases:1.62%
controls:0.40%
—
—
—
—
—
—
cases:1.37%
controls:0.41%
cases:3.31%
controls:0.70%
27
113
1439
14414
24
58
1454
14570
—
—
—
19
56
1369
13563
30
63
875
8990
Alpha tocopherol [Moles/volume] in Serum or Plasma
14590-4 [3000208]
1.0e+00
1.2e+00
—
—
—
1.3e+00
1.5e+00
cases:1.50%
controls:0.54%
cases:0.95%
controls:0.27%
—
—
—
—
—
—
cases:0.86%
controls:0.23%
cases:2.21%
controls:0.51%
22
79
1444
14448
14
40
1464
14588
—
—
—
12
32
1376
13587
20
46
885
9007
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]
2.9e-01
3.8e-01
8.7e-01
2.5e+00
6.9e-01
4.6e-01
5.9e-01
cases:16.03%
controls:12.49%
cases:7.92%
controls:5.57%
cases:2.37%
controls:1.00%
cases:0.47%
controls:0.04%
cases:1.77%
controls:0.90%
cases:8.07%
controls:5.24%
cases:19.56%
controls:11.84%
235
1815
1231
12712
117
815
1361
13813
35
147
1443
14481
7
6
1470
14622
26
131
1442
14414
112
714
1276
12905
177
1072
728
7981
Demanding periodontal treatment
SDA04 [2001310329]
3.8e-01
3.0e-01
5.6e-01
1.0e+50
2.7e+00
1.3e+00
6.9e-01
cases:8.19%
controls:5.74%
cases:3.04%
controls:2.27%
cases:0.41%
controls:0.23%
cases:0.68%
controls:0.00%
cases:2.86%
controls:0.20%
cases:8.14%
controls:2.40%
cases:12.49%
controls:6.68%
120
834
1346
13693
45
332
1433
14296
6
34
1472
14594
10
0
1467
14628
42
29
1426
14516
113
327
1275
13292
113
605
792
8448
Outpatient Hospital
22 [8756]
3.4e-01
7.1e-01
1.1e+00
—
1.1e+00
9.1e-01
8.1e-01
cases:22.31%
controls:16.93%
cases:7.98%
controls:4.07%
cases:1.56%
controls:0.55%
—
—
cases:1.57%
controls:0.52%
cases:6.99%
controls:2.92%
cases:16.80%
controls:8.24%
327
2459
1139
12068
118
596
1360
14032
23
80
1455
14548
—
23
75
1445
14470
97
398
1291
13221
152
746
753
8307
Oxygen [Partial pressure] in Venous blood
2705-2 [3024354]
4.4e-01
8.5e-01
8.2e-01
—
1.4e+00
9.6e-01
1.3e+00
cases:7.84%
controls:5.19%
cases:5.14%
controls:2.27%
cases:1.01%
controls:0.45%
—
—
cases:1.09%
controls:0.28%
cases:4.47%
controls:1.75%
cases:12.38%
controls:3.72%
115
754
1351
13773
76
332
1402
14296
15
66
1463
14562
—
16
40
1452
14505
62
239
1326
13380
112
337
793
8716
Transferrin [Mass/volume] in Serum or Plasma
3034-6 [3004789]
6.3e-01
6.9e-01
1.3e+00
—
1.4e+00
1.0e+00
1.2e+00
cases:6.14%
controls:3.37%
cases:3.52%
controls:1.80%
cases:0.61%
controls:0.17%
—
—
cases:0.75%
controls:0.19%
cases:4.11%
controls:1.48%
cases:11.27%
controls:3.81%
90
489
1376
14038
52
263
1426
14365
9
25
1469
14603
—
11
28
1457
14517
57
202
1331
13417
102
345
803
8708
Pediatric Surgery
OMOP4822020 [45756819]
5.7e-01
7.3e-01
8.7e-01
—
1.1e+00
6.9e-01
9.1e-01
cases:14.26%
controls:8.56%
cases:6.77%
controls:3.36%
cases:1.29%
controls:0.54%
—
—
cases:1.36%
controls:0.46%
cases:5.98%
controls:3.11%
cases:15.25%
controls:6.77%
209
1243
1257
13284
100
492
1378
14136
19
79
1459
14549
—
20
67
1448
14478
83
423
1305
13196
138
613
767
8440
Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
3209-4 [3019250]
7.7e-01
1.2e+00
1.4e+00
—
—
1.4e+00
1.5e+00
cases:4.30%
controls:2.04%
cases:2.57%
controls:0.81%
cases:0.54%
controls:0.14%
—
—
—
—
cases:2.31%
controls:0.55%
cases:5.86%
controls:1.40%
63
296
1403
14231
38
119
1440
14509
8
20
1470
14608
—
—
32
75
1356
13544
53
127
852
8926
Insertion of central venous catheter through external or internal jugular vein
TPH15 [2001309600]
1.5e+00
1.7e+00
—
—
—
8.5e-01
1.7e+00
cases:5.18%
controls:1.21%
cases:1.56%
controls:0.30%
—
—
—
—
—
—
cases:0.36%
controls:0.15%
cases:2.54%
controls:0.49%
76
176
1390
14351
23
44
1455
14584
—
—
—
5
21
1383
13598
23
44
882
9009
Nephrology
39 [38004479]
7.6e-01
9.7e-01
1.3e+00
—
1.7e+00
1.0e+00
1.1e+00
cases:1.36%
controls:0.64%
cases:1.15%
controls:0.44%
cases:0.54%
controls:0.15%
—
—
cases:0.61%
controls:0.11%
cases:1.37%
controls:0.49%
cases:1.99%
controls:0.67%
20
93
1446
14434
17
64
1461
14564
8
22
1470
14606
—
9
16
1459
14529
19
67
1369
13552
18
61
887
8992
Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
62424-7 [40765161]
1.2e+00
2.0e+00
—
—
—
1.3e+00
1.6e+00
cases:2.18%
controls:0.67%
cases:0.95%
controls:0.13%
—
—
—
—
—
—
cases:0.50%
controls:0.14%
cases:1.55%
controls:0.31%
32
98
1434
14429
14
19
1464
14609
—
—
—
7
19
1381
13600
14
28
891
9025
TACROLIMUS - yes
TACROLIMUS-1 [2002330222]
2.3e+00
—
—
—
—
—
2.5e+00
cases:0.55%
controls:0.06%
—
—
—
—
—
—
—
—
—
—
cases:0.66%
controls:0.06%
8
8
1458
14519
—
—
—
—
—
6
5
899
9048
Thrombin time
3243-3 [3036489]
7.8e-01
1.1e+00
1.4e+00
—
—
1.4e+00
1.5e+00
cases:4.43%
controls:2.09%
cases:2.50%
controls:0.84%
cases:0.54%
controls:0.14%
—
—
—
—
cases:2.31%
controls:0.56%
cases:5.75%
controls:1.40%
65
304
1401
14223
37
123
1441
14505
8
20
1470
14608
—
—
32
76
1356
13543
52
127
853
8926
Fissure sealant
SCE00 [2001310316]
5.4e-01
3.3e-01
-1.0e+50
1.0e+50
1.9e+00
1.5e+00
7.8e-01
cases:5.18%
controls:3.08%
cases:1.29%
controls:0.93%
cases:0.00%
controls:0.08%
cases:2.03%
controls:0.00%
cases:0.68%
controls:0.10%
cases:3.96%
controls:0.89%
cases:8.73%
controls:4.21%
76
448
1390
14079
19
136
1459
14492
0
12
1478
14616
30
0
1447
14628
10
15
1458
14530
55
121
1333
13498
79
381
826
8672
Approximal wear
K03.00 [2000502665]
2.9e-01
1.1e-01
—
—
2.2e+00
1.3e+00
1.2e+00
cases:1.36%
controls:1.03%
cases:0.61%
controls:0.55%
—
—
—
—
cases:0.61%
controls:0.07%
cases:1.80%
controls:0.52%
cases:5.41%
controls:1.65%
20
149
1446
14378
9
80
1469
14548
—
—
9
10
1459
14535
25
71
1363
13548
49
149
856
8904
Other labeling with X-ray guidance
XX3BT [2001311121]
—
1.5e+00
—
—
—
2.1e+00
2.6e+00
—
—
cases:0.54%
controls:0.12%
—
—
—
—
—
—
cases:0.58%
controls:0.07%
cases:0.88%
controls:0.07%
—
8
18
1470
14610
—
—
—
8
10
1380
13609
8
6
897
9047
Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
3255-7 [3016407]
7.7e-01
1.1e+00
1.4e+00
—
—
1.3e+00
1.5e+00
cases:4.30%
controls:2.03%
cases:2.50%
controls:0.83%
cases:0.54%
controls:0.13%
—
—
—
—
cases:2.16%
controls:0.59%
cases:5.64%
controls:1.37%
63
295
1403
14232
37
122
1441
14506
8
19
1470
14609
—
—
30
81
1358
13538
51
124
854
8929
Written specialist consultation based on a referral from a dentist or a physician
WZC10 [2001310887]
1.0e+00
1.5e+00
—
—
—
1.8e+00
1.8e+00
cases:1.36%
controls:0.49%
cases:0.47%
controls:0.11%
—
—
—
—
—
—
cases:0.86%
controls:0.15%
cases:2.10%
controls:0.34%
20
71
1446
14456
7
16
1471
14612
—
—
—
12
20
1376
13599
19
31
886
9022
Cleft hard palate
Q35.1 [45539274]
2.1e+00
2.5e+00
—
—
—
—
—
cases:0.41%
controls:0.05%
cases:0.41%
controls:0.03%
—
—
—
—
—
—
—
—
—
—
6
7
1460
14520
6
5
1472
14623
—
—
—
—
—
Leukocyte morphology finding [Identifier] in Blood
11156-7 [3008757]
1.1e+00
1.7e+00
—
—
—
—
1.8e+00
cases:1.30%
controls:0.45%
cases:0.61%
controls:0.11%
—
—
—
—
—
—
—
—
cases:0.88%
controls:0.14%
19
65
1447
14462
9
16
1469
14612
—
—
—
—
8
13
897
9040
Bicarbonate [Moles/volume] standard in Capillary blood
19231-0 [3004490]
3.2e-01
7.5e-01
1.0e+00
—
1.4e+00
1.1e+00
1.4e+00
cases:6.41%
controls:4.72%
cases:3.45%
controls:1.66%
cases:0.74%
controls:0.27%
—
—
cases:0.89%
controls:0.21%
cases:3.10%
controls:1.08%
cases:6.85%
controls:1.87%
94
686
1372
13841
51
243
1427
14385
11
39
1467
14589
—
13
31
1455
14514
43
147
1345
13472
62
169
843
8884
acetylsalicylic acid; oral
B01AC06 [21600991]
7.9e-01
1.2e+00
—
—
—
1.0e+00
1.5e+00
cases:1.91%
controls:0.87%
cases:1.62%
controls:0.47%
—
—
—
—
—
—
cases:1.37%
controls:0.48%
cases:3.31%
controls:0.75%
28
127
1438
14400
24
69
1454
14559
—
—
—
19
66
1369
13553
30
68
875
8985
Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
27811-9 [3000515]
7.7e-01
1.0e+00
1.4e+00
—
—
1.3e+00
1.4e+00
cases:4.71%
controls:2.24%
cases:2.44%
controls:0.88%
cases:0.54%
controls:0.14%
—
—
—
—
cases:2.23%
controls:0.60%
cases:5.52%
controls:1.36%
69
326
1397
14201
36
128
1442
14500
8
20
1470
14608
—
—
31
82
1357
13537
50
123
855
8930
Iron [Moles/volume] in Serum or Plasma
14798-3 [3022948]
5.0e-01
6.5e-01
1.1e+00
—
1.3e+00
1.0e+00
1.1e+00
cases:6.28%
controls:3.90%
cases:3.65%
controls:1.93%
cases:0.61%
controls:0.20%
—
—
cases:0.75%
controls:0.20%
cases:4.39%
controls:1.63%
cases:11.93%
controls:4.44%
92
566
1374
13961
54
283
1424
14345
9
29
1469
14599
—
11
29
1457
14516
61
222
1327
13397
108
402
797
8651
Blood type and Crossmatch panel - Blood
34531-4 [3044640]
3.2e-01
5.9e-01
1.2e+00
—
1.1e+00
6.5e-01
7.4e-01
cases:13.03%
controls:9.85%
cases:5.95%
controls:3.38%
cases:1.15%
controls:0.36%
—
—
cases:1.09%
controls:0.37%
cases:4.83%
controls:2.57%
cases:14.59%
controls:7.54%
191
1431
1275
13096
88
495
1390
14133
17
52
1461
14576
—
16
54
1452
14491
67
350
1321
13269
132
683
773
8370
Periodontal treatment
SDA03 [2001310328]
3.7e-01
3.6e-01
1.1e+00
1.0e+50
2.5e+00
1.1e+00
6.1e-01
cases:12.96%
controls:9.35%
cases:4.60%
controls:3.25%
cases:0.74%
controls:0.26%
cases:1.90%
controls:0.00%
cases:3.95%
controls:0.35%
cases:9.08%
controls:3.19%
cases:17.02%
controls:9.99%
190
1359
1276
13168
68
475
1410
14153
11
38
1467
14590
28
0
1449
14628
58
51
1410
14494
126
434
1262
13185
154
904
751
8149
Central venous catheter
ZX121 [2001311496]
1.7e+00
2.8e+00
—
—
—
—
—
cases:0.95%
controls:0.17%
cases:0.68%
controls:0.04%
—
—
—
—
—
—
—
—
—
—
14
25
1452
14502
10
6
1468
14622
—
—
—
—
—
Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
72720-6 [43055554]
3.3e-01
7.1e-01
1.0e+00
—
1.5e+00
1.0e+00
1.3e+00
cases:7.16%
controls:5.26%
cases:3.72%
controls:1.86%
cases:0.81%
controls:0.30%
—
—
cases:0.95%
controls:0.22%
cases:3.39%
controls:1.23%
cases:8.18%
controls:2.44%
105
764
1361
13763
55
272
1423
14356
12
44
1466
14584
—
14
32
1454
14513
47
167
1341
13452
74
221
831
8832
Office Visit
OMOP4822458 [581477]
5.1e-01
6.4e-01
5.6e-01
—
1.7e+00
8.5e-01
7.7e-01
cases:15.48%
controls:9.89%
cases:6.36%
controls:3.45%
cases:0.81%
controls:0.46%
—
—
cases:2.11%
controls:0.39%
cases:6.84%
controls:3.05%
cases:15.25%
controls:7.69%
227
1436
1239
13091
94
505
1384
14123
12
68
1466
14560
—
31
56
1437
14489
95
415
1293
13204
138
696
767
8357
Parainfluenza type 2 nucleic acid detection
222351000000102 [44790048]
1.2e+00
1.8e+00
—
—
—
1.3e+00
1.5e+00
cases:1.98%
controls:0.63%
cases:1.15%
controls:0.19%
—
—
—
—
—
—
cases:0.72%
controls:0.20%
cases:1.66%
controls:0.38%
29
92
1437
14435
17
28
1461
14600
—
—
—
10
27
1378
13592
15
34
890
9019
Parainfluenza type 4 nucleic acid detection
810871000000102 [44806118]
1.2e+00
1.8e+00
—
—
—
1.3e+00
1.5e+00
cases:1.98%
controls:0.63%
cases:1.15%
controls:0.19%
—
—
—
—
—
—
cases:0.72%
controls:0.20%
cases:1.66%
controls:0.38%
29
92
1437
14435
17
28
1461
14600
—
—
—
10
27
1378
13592
15
34
890
9019
Parainfluenza type 1 nucleic acid detection
222341000000100 [44790047]
1.2e+00
1.8e+00
—
—
—
1.3e+00
1.5e+00
cases:1.98%
controls:0.63%
cases:1.15%
controls:0.19%
—
—
—
—
—
—
cases:0.72%
controls:0.20%
cases:1.66%
controls:0.38%
29
92
1437
14435
17
28
1461
14600
—
—
—
10
27
1378
13592
15
34
890
9019
Parainfluenza type 3 nucleic acid detection
222361000000104 [44790049]
1.2e+00
1.8e+00
—
—
—
1.3e+00
1.5e+00
cases:1.98%
controls:0.63%
cases:1.15%
controls:0.19%
—
—
—
—
—
—
cases:0.72%
controls:0.20%
cases:1.66%
controls:0.38%
29
92
1437
14435
17
28
1461
14600
—
—
—
10
27
1378
13592
15
34
890
9019
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]
1.3e-01
2.9e-01
6.2e-01
2.2e+00
5.9e-01
3.3e-01
4.0e-01
cases:50.41%
controls:47.04%
cases:35.45%
controls:29.06%
cases:9.95%
controls:5.60%
cases:2.03%
controls:0.23%
cases:8.92%
controls:5.13%
cases:34.65%
controls:27.65%
cases:60.55%
controls:50.79%
739
6834
727
7693
524
4251
954
10377
147
819
1331
13809
30
34
1447
14594
131
746
1337
13799
481
3766
907
9853
548
4598
357
4455
Hemodialysis
TK800 [2001305768]
2.5e+00
1.6e+00
—
—
—
—
1.9e+00
cases:1.23%
controls:0.10%
cases:0.34%
controls:0.07%
—
—
—
—
—
—
—
—
cases:0.88%
controls:0.13%
18
15
1448
14512
5
10
1473
14618
—
—
—
—
8
12
897
9041
Carbon dioxide [Partial pressure] in Capillary blood
2020-6 [3023024]
3.3e-01
7.0e-01
1.1e+00
—
1.5e+00
1.0e+00
1.2e+00
cases:7.16%
controls:5.28%
cases:3.86%
controls:1.96%
cases:0.88%
controls:0.31%
—
—
cases:1.02%
controls:0.23%
cases:3.67%
controls:1.37%
cases:8.29%
controls:2.64%
105
767
1361
13760
57
287
1421
14341
13
45
1465
14583
—
15
34
1453
14511
51
187
1337
13432
75
239
830
8814
pH of Capillary blood
2745-8 [3009343]
3.3e-01
7.3e-01
1.1e+00
—
1.4e+00
9.9e-01
1.2e+00
cases:7.16%
controls:5.28%
cases:3.92%
controls:1.93%
cases:0.88%
controls:0.31%
—
—
cases:0.95%
controls:0.23%
cases:3.53%
controls:1.34%
cases:8.18%
controls:2.57%
105
767
1361
13760
58
283
1420
14345
13
45
1465
14583
—
14
33
1454
14512
49
183
1339
13436
74
233
831
8820
Hypertension secondary to other renal disorders
I15.1 [45557535]
2.2e+00
1.5e+00
—
—
—
—
2.2e+00
cases:0.55%
controls:0.06%
cases:0.34%
controls:0.08%
—
—
—
—
—
—
—
—
cases:0.88%
controls:0.10%
8
9
1458
14518
5
11
1473
14617
—
—
—
—
8
9
897
9044
Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
93840-7 [1001833]
1.9e+00
—
—
—
—
—
2.4e+00
cases:0.48%
controls:0.07%
—
—
—
—
—
—
—
—
—
—
cases:1.10%
controls:0.10%
7
10
1459
14517
—
—
—
—
—
10
9
895
9044
sodium chloride; oral
A12CA01 [21600886]
1.9e+00
2.5e+00
—
—
—
—
—
cases:0.95%
controls:0.14%
cases:0.47%
controls:0.04%
—
—
—
—
—
—
—
—
—
—
14
21
1452
14506
7
6
1471
14622
—
—
—
—
—
Single ventricle
Q20.48 [2000503264]
2.3e+00
1.8e+00
—
—
—
2.0e+00
—
cases:0.61%
controls:0.06%
cases:0.41%
controls:0.07%
—
—
—
—
—
—
cases:0.50%
controls:0.07%
—
—
9
9
1457
14518
6
10
1472
14618
—
—
—
7
9
1381
13610
—
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
1.0e-01
2.0e-01
5.7e-01
2.2e+00
5.8e-01
3.4e-01
4.2e-01
cases:47.00%
controls:44.43%
cases:33.49%
controls:29.10%
cases:10.01%
controls:5.94%
cases:1.96%
controls:0.23%
cases:8.99%
controls:5.23%
cases:34.87%
controls:27.61%
cases:58.67%
controls:48.22%
689
6454
777
8073
495
4257
983
10371
148
869
1330
13759
29
33
1448
14595
132
760
1336
13785
484
3760
904
9859
531
4365
374
4688
Cholesterol in LDL [Moles/volume] in Serum or Plasma
22748-8 [3001308]
1.2e-01
1.2e-01
3.6e-01
3.3e+00
6.3e-01
1.6e-01
3.3e-01
cases:32.40%
controls:29.89%
cases:18.00%
controls:16.27%
cases:2.64%
controls:1.86%
cases:0.95%
controls:0.03%
cases:3.13%
controls:1.69%
cases:18.59%
controls:16.26%
cases:42.21%
controls:34.47%
475
4342
991
10185
266
2380
1212
12248
39
272
1439
14356
14
5
1463
14623
46
246
1422
14299
258
2214
1130
11405
382
3121
523
5932
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 [3006923]
1.2e-01
2.2e-01
5.4e-01
2.4e+00
4.3e-01
2.6e-01
4.4e-01
cases:46.38%
controls:43.38%
cases:31.06%
controls:26.48%
cases:8.12%
controls:4.89%
cases:1.76%
controls:0.16%
cases:6.54%
controls:4.34%
cases:30.55%
controls:25.41%
cases:59.34%
controls:48.39%
680
6302
786
8225
459
3873
1019
10755
120
716
1358
13912
26
24
1451
14604
96
631
1372
13914
424
3460
964
10159
537
4381
368
4672
Epstein Barr virus Ab [Presence] in Serum
49178-7 [3048929]
8.4e-01
1.3e+00
—
1.0e+50
—
1.4e+00
7.1e-01
cases:5.25%
controls:2.35%
cases:2.91%
controls:0.79%
—
—
cases:0.47%
controls:0.00%
—
—
cases:2.45%
controls:0.61%
cases:6.30%
controls:3.21%
77
341
1389
14186
43
115
1435
14513
—
7
0
1470
14628
—
34
83
1354
13536
57
291
848
8762
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
1.2e-01
2.3e-01
5.6e-01
2.0e+00
6.1e-01
3.1e-01
4.8e-01
cases:47.34%
controls:44.39%
cases:32.34%
controls:27.58%
cases:8.80%
controls:5.21%
cases:1.96%
controls:0.26%
cases:8.11%
controls:4.57%
cases:33.00%
controls:26.49%
cases:60.77%
controls:49.03%
694
6448
772
8079
478
4035
1000
10593
130
762
1348
13866
29
38
1448
14590
119
664
1349
13881
458
3607
930
10012
550
4439
355
4614
Extensive MRI examination of abdomen with high intensity magnet
JN3CG [2001305563]
1.7e+00
1.8e+00
—
—
—
1.9e+00
2.5e+00
cases:0.82%
controls:0.15%
cases:0.34%
controls:0.05%
—
—
—
—
—
—
cases:0.36%
controls:0.05%
cases:1.10%
controls:0.09%
12
22
1454
14505
5
8
1473
14620
—
—
—
5
7
1383
13612
10
8
895
9045
Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
38917-1 [3042194]
9.8e-01
1.8e+00
—
—
—
1.1e+00
1.5e+00
cases:2.25%
controls:0.85%
cases:1.29%
controls:0.23%
—
—
—
—
—
—
cases:0.72%
controls:0.24%
cases:2.43%
controls:0.56%
33
124
1433
14403
19
33
1459
14595
—
—
—
10
33
1378
13586
22
51
883
9002
Corticotropin [Mass/volume] in Plasma
2141-0 [3035637]
8.2e-01
8.9e-01
—
—
—
1.4e+00
2.0e+00
cases:2.25%
controls:1.01%
cases:0.88%
controls:0.36%
—
—
—
—
—
—
cases:1.08%
controls:0.28%
cases:3.76%
controls:0.51%
33
146
1433
14381
13
53
1465
14575
—
—
—
15
38
1373
13581
34
46
871
9007
Oxygen [Partial pressure] in Capillary blood
2704-5 [3028626]
3.4e-01
7.2e-01
7.8e-01
—
1.3e+00
9.6e-01
1.2e+00
cases:6.41%
controls:4.67%
cases:3.45%
controls:1.71%
cases:0.61%
controls:0.28%
—
—
cases:0.82%
controls:0.22%
cases:2.88%
controls:1.12%
cases:6.52%
controls:2.09%
94
678
1372
13849
51
250
1427
14378
9
41
1469
14587
—
12
32
1456
14513
40
153
1348
13466
59
189
846
8864
Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
40976-3 [3040853]
1.0e+00
1.6e+00
—
—
—
1.0e+00
1.6e+00
cases:2.32%
controls:0.85%
cases:1.29%
controls:0.26%
—
—
—
—
—
—
cases:0.72%
controls:0.26%
cases:2.65%
controls:0.57%
34
123
1432
14404
19
38
1459
14590
—
—
—
10
35
1378
13584
24
52
881
9001
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
1.0e-01
2.1e-01
5.4e-01
2.1e+00
6.2e-01
2.9e-01
4.3e-01
cases:41.88%
controls:39.36%
cases:26.32%
controls:22.37%
cases:6.29%
controls:3.77%
cases:1.76%
controls:0.23%
cases:6.20%
controls:3.42%
cases:26.08%
controls:20.87%
cases:52.60%
controls:41.89%
614
5718
852
8809
389
3273
1089
11355
93
551
1385
14077
26
33
1451
14595
91
497
1377
14048
362
2842
1026
10777
476
3792
429
5261
Norovirus RNA [Presence] in Stool by NAA with probe detection
7974-9 [3008909]
9.8e-01
1.4e+00
—
—
—
1.5e+00
1.8e+00
cases:1.64%
controls:0.62%
cases:0.68%
controls:0.17%
—
—
—
—
—
—
cases:0.58%
controls:0.13%
cases:1.99%
controls:0.33%
24
90
1442
14437
10
25
1468
14603
—
—
—
8
18
1380
13601
18
30
887
9023
High dependency care
WX882 [2001310847]
1.2e+00
1.2e+00
—
—
—
1.9e+00
1.8e+00
cases:3.75%
controls:1.20%
cases:0.88%
controls:0.27%
—
—
—
—
—
—
cases:0.36%
controls:0.05%
cases:1.77%
controls:0.30%
55
174
1411
14353
13
39
1465
14589
—
—
—
5
7
1383
13612
16
27
889
9026
Intravenous
ZX120 [2001311495]
9.7e-01
1.3e+00
1.3e+00
—
1.5e+00
1.0e+00
1.9e+00
cases:3.75%
controls:1.45%
cases:1.83%
controls:0.52%
cases:0.41%
controls:0.11%
—
—
cases:0.54%
controls:0.12%
cases:0.86%
controls:0.32%
cases:3.20%
controls:0.49%
55
211
1411
14316
27
76
1451
14552
6
16
1472
14612
—
8
17
1460
14528
12
43
1376
13576
29
44
876
9009
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
1.1e-01
2.1e-01
5.6e-01
2.1e+00
6.1e-01
2.8e-01
4.2e-01
cases:41.88%
controls:39.32%
cases:26.32%
controls:22.42%
cases:6.36%
controls:3.75%
cases:1.76%
controls:0.23%
cases:6.06%
controls:3.40%
cases:25.86%
controls:20.85%
cases:52.60%
controls:42.05%
614
5712
852
8815
389
3279
1089
11349
94
548
1384
14080
26
33
1451
14595
89
495
1379
14050
359
2840
1029
10779
476
3807
429
5246
Dentistry
C5 [903277]
4.3e-01
5.8e-01
6.8e-01
—
1.4e+00
8.6e-01
8.3e-01
cases:6.14%
controls:4.09%
cases:3.18%
controls:1.80%
cases:0.41%
controls:0.21%
—
—
cases:0.95%
controls:0.23%
cases:3.75%
controls:1.62%
cases:10.39%
controls:4.79%
90
594
1376
13933
47
264
1431
14364
6
30
1472
14598
—
14
33
1454
14512
52
221
1336
13398
94
434
811
8619
Epithelial cells.non-squamous [#/volume] in Urine by Automated count
51485-1 [3030306]
5.0e-01
8.8e-01
8.8e-01
—
1.2e+00
7.4e-01
8.5e-01
cases:8.19%
controls:5.15%
cases:5.28%
controls:2.27%
cases:0.95%
controls:0.40%
—
—
cases:0.89%
controls:0.28%
cases:4.76%
controls:2.32%
cases:11.60%
controls:5.30%
120
748
1346
13779
78
332
1400
14296
14
58
1464
14570
—
13
40
1455
14505
66
316
1322
13303
105
480
800
8573
Protein/Creatinine [Ratio] in Urine
34366-5 [3045462]
1.0e+00
1.3e+00
—
—
—
1.4e+00
1.6e+00
cases:1.16%
controls:0.41%
cases:0.74%
controls:0.21%
—
—
—
—
—
—
cases:0.94%
controls:0.23%
cases:2.76%
controls:0.56%
17
60
1449
14467
11
31
1467
14597
—
—
—
13
32
1375
13587
25
51
880
9002
hydrocortisone; oral, parenteral
H02AB09 [21602737]
9.9e-01
1.1e+00
—
—
1.4e+00
1.0e+00
9.4e-01
cases:6.75%
controls:2.63%
cases:2.77%
controls:0.98%
—
—
—
—
cases:0.54%
controls:0.14%
cases:2.88%
controls:1.03%
cases:6.08%
controls:2.47%
99
382
1367
14145
41
143
1437
14485
—
—
8
20
1460
14525
40
140
1348
13479
55
224
850
8829
Polycystic kidney, autosomal recessive
Q61.1 [45544102]
1.7e+00
2.0e+00
—
—
—
2.0e+00
1.4e+00
cases:0.41%
controls:0.08%
cases:0.41%
controls:0.05%
—
—
—
—
—
—
cases:0.43%
controls:0.06%
cases:0.55%
controls:0.14%
6
11
1460
14516
6
8
1472
14620
—
—
—
6
8
1382
13611
5
13
900
9040
End-stage renal disease
N18.0 [45601717]
2.0e+00
—
—
—
—
—
2.0e+00
cases:0.55%
controls:0.08%
—
—
—
—
—
—
—
—
—
—
cases:0.66%
controls:0.09%
8
11
1458
14516
—
—
—
—
—
6
8
899
9045
Vancomycin [Mass/volume] in Serum or Plasma
20578-1 [3005715]
1.8e+00
2.2e+00
—
—
—
—
—
cases:1.36%
controls:0.23%
cases:0.74%
controls:0.08%
—
—
—
—
—
—
—
—
—
—
20
34
1446
14493
11
12
1467
14616
—
—
—
—
—
Counselling and guidance which enhance independent living
R2130 [2001310196]
5.9e-01
1.0e+00
1.3e+00
—
1.9e+00
1.1e+00
1.3e+00
cases:5.12%
controls:2.89%
cases:1.89%
controls:0.68%
cases:0.34%
controls:0.09%
—
—
cases:0.41%
controls:0.06%
cases:1.73%
controls:0.59%
cases:4.09%
controls:1.19%
75
420
1391
14107
28
100
1450
14528
5
13
1473
14615
—
6
9
1462
14536
24
81
1364
13538
37
108
868
8945
Psychological and behavioural factors associated with disorders or diseases classified elsewhere
F54 [45591146]
1.5e+00
2.5e+00
—
—
—
—
—
cases:0.68%
controls:0.16%
cases:0.47%
controls:0.04%
—
—
—
—
—
—
—
—
—
—
10
23
1456
14504
7
6
1471
14622
—
—
—
—
—
Biopsy of liver with ultrasound guidance
JJ2AT [2001305254]
1.8e+00
1.7e+00
—
—
—
—
2.1e+00
cases:1.36%
controls:0.22%
cases:0.47%
controls:0.09%
—
—
—
—
—
—
—
—
cases:1.66%
controls:0.21%
20
32
1446
14495
7
13
1471
14615
—
—
—
—
15
19
890
9034
Bilirubin.conjugated [Moles/volume] in Serum or Plasma
29760-6 [3005772]
6.2e-01
1.0e+00
1.0e+00
—
1.2e+00
1.1e+00
1.1e+00
cases:6.62%
controls:3.68%
cases:3.79%
controls:1.37%
cases:0.81%
controls:0.29%
—
—
cases:0.68%
controls:0.21%
cases:3.39%
controls:1.10%
cases:7.62%
controls:2.67%
97
535
1369
13992
56
201
1422
14427
12
42
1466
14586
—
10
30
1458
14515
47
150
1341
13469
69
242
836
8811
Thorax X-ray examination
GD1AA [2001303617]
4.3e-01
7.4e-01
1.1e+00
1.0e+50
—
6.3e-01
9.4e-01
cases:10.37%
controls:6.98%
cases:4.80%
controls:2.34%
cases:0.88%
controls:0.28%
cases:0.41%
controls:0.00%
—
—
cases:3.82%
controls:2.08%
cases:12.27%
controls:5.19%
152
1014
1314
13513
71
343
1407
14285
13
41
1465
14587
6
0
1471
14628
—
53
283
1335
13336
111
470
794
8583
metoprolol; oral, parenteral
C07AB02 [21601684]
6.6e-01
7.1e-01
1.1e+00
—
8.5e-01
9.9e-01
1.5e+00
cases:2.46%
controls:1.29%
cases:1.89%
controls:0.94%
cases:0.74%
controls:0.26%
—
—
cases:0.54%
controls:0.23%
cases:2.16%
controls:0.82%
cases:4.09%
controls:0.96%
36
187
1430
14340
28
137
1450
14491
11
38
1467
14590
—
8
34
1460
14511
30
111
1358
13508
37
87
868
8966
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
5.0e-02
1.9e-01
4.9e-01
2.2e+00
4.5e-01
2.3e-01
4.1e-01
cases:45.77%
controls:44.53%
cases:27.94%
controls:24.20%
cases:6.77%
controls:4.24%
cases:1.56%
controls:0.17%
cases:5.93%
controls:3.86%
cases:27.31%
controls:22.98%
cases:58.56%
controls:48.49%
671
6469
795
8058
413
3540
1065
11088
100
620
1378
14008
23
25
1454
14603
87
561
1381
13984
379
3129
1009
10490
530
4390
375
4663
Extraction of tooth
EBA00 [2001301923]
1.9e-03
-2.9e-01
4.3e-01
3.8e+00
1.1e+00
3.6e-01
8.7e-02
cases:11.39%
controls:11.37%
cases:2.57%
controls:3.41%
cases:0.61%
controls:0.40%
cases:1.49%
controls:0.03%
cases:0.89%
controls:0.31%
cases:4.76%
controls:3.36%
cases:13.15%
controls:12.18%
167
1652
1299
12875
38
499
1440
14129
9
58
1469
14570
22
5
1455
14623
13
45
1455
14500
66
458
1322
13161
119
1103
786
7950
pravastatin; oral
C10AA03 [21601858]
7.5e-01
1.3e+00
-1.0e+50
—
—
1.5e+00
2.2e+00
cases:0.48%
controls:0.23%
cases:0.61%
controls:0.16%
cases:0.00%
controls:0.04%
—
—
—
—
cases:0.65%
controls:0.14%
cases:1.22%
controls:0.13%
7
33
1459
14494
9
24
1469
14604
0
6
1478
14622
—
—
9
19
1379
13600
11
12
894
9041
Iron/Transferrin [Ratio] in Serum or Plasma
60517-0 [40763571]
6.4e-01
7.3e-01
1.4e+00
—
1.3e+00
1.2e+00
1.2e+00
cases:5.73%
controls:3.09%
cases:3.38%
controls:1.66%
cases:0.61%
controls:0.14%
—
—
cases:0.61%
controls:0.17%
cases:4.11%
controls:1.31%
cases:10.72%
controls:3.45%
84
449
1382
14078
50
243
1428
14385
9
21
1469
14607
—
9
25
1459
14520
57
178
1331
13441
97
312
808
8741
Toxoplasma gondii IgM Ab [Units/volume] in Serum
8040-8 [3027529]
1.1e+00
2.6e+00
—
—
—
—
3.8e-01
cases:1.64%
controls:0.56%
cases:0.95%
controls:0.07%
—
—
—
—
—
—
—
—
cases:0.77%
controls:0.53%
24
82
1442
14445
14
10
1464
14618
—
—
—
—
7
48
898
9005
Ultrasound examination transplanted kidney
KA2AE [2001305644]
3.7e+00
—
—
1.0e+50
1.0e+50
—
—
cases:2.18%
controls:0.06%
—
—
—
—
cases:0.41%
controls:0.00%
cases:0.34%
controls:0.00%
—
—
—
—
32
8
1434
14519
—
—
6
0
1471
14628
5
0
1463
14545
—
—
Prophylactic measure, unspecified
Z29.9 [45547298]
—
1.9e+00
—
—
—
—
1.7e+00
—
—
cases:0.47%
controls:0.07%
—
—
—
—
—
—
—
—
cases:0.99%
controls:0.18%
—
7
10
1471
14618
—
—
—
—
9
16
896
9037
Methotrexate [Moles/volume] in Serum or Plasma
14836-1 [3017115]
1.7e+00
2.0e+00
—
—
—
—
—
cases:0.61%
controls:0.12%
cases:0.41%
controls:0.05%
—
—
—
—
—
—
—
—
—
—
9
17
1457
14510
6
8
1472
14620
—
—
—
—
—
Biopsy of transplanted kidney with ultrasound guidance
KA2AT [2001305777]
3.6e+00
2.3e+00
—
—
—
1.0e+50
—
cases:1.77%
controls:0.05%
cases:0.34%
controls:0.03%
—
—
—
—
—
—
cases:0.58%
controls:0.00%
—
—
26
7
1440
14520
5
5
1473
14623
—
—
—
8
0
1380
13619
—
Health maint/preventive medicine
A98 [2002000231]
1.1e-01
2.5e-01
4.2e-01
2.2e+00
5.0e-01
2.7e-01
3.5e-01
cases:76.47%
controls:74.36%
cases:58.59%
controls:52.45%
cases:13.26%
controls:9.16%
cases:2.57%
controls:0.29%
cases:13.28%
controls:8.54%
cases:59.22%
controls:52.59%
cases:87.96%
controls:83.75%
1121
10803
345
3724
866
7673
612
6955
196
1340
1282
13288
38
43
1439
14585
195
1242
1273
13303
822
7162
566
6457
796
7582
109
1471
pH of Serum or Plasma
2753-2 [3018418]
3.8e-01
6.2e-01
1.1e+00
—
7.0e-01
7.7e-01
7.3e-01
cases:9.21%
controls:6.48%
cases:5.35%
controls:2.96%
cases:1.49%
controls:0.49%
—
—
cases:0.82%
controls:0.41%
cases:5.40%
controls:2.57%
cases:12.27%
controls:6.31%
135
942
1331
13585
79
433
1399
14195
22
72
1456
14556
—
12
59
1456
14486
75
350
1313
13269
111
571
794
8482
Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
14804-9 [3022250]
5.6e-01
1.1e+00
—
—
1.3e+00
1.0e+00
9.5e-01
cases:4.09%
controls:2.38%
cases:2.71%
controls:0.96%
—
—
—
—
cases:0.61%
controls:0.17%
cases:2.16%
controls:0.78%
cases:4.75%
controls:1.89%
60
346
1406
14181
40
141
1438
14487
—
—
9
24
1459
14521
30
106
1358
13513
43
171
862
8882
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
3.1e-02
1.4e-01
5.0e-01
1.9e+00
4.8e-01
2.4e-01
4.0e-01
cases:59.28%
controls:58.53%
cases:43.71%
controls:40.23%
cases:12.58%
controls:8.05%
cases:2.10%
controls:0.31%
cases:11.31%
controls:7.30%
cases:44.60%
controls:38.78%
cases:74.70%
controls:66.36%
869
8503
597
6024
646
5885
832
8743
186
1178
1292
13450
31
45
1446
14583
166
1062
1302
13483
619
5281
769
8338
676
6008
229
3045
Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
9838-4 [3003265]
8.3e-01
1.2e+00
—
—
—
1.7e+00
1.8e+00
cases:1.16%
controls:0.51%
cases:0.61%
controls:0.18%
—
—
—
—
—
—
cases:0.58%
controls:0.10%
cases:3.20%
controls:0.53%
17
74
1449
14453
9
26
1469
14602
—
—
—
8
14
1380
13605
29
48
876
9005
Karyotype in Bone marrow
81861-7 [21494434]
1.5e+00
—
—
—
—
—
2.0e+00
cases:0.89%
controls:0.19%
—
—
—
—
—
—
—
—
—
—
cases:0.66%
controls:0.09%
13
28
1453
14499
—
—
—
—
—
6
8
899
9045
Fever, unspecified
R50.9 [45582716]
6.4e-01
1.1e+00
—
—
—
1.0e+00
8.3e-01
cases:7.03%
controls:3.85%
cases:2.84%
controls:0.98%
—
—
—
—
—
—
cases:2.23%
controls:0.84%
cases:5.64%
controls:2.53%
103
559
1363
13968
42
144
1436
14484
—
—
—
31
114
1357
13505
51
229
854
8824
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
3.5e-02
1.4e-01
5.0e-01
1.9e+00
4.9e-01
2.4e-01
4.1e-01
cases:59.48%
controls:58.64%
cases:43.71%
controls:40.29%
cases:12.65%
controls:8.08%
cases:2.03%
controls:0.31%
cases:11.38%
controls:7.32%
cases:44.74%
controls:38.90%
cases:74.81%
controls:66.42%
872
8518
594
6009
646
5894
832
8734
187
1182
1291
13446
30
45
1447
14583
167
1064
1301
13481
621
5298
767
8321
677
6013
228
3040
MCH [Entitic mass]
28539-5 [3035941]
3.0e-02
1.4e-01
5.0e-01
1.9e+00
4.8e-01
2.4e-01
4.0e-01
cases:59.28%
controls:58.54%
cases:43.71%
controls:40.18%
cases:12.58%
controls:8.03%
cases:2.03%
controls:0.31%
cases:11.31%
controls:7.29%
cases:44.60%
controls:38.75%
cases:74.70%
controls:66.35%
869
8504
597
6023
646
5878
832
8750
186
1175
1292
13453
30
45
1447
14583
166
1061
1302
13484
619
5278
769
8341
676
6007
229
3046
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
2.8e-02
1.4e-01
5.0e-01
1.9e+00
4.8e-01
2.4e-01
4.0e-01
cases:59.21%
controls:58.53%
cases:43.64%
controls:40.16%
cases:12.58%
controls:8.03%
cases:2.03%
controls:0.31%
cases:11.31%
controls:7.29%
cases:44.52%
controls:38.73%
cases:74.59%
controls:66.28%
868
8502
598
6025
645
5874
833
8754
186
1175
1292
13453
30
45
1447
14583
166
1060
1302
13485
618
5274
770
8345
675
6000
230
3053
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
3.0e-02
1.4e-01
5.0e-01
1.9e+00
4.8e-01
2.4e-01
4.0e-01
cases:59.28%
controls:58.54%
cases:43.71%
controls:40.22%
cases:12.58%
controls:8.05%
cases:2.03%
controls:0.31%
cases:11.31%
controls:7.31%
cases:44.60%
controls:38.80%
cases:74.70%
controls:66.38%
869
8504
597
6023
646
5884
832
8744
186
1178
1292
13450
30
45
1447
14583
166
1063
1302
13482
619
5284
769
8335
676
6009
229
3044
Platelets [#/volume] in Blood
26515-7 [3007461]
2.5e-02
1.5e-01
4.9e-01
1.9e+00
4.7e-01
2.4e-01
4.1e-01
cases:59.00%
controls:58.39%
cases:43.71%
controls:40.12%
cases:12.45%
controls:8.04%
cases:2.03%
controls:0.31%
cases:11.24%
controls:7.30%
cases:44.52%
controls:38.76%
cases:74.70%
controls:66.21%
865
8482
601
6045
646
5869
832
8759
184
1176
1294
13452
30
45
1447
14583
165
1062
1303
13483
618
5279
770
8340
676
5994
229
3059
Caries limited to enamel
K02.0 [45576967]
2.6e-01
2.8e-01
—
—
1.8e+00
8.0e-01
8.5e-01
cases:10.71%
controls:8.46%
cases:4.80%
controls:3.67%
—
—
—
—
cases:2.72%
controls:0.44%
cases:8.50%
controls:4.01%
cases:25.75%
controls:12.91%
157
1229
1309
13298
71
537
1407
14091
—
—
40
64
1428
14481
118
546
1270
13073
233
1169
672
7884
Leukocytes [#/volume] in Blood
26464-8 [3010813]
2.7e-02
1.5e-01
4.9e-01
1.9e+00
4.8e-01
2.4e-01
3.9e-01
cases:59.28%
controls:58.64%
cases:43.91%
controls:40.29%
cases:12.58%
controls:8.09%
cases:2.03%
controls:0.31%
cases:11.38%
controls:7.34%
cases:44.74%
controls:38.90%
cases:74.70%
controls:66.59%
869
8518
597
6009
649
5893
829
8735
186
1184
1292
13444
30
46
1447
14582
167
1068
1301
13477
621
5298
767
8321
676
6028
229
3025
Pediatric Infectious Diseases
OMOP4822027 [45756812]
7.5e-01
4.9e-01
—
—
—
1.2e+00
1.6e+00
cases:3.55%
controls:1.71%
cases:0.88%
controls:0.54%
—
—
—
—
—
—
cases:0.94%
controls:0.29%
cases:2.54%
controls:0.54%
52
248
1414
14279
13
79
1465
14549
—
—
—
13
40
1375
13579
23
49
882
9004
Retinol [Moles/volume] in Serum or Plasma
14905-4 [3013005]
8.9e-01
1.1e+00
—
—
—
1.1e+00
1.4e+00
cases:1.77%
controls:0.74%
cases:1.08%
controls:0.35%
—
—
—
—
—
—
cases:0.86%
controls:0.29%
cases:2.54%
controls:0.62%
26
107
1440
14420
16
51
1462
14577
—
—
—
12
40
1376
13579
23
56
882
8997
Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
34720-3 [3030558]
1.4e+00
—
—
—
—
1.6e+00
2.0e+00
cases:0.68%
controls:0.17%
—
—
—
—
—
—
—
—
cases:0.36%
controls:0.07%
cases:0.99%
controls:0.13%
10
24
1456
14503
—
—
—
—
5
10
1383
13609
9
12
896
9041
Blood group antibody screen [Presence] in Serum or Plasma
890-4 [3001079]
2.1e-01
4.8e-01
8.7e-01
—
9.4e-01
5.8e-01
5.6e-01
cases:18.01%
controls:15.14%
cases:8.25%
controls:5.26%
cases:1.42%
controls:0.60%
—
—
cases:1.29%
controls:0.51%
cases:7.13%
controls:4.13%
cases:19.12%
controls:11.85%
264
2200
1202
12327
122
769
1356
13859
21
88
1457
14540
—
19
74
1449
14471
99
562
1289
13057
173
1073
732
7980
Toxoplasma gondii IgG Ab [Units/volume] in Serum
8039-0 [3014959]
1.0e+00
2.4e+00
—
—
—
—
3.8e-01
cases:1.71%
controls:0.61%
cases:0.95%
controls:0.09%
—
—
—
—
—
—
—
—
cases:0.77%
controls:0.53%
25
89
1441
14438
14
13
1464
14615
—
—
—
—
7
48
898
9005
Secondary hypertension
I15 [45562338]
3.4e+00
—
—
—
—
—
—
cases:1.23%
controls:0.04%
—
—
—
—
—
—
—
—
—
—
—
—
18
6
1448
14521
—
—
—
—
—
—
Nephrectomy
KAC00 [2001305666]
3.4e+00
—
—
—
—
—
—
cases:1.02%
controls:0.03%
—
—
—
—
—
—
—
—
—
—
—
—
15
5
1451
14522
—
—
—
—
—
—
Protein [Mass/volume] in Serum or Plasma
2885-2 [3020630]
7.6e-01
1.5e+00
—
—
—
6.8e-01
1.1e+00
cases:2.59%
controls:1.23%
cases:1.35%
controls:0.31%
—
—
—
—
—
—
cases:0.72%
controls:0.37%
cases:1.77%
controls:0.59%
38
178
1428
14349
20
45
1458
14583
—
—
—
10
50
1378
13569
16
53
889
9000
Allogenic transplantation of kidney from cadaver donor
KAS10 [2001305738]
3.4e+00
—
—
—
—
—
—
cases:1.36%
controls:0.05%
—
—
—
—
—
—
—
—
—
—
—
—
20
7
1446
14520
—
—
—
—
—
—
Other dialysis
Z49.2 [45576160]
3.3e+00
1.0e+50
—
—
—
—
—
cases:1.16%
controls:0.04%
cases:0.34%
controls:0.00%
—
—
—
—
—
—
—
—
—
—
17
6
1449
14521
5
0
1473
14628
—
—
—
—
—
erythropoietin; parenteral
B03XA01 [21601133]
3.3e+00
—
—
—
—
—
—
cases:1.16%
controls:0.04%
—
—
—
—
—
—
—
—
—
—
—
—
17
6
1449
14521
—
—
—
—
—
—
TREATMENT - Kidney transplant
TREATMENT-51 [2002330239]
3.3e+00
—
—
—
—
—
2.1e+00
cases:1.98%
controls:0.08%
—
—
—
—
—
—
—
—
—
—
cases:0.55%
controls:0.07%
29
11
1437
14516
—
—
—
—
—
5
6
900
9047
Osmolality of Urine
2695-5 [3026782]
2.9e-01
5.7e-01
8.3e-01
—
1.7e+00
5.5e-01
9.7e-01
cases:8.05%
controls:6.15%
cases:3.32%
controls:1.89%
cases:0.41%
controls:0.18%
—
—
cases:0.95%
controls:0.17%
cases:2.23%
controls:1.30%
cases:9.61%
controls:3.89%
118
893
1348
13634
49
277
1429
14351
6
26
1472
14602
—
14
25
1454
14520
31
177
1357
13442
87
352
818
8701
Teeth/gum disease
D82 [2002000380]
1.3e-01
3.1e-01
6.4e-01
—
2.0e+00
8.8e-01
3.9e-01
cases:13.37%
controls:11.98%
cases:5.41%
controls:4.03%
cases:0.88%
controls:0.46%
—
—
cases:3.20%
controls:0.46%
cases:9.15%
controls:4.01%
cases:18.78%
controls:13.55%
196
1741
1270
12786
80
589
1398
14039
13
68
1465
14560
—
47
67
1421
14478
127
546
1261
13073
170
1227
735
7826
Dental calculus supragingival
K03.64 [2000502689]
4.1e-01
2.9e-02
9.5e-02
—
1.6e+00
5.6e-01
6.5e-01
cases:14.94%
controls:10.44%
cases:4.13%
controls:4.01%
cases:0.47%
controls:0.43%
—
—
cases:2.38%
controls:0.50%
cases:6.77%
controls:3.97%
cases:24.42%
controls:14.42%
219
1517
1247
13010
61
587
1417
14041
7
63
1471
14565
—
35
72
1433
14473
94
541
1294
13078
221
1305
684
7748
Influenza with other respiratory manifestations, seasonal influenza virus identified
J10.1 [45601120]
1.5e+00
—
—
—
—
-1.0e+50
1.7e+00
cases:0.89%
controls:0.19%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.05%
cases:0.88%
controls:0.17%
13
28
1453
14499
—
—
—
—
0
7
1388
13612
8
15
897
9038
Bile acid [Moles/volume] in Serum --fasting
35562-8 [3034274]
2.4e-01
6.5e-01
—
1.0e+50
1.9e+00
7.7e-01
1.3e+00
cases:1.77%
controls:1.40%
cases:1.29%
controls:0.68%
—
—
cases:0.34%
controls:0.00%
cases:0.54%
controls:0.08%
cases:1.15%
controls:0.54%
cases:3.76%
controls:1.04%
26
204
1440
14323
19
99
1459
14529
—
5
0
1472
14628
8
12
1460
14533
16
73
1372
13546
34
94
871
8959
Biopsy of skin and subcutaneous tissue
TQX10 [2001310152]
2.5e-02
1.6e+00
—
—
—
—
1.6e+00
cases:0.61%
controls:0.60%
cases:0.54%
controls:0.11%
—
—
—
—
—
—
—
—
cases:1.88%
controls:0.39%
9
87
1457
14440
8
16
1470
14612
—
—
—
—
17
35
888
9018
Left side
ZXA05 [2001311347]
6.7e-01
1.3e+00
—
—
—
1.1e+00
1.2e+00
cases:3.27%
controls:1.70%
cases:1.08%
controls:0.30%
—
—
—
—
—
—
cases:0.65%
controls:0.22%
cases:2.10%
controls:0.63%
48
247
1418
14280
16
44
1462
14584
—
—
—
9
30
1379
13589
19
57
886
8996
Potassium [Moles/volume] in Urine
2828-2 [3016038]
1.2e+00
—
—
—
—
—
2.0e+00
cases:0.95%
controls:0.29%
—
—
—
—
—
—
—
—
—
—
cases:1.10%
controls:0.15%
14
42
1452
14485
—
—
—
—
—
10
14
895
9039
Hemoglobin [Presence] in Urine by Test strip
5794-3 [3011397]
3.6e-01
7.0e-01
9.1e-01
—
8.5e-01
6.9e-01
5.0e-01
cases:10.10%
controls:7.26%
cases:7.17%
controls:3.71%
cases:1.42%
controls:0.57%
—
—
cases:1.23%
controls:0.53%
cases:7.06%
controls:3.66%
cases:14.36%
controls:9.26%
148
1055
1318
13472
106
543
1372
14085
21
84
1457
14544
—
18
77
1450
14468
98
498
1290
13121
130
838
775
8215
Hemoglobin [Mass/volume] in Venous blood
30350-3 [3004119]
3.3e-01
1.1e+00
—
—
—
1.1e+00
9.2e-01
cases:1.77%
controls:1.29%
cases:1.62%
controls:0.53%
—
—
—
—
—
—
cases:1.66%
controls:0.55%
cases:3.98%
controls:1.62%
26
187
1440
14340
24
78
1454
14550
—
—
—
23
75
1365
13544
36
147
869
8906
Periodontal treatment, brief
SDA02 [2001310327]
3.4e-01
3.7e-01
7.6e-01
—
1.7e+00
5.8e-01
5.0e-01
cases:12.96%
controls:9.58%
cases:3.99%
controls:2.80%
cases:0.54%
controls:0.25%
—
—
cases:1.50%
controls:0.27%
cases:5.33%
controls:3.05%
cases:17.57%
controls:11.47%
190
1392
1276
13135
59
409
1419
14219
8
37
1470
14591
—
22
39
1446
14506
74
415
1314
13204
159
1038
746
8015
Blood transfusion
WW500 [2001310603]
1.3e+00
1.8e+00
—
—
—
—
1.3e+00
cases:2.05%
controls:0.56%
cases:0.74%
controls:0.12%
—
—
—
—
—
—
—
—
cases:0.66%
controls:0.18%
30
81
1436
14446
11
18
1467
14610
—
—
—
—
6
16
899
9037
Extensive MRI examination of upper part of abdomen with high intensity magnet
JN1CG [2001305527]
1.3e+00
1.6e+00
—
—
—
—
1.8e+00
cases:0.75%
controls:0.20%
cases:0.34%
controls:0.07%
—
—
—
—
—
—
—
—
cases:0.77%
controls:0.13%
11
29
1455
14498
5
10
1473
14618
—
—
—
—
7
12
898
9041
Removal of fixed intravenous catheter
TPH90 [2001309607]
1.2e+00
1.9e+00
—
—
—
1.3e+00
1.1e+00
cases:3.07%
controls:0.97%
cases:1.62%
controls:0.25%
—
—
—
—
—
—
cases:0.72%
controls:0.20%
cases:0.99%
controls:0.33%
45
141
1421
14386
24
36
1454
14592
—
—
—
10
27
1378
13592
9
30
896
9023
Right side
ZXA00 [2001311346]
7.8e-01
1.2e+00
—
—
—
9.3e-01
1.1e+00
cases:4.16%
controls:1.95%
cases:1.29%
controls:0.38%
—
—
—
—
—
—
cases:0.79%
controls:0.32%
cases:2.54%
controls:0.88%
61
284
1405
14243
19
56
1459
14572
—
—
—
11
43
1377
13576
23
80
882
8973
Severe anaemia associated with chronic renal failure
138 [2001600134]
3.0e+00
—
—
—
—
—
—
cases:1.57%
controls:0.08%
—
—
—
—
—
—
—
—
—
—
—
—
23
11
1443
14516
—
—
—
—
—
—
Urgent procedure
ZXD05 [2001311386]
8.7e-01
1.1e+00
—
—
—
3.0e-01
1.1e+00
cases:8.25%
controls:3.63%
cases:1.89%
controls:0.64%
—
—
—
—
—
—
cases:0.79%
controls:0.59%
cases:4.53%
controls:1.61%
121
528
1345
13999
28
94
1450
14534
—
—
—
11
80
1377
13539
41
146
864
8907
Mitochondria Ab [Titer] in Serum
20483-4 [3034770]
6.7e-01
9.9e-01
—
—
—
1.6e+00
1.4e+00
cases:1.50%
controls:0.77%
cases:0.68%
controls:0.25%
—
—
—
—
—
—
cases:0.79%
controls:0.15%
cases:3.43%
controls:0.88%
22
112
1444
14415
10
37
1468
14591
—
—
—
11
21
1377
13598
31
80
874
8973
Cortisol [Moles/volume] in Serum or Plasma
14675-3 [3036481]
3.5e-01
8.1e-01
—
—
1.2e+00
1.1e+00
1.1e+00
cases:5.39%
controls:3.87%
cases:2.84%
controls:1.29%
—
—
—
—
cases:0.48%
controls:0.14%
cases:2.95%
controls:0.98%
cases:8.07%
controls:2.88%
79
562
1387
13965
42
188
1436
14440
—
—
7
21
1461
14524
41
133
1347
13486
73
261
832
8792
General anaesthesia
WX402 [2001310806]
4.1e-01
4.1e-01
8.2e-01
—
1.4e+00
6.4e-01
5.6e-01
cases:8.53%
controls:5.82%
cases:3.32%
controls:2.24%
cases:0.54%
controls:0.24%
—
—
cases:0.82%
controls:0.20%
cases:3.89%
controls:2.10%
cases:9.06%
controls:5.40%
125
846
1341
13681
49
327
1429
14301
8
35
1470
14593
—
12
29
1456
14516
54
286
1334
13333
82
489
823
8564
Smooth muscle Ab [Titer] in Serum
8095-2 [3007566]
5.9e-01
8.0e-01
—
—
—
1.6e+00
1.4e+00
cases:1.50%
controls:0.84%
cases:0.61%
controls:0.27%
—
—
—
—
—
—
cases:0.86%
controls:0.17%
cases:3.54%
controls:0.94%
22
122
1444
14405
9
40
1469
14588
—
—
—
12
23
1376
13596
32
85
873
8968
Diastolic blood pressure
8462-4 [3012888]
3.0e+00
—
—
—
—
—
—
cases:1.43%
controls:0.08%
—
—
—
—
—
—
—
—
—
—
—
—
21
11
1445
14516
—
—
—
—
—
—
Systolic blood pressure
8480-6 [3004249]
3.0e+00
—
—
—
—
—
—
cases:1.43%
controls:0.08%
—
—
—
—
—
—
—
—
—
—
—
—
21
11
1445
14516
—
—
—
—
—
—
Personal history of diseases of the digestive system
Z87.1 [45542474]
3.3e-01
8.1e-01
1.0e+00
—
1.0e+00
1.1e+00
6.4e-01
cases:10.85%
controls:8.01%
cases:4.06%
controls:1.85%
cases:0.61%
controls:0.22%
—
—
cases:0.41%
controls:0.14%
cases:4.25%
controls:1.40%
cases:9.83%
controls:5.42%
159
1163
1307
13364
60
270
1418
14358
9
32
1469
14596
—
6
21
1462
14524
59
190
1329
13429
89
491
816
8562
X-ray examination of the lungs in one projection
GD1PA [2001303645]
4.9e-01
8.6e-01
—
—
—
1.2e+00
8.5e-01
cases:2.93%
controls:1.82%
cases:1.42%
controls:0.61%
—
—
—
—
—
—
cases:1.01%
controls:0.30%
cases:2.65%
controls:1.15%
43
264
1423
14263
21
89
1457
14539
—
—
—
14
41
1374
13578
24
104
881
8949
Phosphate [Moles/volume] in Urine
13539-2 [3022229]
1.2e+00
—
—
—
—
9.9e-01
1.7e+00
cases:1.16%
controls:0.35%
—
—
—
—
—
—
—
—
cases:0.43%
controls:0.16%
cases:1.88%
controls:0.34%
17
51
1449
14476
—
—
—
—
6
22
1382
13597
17
31
888
9022

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
117
73
16.58
133.11
55.9
44.3
6.36
7.24
ug/l
2.70
107
67
75
25
30.24
109.79
8.1
6.3
423081.60
126017.00
u/ml
—
25
5
81
43
19.04
99.27
8.8
9.3
2.32
2.44
mg/l
0.12
65
38
97
82
12.06
92.48
40.4
37.8
143.68
129.59
ug/l
0.58
88
77
269
813
3.64
71.12
16.2
5.5
68.81
57.06
ng/l
1.73
260
784
264
792
3.66
70.54
37.4
13.4
1.31
1.02
mg/l
11.96
257
772
69
68
10.16
59.15
3.1
2.0
—
—
—
0
0
62
56
11.04
56.39
4.0
3.7
—
—
—
0
0
168
473
3.71
48.60
3.9
1.7
106.44
115.62
au/ml
0.45
88
144
169
486
3.63
47.35
3.8
1.7
—
—
—
0
0
238
884
2.88
43.47
6.4
4.3
59.59
66.94
e9/l
2.61
165
528
291
1255
2.51
39.28
10.3
5.1
1.36
1.46
%
1.94
277
1177
384
1881
2.28
38.87
31.1
7.8
1.27
1.25
mmol/l
0.76
377
1787
158
495
3.30
38.55
13.0
6.1
241.43
313.04
mg/l
1.00
139
327
187
650
3.01
38.28
3.4
1.5
189.06
179.67
u/ml
0.16
121
321
194
692
2.94
37.91
9.0
5.3
21.98
21.93
s
0.04
184
639
92
203
4.57
36.82
5.0
3.2
0.23
0.38
e9/l
2.50
55
121
333
1616
2.25
33.97
9.5
4.6
30.48
30.00
s
0.77
333
1593
343
1686
2.23
33.91
27.1
10.0
—
—
—
0
0
510
2954
1.98
32.34
13.9
5.7
90.20
90.04
%
0.05
505
2909
65
121
5.34
31.68
2.4
1.8
—
—
—
0
0
283
1363
2.22
29.00
13.9
4.4
6.82
5.94
umol/l
0.34
246
1137
301
1499
2.15
28.31
7.6
2.5
22.25
22.93
%
0.49
295
1423
350
1866
2.04
27.38
26.3
7.1
5.77
5.85
kpa
1.22
345
1822
320
1651
2.09
27.36
7.3
2.4
2.41
2.56
g/l
5.30
308
1551
349
1861
2.04
27.27
26.9
7.2
7.37
7.37
ph
1.37
283
1237
346
1846
2.03
26.97
26.3
7.2
1.02
1.19
mmol/l
0.47
313
1518
89
247
3.61
26.08
5.2
3.1
1074.06
1590.98
e6/l
4.88
64
181
338
1813
2.01
25.83
7.2
2.5
13.57
14.53
umol/l
2.05
331
1719
81
213
3.80
25.67
4.4
3.4
1.84
1.63
umol/l
0.85
81
208
335
1795
2.01
25.66
8.2
3.0
309.30
305.09
umol/l
0.29
324
1677
378
2120
1.94
25.35
7.1
3.0
0.58
0.93
e6/l
2.82
226
1037
153
611
2.56
23.72
2.3
1.5
—
—
—
0
0
364
2062
1.91
23.47
7.4
3.1
2.89
3.24
e6/l
0.26
215
984
428
2557
1.84
23.35
10.0
3.5
7.39
7.39
ph
1.80
299
1729
69
175
3.92
23.00
4.1
3.6
2.33
2.61
mmol/l
0.49
63
165
81
231
3.50
22.79
5.1
3.0
397.05
603.37
e6/l
3.25
55
160
613
4100
1.72
22.54
15.1
6.5
—
—
—
0
0
81
236
3.42
22.05
5.2
3.0
145.62
200.64
e6/l
1.90
55
168
706
4928
1.69
22.02
19.4
8.0
—
—
—
0
0
86
263
3.27
21.69
3.1
1.8
—
—
—
0
0
86
263
3.27
21.69
3.1
1.8
—
—
—
0
0
86
264
3.26
21.56
3.1
1.8
—
—
—
0
0
86
264
3.26
21.56
3.1
1.8
—
—
—
0
0
247
1266
2.04
21.06
6.6
3.0
9.03
9.81
g/l
2.15
240
1203
520
3409
1.70
20.01
9.2
3.2
13.14
2.28
estimate
—
7
9
261
1391
1.97
19.86
22.4
6.9
—
—
—
0
0
253
1350
1.96
19.14
3.0
1.5
—
—
—
0
0
228
1178
2.01
18.90
6.5
3.9
0.23
0.22
g/l
0.92
223
1129
579
3954
1.65
18.79
16.4
5.8
37.88
38.04
g/l
0.31
562
3757
542
3642
1.66
18.72
4.9
2.6
—
—
—
0
0
377
2300
1.76
18.56
6.5
2.7
572.63
570.42
mosm/kgh2o
0.06
343
2015
516
3442
1.66
18.23
9.5
3.2
0.19
0.24
e6/l
0.55
385
2433
270
1502
1.88
17.94
4.4
2.2
310.18
367.97
nmol/l
5.30
261
1425
256
1408
1.90
17.59
22.6
7.2
10.17
9.72
kpa
3.70
249
1365
667
4777
1.60
17.49
11.9
4.0
31.01
54.96
e6/l
1.12
436
3027
36
70
5.03
16.74
1.0
1.2
—
—
—
0
0
204
1058
1.98
16.63
2.8
2.4
33.04
29.85
u/l
0.49
169
858
195
998
2.00
16.50
2.8
1.9
1.03
1.12
g/l
0.67
189
952
36
71
4.96
16.48
1.0
1.0
—
—
—
0
0
285
1658
1.80
16.27
23.1
7.0
7.41
7.41
ph
0.18
258
1330
57
162
3.47
16.15
15.3
4.1
5.99
5.60
pmol/l
0.24
57
162
395
2528
1.67
16.01
7.9
2.6
4.83
8.57
e6/l
8.62
359
2247
238
1316
1.87
16.00
2.6
1.9
—
—
—
0
0
285
1667
1.79
15.96
23.2
7.0
5.00
5.04
kpa
0.63
280
1613
86
315
2.72
15.81
4.8
3.0
4.35
5.81
index
0.40
49
187
201
1058
1.95
15.66
2.8
1.9
6.54
7.12
u/l
0.22
136
739
105
427
2.46
15.61
8.6
4.3
199.77
138.28
ng/l
0.55
97
372
36
75
4.70
15.47
3.3
2.7
219.90
156.24
ug/g
0.87
31
68
957
7578
1.56
15.38
11.5
6.3
103.02
92.11
u/l
4.85
926
7179
656
4797
1.55
15.00
31.9
9.0
1.22
1.22
mmol/l
0.22
630
4558
539
3774
1.57
14.94
2.2
1.8
1.29
1.26
mmol/l
0.34
513
3430
546
3836
1.57
14.90
10.2
3.3
20.95
50.27
e6/l
2.32
414
2806
473
3226
1.59
14.61
7.9
3.9
7.47
8.71
mmol/l
6.31
445
2968
68
229
2.94
14.61
1.5
1.3
—
—
—
0
0
701
5252
1.52
14.02
4.6
3.0
—
—
estimate
—
0
0
83
318
2.59
13.98
1.8
1.7
—
23.20
—
0
5
698
5252
1.51
13.51
29.6
8.2
1.22
1.22
mmol/l
0.08
654
4745
719
5449
1.50
13.41
7.0
2.8
72.83
68.86
nmol/l
4.29
697
5198
42
112
3.68
13.11
6.5
4.3
0.62
0.70
index
0.26
42
112
635
4715
1.50
12.94
13.1
6.4
13.33
13.99
umol/l
0.31
614
4403
223
1296
1.76
12.57
2.5
1.5
—
—
—
0
0
843
6662
1.48
12.37
19.6
7.7
0.63
0.66
%
0.68
817
6342
196
1104
1.81
12.27
22.3
10.5
105.46
105.18
mmol/l
0.48
196
1104
85
351
2.40
12.25
2.6
1.7
45.00
79.32
titre
—
6
44
843
6672
1.47
12.21
19.6
7.7
3.04
2.99
%
0.28
816
6353
114
534
2.13
12.19
1.6
1.8
8.46
6.01
iu/ml
0.32
18
100
32
75
4.16
11.93
1.9
2.1
13.67
17.10
nmol/l
—
6
21
218
1281
1.74
11.79
2.7
1.7
12.56
13.04
iu/l
0.08
154
968
51
165
3.04
11.79
2.6
2.3
140.47
126.92
ng/l
0.39
46
156
859
6867
1.46
11.51
18.8
7.4
52.50
52.61
%
0.10
839
6644
841
6698
1.45
11.48
19.7
7.7
8.74
8.25
%
7.42
813
6379
534
3898
1.48
11.48
7.3
3.8
28.90
29.92
u/l
0.48
524
3737
39
110
3.47
11.24
1.9
1.5
—
—
—
0
0
28
63
4.33
11.00
6.9
2.6
-0.47
0.11
mmol/l
0.28
21
53
34
89
3.73
10.93
2.2
2.0
—
—
—
0
0
24
48
4.86
10.84
1.7
1.8
0.38
0.25
iu/ml
0.54
13
33
324
2151
1.57
10.78
7.5
3.8
—
—
—
0
0
26
57
4.44
10.55
1.8
1.6
1.25
1.10
iu/ml
0.17
14
33
866
6997
1.43
10.54
19.3
7.5
32.60
32.86
%
0.30
842
6731
22
42
5.09
10.47
9.2
5.5
—
—
—
0
0
880
7137
1.43
10.45
19.2
7.6
0.03
0.04
e9/l
4.38
765
6076
440
3138
1.49
10.43
5.3
2.7
2.38
2.37
mmol/l
0.44
422
2917
880
7139
1.43
10.42
19.2
7.5
0.55
0.54
e9/l
1.31
764
6077
939
7714
1.43
10.32
21.7
9.5
3.51
3.73
e9/l
2.46
806
6546
24
51
4.58
10.12
2.7
1.9
—
—
—
0
0
900
7355
1.42
10.06
20.8
8.0
0.20
0.20
e9/l
0.35
793
6388
898
7344
1.42
9.94
18.9
7.5
2.07
2.17
e9/l
1.91
802
6442
56
211
2.61
9.82
13.4
3.4
—
—
—
0
0
34
96
3.46
9.81
5.2
6.7
3546.68
86.29
mg/l
0.49
34
90
55
206
2.62
9.76
32.3
14.8
11.19
11.55
%
0.38
55
206
20
22
8.83
9.74
1.9
1.4
5.81
5.03
pmol/l
—
13
8
30
79
3.70
9.59
1.5
1.3
—
—
—
0
0
242
1544
1.60
9.45
2.5
1.6
—
—
—
0
0
87
406
2.12
9.42
1.2
1.2
—
—
—
0
0
20
24
8.10
9.28
3.3
3.2
0.58
0.61
mmol/l
1.40
20
24
48
174
2.70
9.10
2.1
3.1
77.07
83.30
mmol/l
0.36
41
157
809
6557
1.39
9.07
22.6
9.9
0.00
0.00
e9/l
0.71
648
5167
681
5364
1.39
9.06
6.2
3.0
6.36
6.30
ph
0.63
295
2798
480
3562
1.43
8.99
1.9
1.8
—
—
—
0
0
991
8326
1.40
8.86
8.6
4.0
—
2.08
—
0
7
801
6498
1.38
8.84
14.5
5.9
5.85
6.12
mmol/l
4.10
743
5963
457
3379
1.43
8.68
3.8
2.8
2.55
2.46
mg/l
0.44
410
2998
918
7634
1.38
8.60
5.5
3.4
67.84
56.22
ug/l
1.67
901
7326
25
63
3.86
8.51
3.0
3.0
1.13
1.14
umol/l
0.04
25
58
53
209
2.49
8.51
18.2
4.0
95.28
92.30
%
5.99
53
201
43
153
2.75
8.46
1.1
1.3
—
—
—
0
0
44
160
2.69
8.31
1.1
1.3
—
—
—
0
0
339
2394
1.46
8.17
6.2
2.9
2.23
1.11
mg/l
1.55
265
1723
273
1877
1.48
7.49
1.9
1.5
404.44
496.81
titre
0.59
54
326
426
3184
1.39
7.41
3.7
2.3
—
—
—
0
0
1333
11953
1.53
7.37
31.8
14.0
13.24
13.12
%
3.90
1321
11818
330
2375
1.43
7.09
2.0
1.7
—
—
—
0
0
935
7921
1.34
7.05
8.0
3.8
170.53
1062.34
e6/l
0.85
17
83
74
367
1.98
6.87
1.2
1.3
—
5.72
—
0
31
1373
12447
1.54
6.57
17.5
8.9
25.19
24.91
u/l
0.23
1354
12136
104
588
1.75
6.44
6.4
3.2
14.27
7.14
umol/l
1.16
98
471
105
597
1.74
6.37
1.8
1.4
5.79
4.60
ug/l
0.36
94
565
200
1332
1.51
6.37
9.6
4.8
1324.18
757.30
ng/l
1.04
175
1049
10
7
13.80
6.25
4.8
3.0
6.95
7.21
mmol/l
—
10
7
777
6480
1.31
6.18
6.9
3.2
0.00
0.00
estimate
0.50
143
1294
1015
8785
1.32
6.12
5.0
3.9
34.98
36.13
mmol/mol
5.09
981
8418
1098
9629
1.33
5.92
4.7
3.3
1.43
1.44
mmol/l
0.72
1070
9217
782
6551
1.30
5.91
6.9
3.3
0.00
0.00
estimate
0.50
137
1254
42
178
2.30
5.85
1.1
1.3
—
52.03
—
0
11
1346
12206
1.47
5.84
30.6
13.8
334.26
334.16
g/l
0.17
1338
12117
778
6526
1.29
5.77
7.0
3.3
8.79
2.29
estimate
0.33
140
1271
68
349
1.91
5.77
2.9
2.3
—
—
—
0
0
918
7872
1.30
5.73
7.1
3.5
32.26
29.88
u/l
0.39
891
7598
572
4621
1.30
5.60
2.1
1.6
1.76
1.79
g/l
0.17
346
2675
119
727
1.62
5.54
21.7
13.3
-0.85
0.04
mmol/l
1.44
100
592
14
23
5.89
5.50
2.4
2.2
—
—
—
0
0
1103
9721
1.32
5.46
4.9
3.4
4.45
4.53
mmol/l
2.57
1083
9345
1102
9713
1.32
5.44
5.0
3.5
2.65
2.72
mmol/l
1.98
1074
9294
307
2276
1.37
5.42
1.8
1.5
20.69
19.47
nmol/l
0.89
286
2053
217
1517
1.44
5.39
4.3
3.2
655.39
785.35
ng/l
0.25
125
777
119
736
1.60
5.28
21.8
13.2
7.42
7.40
ph
1.12
44
321
75
411
1.79
5.21
1.5
1.3
—
—
—
0
0
1278
11538
1.37
5.17
28.4
10.9
139.53
139.49
mmol/l
0.29
1258
11249
48
227
2.06
5.15
5.8
3.8
3.52
3.73
e9/l
0.33
48
227
202
1406
1.44
5.14
1.2
1.2
—
46.05
—
0
8
143
931
1.52
5.08
1.6
1.5
—
—
—
0
0
1374
12571
1.46
5.04
23.5
10.6
66.52
63.73
umol/l
2.02
1362
12391
167
1128
1.47
4.97
1.2
1.2
—
—
—
0
0
406
3183
1.31
4.85
7.5
5.9
1.15
1.10
inr
1.26
329
2646
1276
11545
1.36
4.85
28.8
10.9
3.92
3.90
mmol/l
2.37
1253
11207
151
1007
1.49
4.79
2.7
2.2
9.78
9.75
nmol/l
0.01
138
929
39
177
2.15
4.67
14.1
4.2
1.37
1.97
mmol/l
0.84
19
100
26
99
2.55
4.60
1.3
1.2
112.08
121.90
pmol/l
0.41
26
99
277
2076
1.34
4.51
1.3
1.3
—
—
—
0
0
102
633
1.59
4.50
1.6
1.2
—
—
—
0
0
87
523
1.63
4.37
1.7
1.4
—
—
—
0
0
17
53
3.10
4.31
1.9
3.2
13.58
25.09
mg/l
—
9
25
42
204
2.01
4.24
1.1
1.2
—
—
—
0
0
17
54
3.05
4.18
1.8
1.2
—
—
—
0
0
17
54
3.05
4.18
1.8
1.2
—
—
—
0
0
17
54
3.05
4.18
1.8
1.2
—
—
—
0
0
128
850
1.49
4.17
7.8
4.9
0.54
0.48
%
0.17
61
221
497
4063
1.26
4.15
2.0
1.9
—
—
—
0
0
1010
8930
1.25
4.14
4.3
3.0
1.18
1.14
mmol/l
1.10
979
8527
203
1475
1.37
4.03
1.8
1.6
—
—
—
0
0
76
452
1.65
4.01
1.7
1.5
0.26
0.37
nmol/l
1.25
62
379
338
2654
1.29
3.90
4.0
3.1
111.36
88.45
ug/g
0.46
295
2121
51
273
1.82
3.90
2.2
1.8
—
—
—
0
0
162
1140
1.41
3.89
1.4
1.3
—
—
—
0
0
572
4789
1.23
3.78
1.8
1.8
—
—
—
0
0
47
249
1.84
3.72
1.4
1.4
2.42
3.95
u/ml
1.53
26
132
14
43
3.15
3.65
1.5
1.5
111.50
91.28
nmol/l
—
8
32
38
191
1.93
3.54
2.4
2.5
—
—
—
0
0
49
268
1.78
3.52
5.4
2.3
130.05
135.12
g/l
1.04
42
234
20
77
2.51
3.51
2.6
2.3
37.40
44.07
%
0.71
11
33
63
373
1.65
3.42
1.3
1.2
—
—
—
0
0
128
887
1.42
3.38
8.7
5.6
0.05
0.06
%
0.04
57
195
616
5244
1.21
3.36
2.5
2.3
—
—
—
0
0
191
1417
1.34
3.33
1.8
1.4
211.16
363.83
u/ml
1.23
177
1327
179
1316
1.35
3.31
2.3
2.0
—
—
—
0
0
128
892
1.41
3.28
8.7
5.2
0.63
0.65
%
0.03
62
233
43
233
1.80
3.21
4.8
2.7
—
—
—
0
0
1047
9429
1.21
2.99
3.5
3.1
5.36
5.46
mmol/l
2.42
1003
8883
18
72
2.42
2.95
1.5
1.3
—
—
—
0
0
106
730
1.42
2.93
1.3
1.2
—
—
—
0
0
184
1386
1.31
2.90
2.8
2.8
4.06
4.68
e9/l
1.11
171
1263
1363
12644
1.31
2.86
22.6
10.7
21.28
21.10
mg/l
0.07
1079
9487
433
3611
1.21
2.83
1.9
1.7
101.46
97.05
pmol/l
1.27
216
2003
33
173
1.85
2.77
1.6
1.4
248.75
232.50
titre
—
8
36
224
1744
1.27
2.75
5.3
3.9
109.51
73.35
mg/l
0.76
173
1291
1499
14144
1.65
2.73
33.1
16.6
265.11
267.22
e9/l
0.60
1467
13731
37
204
1.76
2.66
1.4
1.4
0.39
0.35
g/l
0.30
31
170
1499
14150
1.64
2.64
35.7
17.3
39.59
40.73
%
2.21
1490
14025
1499
14150
1.64
2.64
33.0
16.5
29.53
29.48
pg
0.48
1490
14031
1499
14151
1.63
2.62
33.0
16.5
4.53
4.59
e12/l
6.07
1465
13710
9
24
3.62
2.56
6.1
2.1
164.00
85.78
ng/l
—
9
24
1499
14156
1.62
2.55
33.6
16.7
132.72
134.74
g/l
6.84
1491
14039
1499
14159
1.61
2.50
33.1
16.6
6.69
6.78
e9/l
0.86
1463
13712
16
67
2.31
2.41
1.4
2.0
2223.13
1924.99
ml
0.39
16
67
287
2337
1.22
2.36
3.5
2.2
297.56
263.78
u/l
0.14
279
2249
62
403
1.50
2.35
6.2
2.7
—
—
—
0
0
19
87
2.11
2.34
1.1
1.1
218.83
308.76
u/ml
—
6
25
1497
14147
1.57
2.34
33.1
16.5
88.03
87.95
fl
0.27
1488
14028
10
32
3.01
2.32
5.2
2.6
8.40
9.53
%
—
10
32
5
8
6.02
2.30
2.4
2.3
—
—
—
0
0
50
312
1.56
2.29
2.2
1.6
0.53
0.72
g/l
0.94
42
268
35
202
1.68
2.19
1.5
1.4
—
—
—
0
0
14
58
2.33
2.18
14.3
3.9
5.04
5.03
kpa
0.00
14
58
342
2856
1.19
2.16
3.8
2.7
58.23
58.35
u/l
0.01
333
2682
117
865
1.32
2.15
9.1
5.3
0.37
0.06
%
0.41
52
205
5
9
5.35
2.14
1.2
2.4
—
—
—
0
0
16
71
2.18
2.14
1.7
1.3
—
—
—
0
0
21
104
1.95
2.13
5.1
4.1
3.12
3.23
%
—
9
39
31
176
1.71
2.07
3.3
1.8
2.41
1.98
ug/l
0.12
26
156
10
36
2.68
2.03
5.3
2.4
30.80
29.64
%
—
10
36
19
93
1.97
2.00
1.6
2.7
1243.84
817.65
u/ml
0.70
19
93
6
15
3.85
1.96
1.5
1.0
—
—
—
0
0
65
444
1.42
1.96
5.7
2.8
53.07
55.26
%
0.60
65
444
7
21
3.21
1.88
1.0
1.1
—
—
—
0
0
44
283
1.51
1.81
8.3
3.3
—
—
—
0
0
7
22
3.07
1.80
5.3
3.4
4.63
4.54
mmol/l
—
7
22
23
126
1.77
1.76
1.3
1.1
—
—
—
0
0
114
868
1.28
1.73
1.5
1.6
—
—
—
0
0
167
1330
1.23
1.73
2.5
2.0
2.41
2.41
mmol/l
0.04
153
1152
214
1750
1.20
1.71
5.9
4.5
17.70
9.29
mg/mmol
1.59
163
1269
1378
12928
1.23
1.70
14.3
8.8
—
—
—
0
0
109
835
1.27
1.60
1.4
1.5
1.28
1.25
mm
0.37
92
613
40
260
1.49
1.60
3.9
5.6
—
—
—
0
0
14
67
2.02
1.59
18.6
4.1
—
—
—
0
0
111
853
1.27
1.59
1.5
1.5
—
—
—
0
0
580
5150
1.13
1.56
1.7
1.7
4.16
2.32
u/ml
0.79
104
1187
12
56
2.07
1.46
4.6
2.4
152.58
219.79
e6/l
0.71
12
56
45
308
1.42
1.41
1.3
1.4
349.28
343.48
ug/g
0.06
25
165
17
92
1.78
1.39
2.6
1.9
32.18
32.54
pg
0.13
17
92
54
385
1.36
1.35
2.2
2.0
17.29
6.84
ug/l
1.46
43
337
23
138
1.61
1.33
1.2
1.2
1.11
0.63
ratio
0.70
11
75
9
41
2.12
1.31
1.3
1.3
140.33
143.20
nmol/l
—
9
41
17
94
1.75
1.31
2.1
1.6
16.93
15.27
u/l
0.07
17
84
58
424
1.33
1.25
6.7
2.6
403.61
282.75
e6/l
0.18
41
307
61
450
1.31
1.24
6.4
2.5
449.02
399.07
mg/l
0.14
61
438
9
43
2.02
1.24
1.7
3.7
46.00
66.84
u/l
—
9
43
14
75
1.80
1.20
1.9
1.5
0.99
0.86
%
—
8
27
62
461
1.30
1.20
1.1
1.1
—
—
—
0
0
108
861
1.22
1.17
1.3
1.2
36.77
29.52
au/ml
—
6
35
11
55
1.93
1.15
3.3
2.2
23.91
46.22
%
2.44
11
55
11
55
1.93
1.15
6.5
4.5
11.45
7.78
%
0.55
11
55
57
422
1.31
1.14
6.8
2.6
5.46
14.59
e6/l
0.78
39
292
102
812
1.22
1.13
1.3
1.2
—
—
—
0
0
116
936
1.21
1.12
2.3
2.2
13.75
14.70
au/ml
0.10
11
98
28
184
1.47
1.12
1.0
1.0
3.53
3.30
kpa
0.40
23
152
7
29
2.32
1.12
1.6
1.6
—
—
—
0
0
137
1124
1.19
1.11
1.5
1.6
72.62
59.21
ug/l
1.92
125
972
230
2473
0.87
1.10
2.7
2.5
61.60
83.62
ng/l
0.19
102
976
10
50
1.93
1.05
1.5
1.4
—
—
—
0
0
28
187
1.45
1.05
1.0
1.0
7.07
7.41
kpa
0.36
23
155
28
187
1.45
1.05
1.0
1.0
—
—
—
0
0
9
44
1.97
1.04
2.9
2.3
1.25
1.19
mmol/l
—
9
44
1222
11456
1.12
1.03
5.3
4.9
1.83
1.83
mu/l
0.02
1184
10982
7
33
2.04
1.01
1.6
1.6
—
—
—
0
0
21
133
1.52
1.01
1.1
1.2
—
—
—
0
0
11
58
1.83
1.00
1.1
1.2
—
—
—
0
0
20
286
0.67
1.00
1.7
1.7
8.06
7.57
mmol/l
0.52
20
277
9
46
1.88
1.00
2.9
2.3
106.67
105.59
mmol/l
—
9
46
147
1227
1.17
0.99
1.5
1.6
277.74
320.66
mu/l
1.84
138
1116
7
34
1.98
0.98
2.4
2.7
600.00
537.29
ml
—
7
24
13
73
1.72
0.98
1.2
1.2
—
—
—
0
0
0
29
0.00
0.97
0.0
1.1
—
—
—
0
0
9
48
1.81
0.96
2.9
2.2
4.44
3.86
mmol/l
—
9
48
12
189
0.61
0.93
1.9
1.6
7.07
6.71
mmol/l
0.22
12
174
18
113
1.54
0.91
1.4
1.3
—
—
—
0
0
25
169
1.43
0.90
1.8
1.3
4.17
11.63
u/ml
1.56
17
120
14
83
1.63
0.89
1.0
1.0
161.57
163.66
g/l
0.12
14
83
26
178
1.41
0.88
1.4
1.6
0.48
0.50
e9/l
0.16
26
178
45
340
1.28
0.83
1.2
1.4
6.11
3.39
u/ml
0.41
24
214
30
383
0.75
0.82
2.0
2.5
1.50
0.59
nmol/l
1.24
25
339
0
24
0.00
0.79
0.0
1.5
—
13.28
—
0
24
9
53
1.64
0.73
1.2
1.5
29.89
27.26
s
—
9
53
7
37
1.82
0.73
1.3
1.3
—
—
—
0
0
46
356
1.25
0.72
1.2
1.2
—
—
—
0
0
1092
10246
1.08
0.72
4.5
4.3
14.44
14.34
pmol/l
0.75
1024
9494
9
54
1.60
0.72
1.2
1.0
—
—
—
0
0
163
1409
1.12
0.71
1.3
1.3
983.75
147.65
titre
—
8
55
49
384
1.23
0.70
2.9
2.3
0.49
0.65
ug/l
1.39
24
168
16
218
0.70
0.68
1.3
1.2
—
—
—
0
0
53
421
1.22
0.67
7.0
2.5
3.24
3.42
mmol/l
1.56
53
403
7
43
1.57
0.64
1.0
1.0
—
—
—
0
0
8
47
1.64
0.62
1.9
1.3
0.00
0.00
estimate
—
8
47
19
246
0.74
0.61
10.7
7.9
—
—
—
0
0
8
48
1.60
0.61
2.4
2.4
98.88
98.31
g/l
—
8
48
67
749
0.85
0.61
1.4
1.5
—
—
—
0
0
165
1444
1.11
0.60
1.3
1.5
498.10
32012861.31
pmol/l
1.54
152
1287
0
20
0.00
0.60
0.0
3.8
—
0.49
—
0
20
0
21
0.00
0.59
0.0
1.9
—
—
—
0
0
10
145
0.66
0.59
1.0
1.3
0.89
10.50
u/ml
—
10
132
12
77
1.50
0.59
2.9
2.4
17.97
16.13
umol/l
0.27
12
77
134
1424
0.89
0.59
1.3
1.2
—
—
—
0
0
6
33
1.75
0.58
2.7
2.7
556.17
540.08
min
—
6
24
105
898
1.13
0.57
1.3
1.5
1013.62
1141.83
nmol/l
0.77
81
705
58
474
1.18
0.57
1.7
1.7
6.51
4.43
u/ml
0.25
13
120
15
102
1.42
0.57
3.2
1.9
—
—
—
0
0
8
117
0.66
0.55
1.0
1.1
1609.75
1374.58
miu/ml
—
8
117
13
175
0.71
0.54
1.0
1.0
—
—
—
0
0
63
697
0.86
0.52
1.0
1.1
7.81
6.65
u/ml
0.14
40
442
341
3105
1.07
0.52
5.5
2.9
6.06
2.06
kg/l
0.36
200
1957
14
96
1.40
0.51
5.4
3.7
11.36
10.64
mg/l
0.19
14
84
17
216
0.75
0.50
3.4
2.9
27.06
24.82
mg/l
0.10
12
147
422
3874
1.06
0.50
2.0
2.0
—
—
—
0
0
50
560
0.85
0.49
1.1
1.1
2.66
10.27
eliau/ml
—
8
78
34
271
1.21
0.46
1.1
1.1
—
—
—
0
0
40
325
1.19
0.45
1.2
1.5
5.83
10.60
u/ml
0.36
19
187
9
123
0.70
0.43
19.3
12.6
0.79
0.59
mmol/l
—
9
118
8
53
1.45
0.43
1.0
1.9
—
—
—
0
0
14
177
0.76
0.42
2.8
2.5
3.22
4.78
u/ml
—
5
73
138
1432
0.92
0.41
1.3
1.3
125.35
148.84
u/ml
0.25
41
499
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
0
15
0.00
0.41
0.0
1.1
—
55.00
—
0
8
10
133
0.72
0.41
1.6
1.3
—
4.76
—
0
5
0
16
0.00
0.41
0.0
1.1
—
0.63
—
0
11
18
135
1.28
0.41
1.4
1.2
—
—
—
0
0
8
57
1.35
0.40
1.4
1.2
—
—
—
0
0
50
549
0.87
0.40
1.2
1.1
0.45
0.59
ratio
—
6
42
87
756
1.11
0.40
1.1
1.1
—
—
—
0
0
59
501
1.14
0.40
1.4
1.2
—
—
—
0
0
59
502
1.13
0.39
1.4
1.2
—
—
—
0
0
88
927
0.91
0.37
1.1
1.2
4.32
3.31
u/ml
0.16
63
628
32
361
0.85
0.37
1.1
1.1
3.33
4.78
eliau/ml
0.34
13
131
43
359
1.16
0.37
3.0
4.2
2.00
6.68
ug/l
1.78
28
239
30
243
1.19
0.36
1.5
2.0
—
—
—
0
0
224
2040
1.06
0.36
1.3
1.3
23.90
21.22
iu/ml
0.15
56
484
107
947
1.09
0.36
3.2
3.6
4.86
4.89
pmol/l
0.14
100
880
137
1411
0.93
0.36
2.0
2.1
—
—
—
0
0
5
75
0.64
0.35
1.0
1.1
—
0.19
—
0
14
16
121
1.27
0.35
3.5
2.6
—
—
—
0
0
22
255
0.83
0.34
1.4
1.4
179.86
112.46
pmol/l
0.30
22
241
40
335
1.15
0.34
1.4
1.2
190.13
193.55
iu/ml
—
8
101
89
929
0.92
0.32
1.2
1.2
0.78
1.16
u/ml
0.59
60
587
125
1283
0.93
0.31
1.4
1.4
3.34
3.27
mmol/l
0.33
76
796
15
115
1.26
0.30
2.2
1.6
5.82
5.40
ug/l
0.09
15
106
56
485
1.11
0.30
2.7
1.8
0.00
0.00
estimate
0.50
24
206
178
1801
0.94
0.29
2.0
2.0
—
—
—
0
0
33
276
1.15
0.29
1.1
1.2
0.80
2.60
u/ml
0.90
18
156
135
1220
1.07
0.29
1.7
1.4
—
—
—
0
0
175
1770
0.94
0.29
2.9
2.4
7008.80
7641.98
u/l
0.09
62
654
101
906
1.08
0.27
1.5
1.4
—
—
—
0
0
65
573
1.09
0.26
5.8
3.8
7.39
7.32
ph
1.30
47
420
29
243
1.15
0.26
1.0
1.0
8.98
9.33
mu/l
0.12
23
201
50
435
1.11
0.26
1.7
1.6
—
—
—
0
0
62
648
0.92
0.25
1.0
1.1
9.72
9.68
u/ml
0.00
36
383
16
127
1.21
0.25
1.1
1.1
—
—
—
0
0
38
326
1.12
0.25
1.7
1.6
396.38
355.84
mu/l
0.28
32
268
313
3105
0.96
0.25
9.8
4.3
—
—
—
0
0
33
281
1.13
0.24
1.6
1.4
20.30
12.13
u/l
0.71
28
247
5
36
1.34
0.23
2.6
2.1
2648.00
1932.92
ml
—
5
36
93
950
0.94
0.22
1.2
1.2
4.56
6.76
u/ml
0.60
65
668
7
89
0.75
0.22
1.1
1.1
383.00
196.69
iu/ml
—
7
89
162
1626
0.95
0.22
1.6
1.6
3.42
3.32
ratio
0.41
106
1111
169
1694
0.95
0.22
2.0
2.0
—
—
—
0
0
10
76
1.27
0.22
1.3
1.3
1.71
1.23
nmol/l
—
10
68
0
10
0.00
0.21
0.0
2.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.4
—
47.60
—
0
10
0
10
0.00
0.21
0.0
2.5
—
—
—
0
0
0
11
0.00
0.21
0.0
1.2
—
1.40
—
0
11
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
106
964
1.06
0.21
2.5
1.8
0.00
0.03
estimate
1.05
34
261
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
0
14
0.00
0.20
0.0
1.4
—
16.08
—
0
14
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
12
95
1.22
0.19
2.1
6.2
330.40
164.34
umol/l
—
5
59
429
4209
0.97
0.19
2.2
2.2
—
—
—
0
0
6
50
1.15
0.19
2.3
1.4
139.50
88.72
nmol/24h
—
6
50
12
96
1.20
0.18
3.8
3.4
—
—
—
0
0
182
1809
0.96
0.17
1.9
2.0
—
—
—
0
0
26
224
1.12
0.17
1.2
1.3
2.47
19.91
u/ml
0.98
16
180
23
197
1.12
0.17
1.1
2.3
—
—
—
0
0
59
604
0.94
0.17
1.0
1.1
0.33
0.73
u/ml
0.58
30
272
103
1035
0.95
0.16
1.3
1.2
1.85
3.05
u/ml
1.09
72
690
44
453
0.93
0.15
2.3
2.2
2.43
3.88
iu/l
1.67
20
205
347
3270
1.03
0.14
7.5
3.2
0.00
0.00
estimate
1.08
134
1239
20
213
0.90
0.13
1.3
1.4
23.54
13.27
u/ml
0.29
15
169
31
275
1.08
0.13
1.1
1.1
—
—
—
0
0
12
132
0.87
0.12
3.1
4.0
3.67
3.85
mmol/l
0.51
12
132
183
1797
0.98
0.10
1.9
1.9
—
—
—
0
0
10
110
0.87
0.10
1.1
1.2
—
—
—
0
0
185
1815
0.98
0.10
1.9
2.0
—
—
—
0
0
5
44
1.09
0.09
1.4
1.2
—
—
—
0
0
6
53
1.09
0.09
9.7
4.3
—
—
—
0
0
8
75
1.02
0.07
2.0
3.0
3.84
2.18
nmol/l
—
8
75
155
1463
1.02
0.07
2.0
2.1
—
—
—
0
0
8
91
0.84
0.06
1.9
1.7
6.24
5.55
mmol/l
—
8
79
11
95
1.11
0.06
4.1
2.2
—
—
—
0
0
9
98
0.88
0.06
1.1
1.2
—
—
—
0
0
15
133
1.08
0.06
2.1
1.9
26.20
29.43
mg/l
—
10
79
97
952
0.98
0.06
2.4
2.0
6.28
6.30
ph
0.07
66
606
486
4702
0.99
0.06
6.1
2.9
0.05
0.01
estimate
0.52
121
1062
13
116
1.08
0.04
1.0
1.1
19.39
33.92
iu/ml
0.91
13
116
20
202
0.95
0.04
1.6
2.2
291.93
291.50
mosm/kgh2o
0.03
14
157
33
328
0.97
0.04
1.1
1.1
4.75
5.73
iu/ml
0.18
11
60
136
1291
1.01
0.03
2.4
2.5
—
—
—
0
0
14
127
1.06
0.02
1.1
1.1
—
—
—
0
0
105
1020
0.99
0.02
8.2
3.2
—
—
—
0
0
10
103
0.93
0.02
1.8
1.4
—
—
nmol/l
—
0
0
24
223
1.03
0.02
1.1
1.1
—
—
—
0
0
218
2086
1.00
0.01
1.6
1.6
975.63
976.43
mu/l
0.00
203
1827
20
186
1.03
0.01
1.1
1.1
—
—
—
0
0
10
101
0.95
0.00
1.6
1.7
—
—
—
0
0
30
288
1.00
0.00
1.1
1.1
11.00
16.34
u/ml
—
10
80
85
814
1.00
0.00
2.6
2.6
—
—
—
0
0
45
431
1.00
0.00
1.2
1.1
—
—
—
0
0
76
729
1.00
0.00
1.6
1.6
0.21
0.21
mg/l
0.01
29
292
33
318
1.00
0.00
1.2
1.2
—
—
—
0
0
60
576
1.00
0.00
1.2
1.1
9.56
18.87
au/ml
—
10
95
378
3631
1.00
0.00
5.8
2.6
0.03
0.01
estimate
0.44
118
1064
193
1857
1.00
0.00
1.3
1.3
2.77
6.92
u/ml
1.95
68
679
96
920
1.00
0.00
1.3
1.3
179.40
237.96
miu/ml
0.94
42
462
0
6
0.00
0.00
0.0
3.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
5
54
0.89
0.00
1.2
1.2
—
20.86
—
0
7
0
6
0.00
0.00
0.0
3.0
—
41.50
—
0
6
0
6
0.00
0.00
0.0
1.3
—
28.83
—
0
6
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.8
—
551.20
—
0
5
0
7
0.00
-0.00
0.0
3.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.9
—
1.69
—
0
7
8
78
0.99
-0.00
1.0
1.1
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
0.07
—
0
8
5
53
0.91
-0.00
1.0
1.3
116.40
152.11
mmol/24h
—
5
53
0
8
0.00
-0.00
0.0
1.9
—
269.38
—
0
8
0
5
0.00
-0.00
0.0
3.8
—
7.14
—
0
5
6
57
1.01
-0.00
1.2
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
4.0
—
—
—
0
0
5
55
0.87
-0.00
1.2
1.0
—
15.96
—
0
14
0
8
0.00
-0.00
0.0
8.8
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.0
—
161.60
—
0
5
0
5
0.00
-0.00
0.0
1.4
—
2.34
—
0
5
0
5
0.00
-0.00
0.0
1.4
—
21.84
—
0
5

Mortality – FinRegistry

↥

Association

Association between endpoint K11_HYPOPLASIA_ENAMEL_INCLAVO and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have K11_HYPOPLASIA_ENAMEL_INCLAVO.

N-year risk Females Males
1 No data No data
5 No data No data
10 No data No data
15 No data No data
20 No data No data

Relationships between endpoints

↥

Index endpoint: K11_HYPOPLASIA_ENAMEL_INCLAVO – Hypoplasia of dental enamel , including avohilmo

GWS hits: 1

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data